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Abstract
Ionizing radiation is a health hazard to humans, but is exploited at the same time in various
applications, in particular in diagnostic and therapeutic medicine. A profound understanding of
the underlying processes, starting from the physical energy deposit up to the biological radiation
response, is the basis for a reliable prediction of radiation effects. The subject of this work is the
formulation of predictive dose response models.
Special emphasis is set on two aspects, namely the prediction of radiation effects as well as
their uncertainties: First, the dependence of radiation effects on physical properties like particle
type and energy of the radiation used is discussed. The physical characterization of radiation
to which cells or tissues are exposed to is one of the most important determining factors for
the effect. Particularly the spatial and temporal pattern of radiation damage induction have to
be considered: High ionization densities give rise to clustering of lesions to the DNA, and such
complex DNA damage is most critical for the fate of individual cells. Based on experimental
findings and theoretic considerations, strategies are developed on how to implement the com-
plex involved physical and biological processes into mathematical models. Such models must be
sufficiently simple, testable against experimental data, and practical for application purposes.
A set of requirements for radiation effect models has been identified, which is proposed as a
list of general criteria for successful models in radiobiology. Based on these requirements, a
comprehensive radiobiological model framework for the prediction of radiation damage is in-
troduced. The model applicability to many different aspects of radiobiology is demonstrated,
based on one consistent set of concepts, strongly supporting the model assumptions. Second, in
addition to effect predictions, strategies to assess the corresponding uncertainties are discussed
theoretically and at hand of experimental data. The variability of biological targets as well as
errors inferred by model applications are regarded side by side. This is of importance, e.g., for
evaluating the accuracy of treatment planning in radiation therapy of cancer.
The developed model framework is put in perspective of current radiobiologic research. The
core of the work are six research publications, focusing on various aspects in effect modeling
for different radiation qualities. They cover strategies of model set-up and benchmarking using
experimental data, as well as aspects of effect uncertainty estimates.
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Zusammenfassung
Ionisierende Strahlung stellt ein Gesundheitsrisiko für den Menschen dar, wird aber gleichzeitig
in verschiedenen Anwendungsbereichen wie zum Beispiel der diagnostischen und therapeutis-
chen Medizin genutzt. Ein tiefgreifendes Verständnis der zugrunde liegenden Prozesse von
der physikalischen Energiedeposition bis hin zur biologischen Strahlenantwort ist die Grund-
lage für eine verlässliche Vorhersage von Strahlenwirkungen. Das Thema dieser Arbeit ist die
Formulierung von prädiktiven Dosis-Wirkungs-Modellen.
Einen Schwerpunkt bilden die beiden Aspekte der Vorhersage von Strahlenwirkungen sowie
deren Unsicherheiten. Zunächst wird die Abhängigkeit der Strahlenwirkung von der Strahle-
nart und der Energie diskutiert. Die physikalische Charakterisierung der Strahlung, der
Zellen oder Gewebe ausgesetzt sind, ist einer der wichtigsten bestimmenden Faktoren für
die Wirkung. Besonders berücksichtigt werden die räumlichen und zeitlichen Muster der in-
duzierten Schäden: Hohe Ionisationsdichten führen zur Clusterung von Schäden an der DNA.
Sich so formierende komplexe DNA Schäden bestimmen maßgeblich das weitere Schicksal der
bestrahlten Zellen. Basierend auf experimentellen Befunden und theoretischen Überlegungen
werden Strategien entwickelt, wie die beteiligten physikalischen und biologischen Prozesse in
mathematische Modelle implementiert werden können. Solche Modelle müssen hinreichend
einfach, an experimentellen Daten verifizierbar und praktisch für Anwendungszwecke sein.
Eine Reihe von Anforderungen für Strahleneffektmodelle wurde zusammengetragen, die als
eine generelle Aufstellung von Kriterien für erfolgreiche Modelle in Radiobiologie vorgeschla-
gen wird. Auf der Grundlage dieser Anforderungen wird ein konsistentes radiobiologisches
Modellgebäude zur Vorhersage der Strahlenwirkung vorgestellt. Die Anwendbarkeit des Mod-
ells auf viele verschiedene Aspekte der Radiobiologie wird auf der Basis eines einheitlichen
Satzes von Konzepten und Parametern gezeigt, die nachdrücklich die Modellannahmen unter-
stützen. Den Zweiten Hauptaspekt der Arbeit bildet die Entwicklung von Methoden, um die
entsprechenden Unsicherheiten zu beurteilen. Diese Unsicherheiten werden theoretisch sowie
durch die Untersuchung experimenteller Daten quantifiziert. Die Variabilität biologischer Sys-
teme in ihrer Reaktion auf Strahlung sowie die durch die Modellannahmen eingebrachten Fehler
werden nebeneinander betrachtet. Dies ist beispielsweise für die Bewertung von Unsicherheiten
bei der Bestrahlungsplanung in der Krebstherapie von Bedeutung.
Die entwickelten Modellkonzepte werden in den Rahmen aktueller strahlenbiologischer
Forschung gestellt. Der Kern der Arbeit besteht aus sechs Publikationen, die sich auf eine
Reihe von Aspekten der Effektmodellierung für verschiedene Strahlenqualitäten konzentrieren.
Sie decken Strategien der Modellformulierung, deren Validierung durch experimentelle Daten
sowie Abschätzung verbundener Unsicherheiten ab.
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1 Introduction
1.1 Motivation
Ionizing radiation is a part of nature. It occurs in space as cosmic radiation and on earth as
terrestrial radiation. Ionizing radiation is exploited in various ways by mankind in scientific,
industrial and medical applications. Examples are accelerator-driven research, material testing
and diagnostic and therapeutic methods of radiology, respectively.
Energetic photons like X-rays or γ-rays and massive charged particles like electrons or ions
deliver energy to a target, giving rise to energy deposition by excitations and ionizations in the
target material. When interacting with biologic target material ionizing radiation is therefore
able to inflict damage to the cells and tissue on the molecular level [1,2]. This might be harmful,
but also beneficial in some situations. Knowledge about the consequences of ionizing radiation
and underpinning mechanisms facilitates to prevent from unwanted radiation exposures or to
mitigate the associated effects. Likewise, radiation can be delivered on purpose and its biologic
effects may be exploited. For all that, a proper quantification of radiation effects is needed.
In particular mathematical modeling of radiation is a fruitful approach to a predictive quan-
tification of radiation action and the associated damage. The underlying model assumptions
may be verified or falsified by testing such models against measured data of radiation damage.
Predictive modeling of radiation effects has large impact and relevance for different fields of
application and research:
• Radiation cancer therapy: Cancer is one of the leading mortality reasons ranks as the
second most mortal disease worldwide after heart diseases [3]. For solid tumors, radia-
tion therapy is besides surgery and chemotherapy the most important therapeutic strategy.
The aim is to inactivate tumor cells by irradiation of the tumor tissue, while sparing the
surrounding healthy tissue as good as possible [4]. Conventionally this is done by ir-
radiation with photon radiation. Typically 60Co was used as radiation source in earlier
times, while nowadays high energetic (MV) synchrotron radiation is delivered from small
electron linear accelerators. Convenient beam delivery techniques like irradiation from
various angles to the tumor and a shaping of the beam contours optimize this method.
Clearly, an understanding of how tumor conformity, the dose coverage of healthy tissue
and various other factors affect the control of the tumor (i.e. the growth prevention) and
the side effects in the normal tissue is mandatory. In particular novel promising forms of
treatments with protons and heavier ions (typically carbon) emerged, primarily driven by
their favorable physical properties for therapy [5–7]. Carbon ion therapy was promoted at
GSI during a pilot project in 1997 - 2008 [8–10]. Currently, dedicated clinics for particle
therapy are raised all over the world [11]. As charged particles carry an enhanced effect
as compared to comparable doses of conventional photon radiation, again the question
for the dose-effect relation arises. In turn, to plan a patient specific irradiation treatment,
the prediction of the radiation effects are needed. Mathematical effect modeling facili-
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tates a safe treatment planning considering the physical and biological aspects of radiation
effectiveness.
• Radiation protection on earth and in space: Exposure of the human body to ionizing
radiation bears a potential to induce cancer as a late effect, e.g. typically occurring years
after exposure [12]. This is important to be considered in e.g. in medical diagnostics
with X-ray computer tomography (CT) scans [13,14], for occupational exposures [15,16],
but also in radiation therapy [17] to minimize side effects. For space travelers, e.g. on
a planned Mars mission, radiation exposure by the cosmic galactic radiation and the ra-
diation delivered by the sun is a hazard with a mortality risk to the astronauts [18, 19].
The carcinogenic potential is particularly relevant for lower doses where the received dose
is not large enough to cause cell death, which is regarded as a self-protecting mechanism
of organisms against the development of cancer. The relation between dose (and possibly
dose rate) and the enhanced risk to develop cancer is derived from epidemiological stud-
ies and interpreted in terms of appropriate models [20]. Again, the dose-effect relation,
accounting for the radiation and biologic factors for radio response, is a key aspect to be
considered.
• Other therapy modalities using radiation: In medicine also different forms of radiation-
involved therapies for non-tumor diseases have been established [21]. For instance, high
doses of very small radiation beams are given to treat arteriovascular malformations. More-
over the treatment of artrial fibrillation with radiation beams is possible [22]. In these
cases tissue degradation by high doses of ionizing radiation is exploited. On the other
hand, low doses of α radiation are known to show anti-inflammatory effects, which is why
patients with rheumatic diseases benefit from radon inhalation [23]. Suspiciously a close
interference of the radiation action with the immune system plays a role. To understand
and predict these effects and related side effects, modeling will be needed.
• Radiation as research tool in cell biology: The induction of damage to cells on the
molecular level and the observation of subsequent processes can be used in radiobiology
to learn about these processes. It is clear by now that after the initial damage induction
to the DNA, which is considered to be the most radio-sensitive site of the cell contained in
the cell nucleus, cells attempt to repair the damage, which exploits complicated pathways
involving cascades of proteins. Finally, harmed cells either have their damage repaired
successfully, have persistent but viable damage, or enter a form of cell death [1, 2]. To
explore the mechanism of DNA repair, radiation is frequently used as a damaging agent
[24]. Mathematical models of radiation effects have to explicitly or implicitly reflect these
processes, and a joint consideration of experimental studies and model assumptions helps
to confirm or reject hypotheses about how cells react to radiation.
Summarizing, quantitative modeling of radiation damage is an inherent part of research in ra-
diation biophysics with a strong impact to radiation protection and medical applications. Many
models aiming at different aspects of radiation damage and / or processing have been devel-
oped throughout the last decades and find applications in the related disciplines. However, as
the physical processes, namely the interaction of radiation with matter, as well as the biological
processes, namely damage induction and processing, are very complex, up to now still many ba-
sic questions remain unsolved and an comprehensive understanding of all processes is lacking.
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Consequently models have to restrict to essential parts, allowing for reasonable predictions. The
exploitation of model limits and associated uncertainties is therefore of great importance.
1.2 Objective
The basic problem in modeling radiation effects is that both the interaction processes of radi-
ation with biologic matter and the subsequent damage processing are highly complex. Thus
the observed dose response is a product of this complexity, which has to be reflected in proper
modeling. Different approaches to tackle this problem have been developed, but most of them
are limited either in predictive power or applicability to different endpoints, i.e. biological ob-
servable such as cell kill or skin reddening. A sound modeling, however, should provide reliable
predictions for a wide span of situations varying in the radiation quality used or the cells or tis-
sue under investigation. Moreover, if it reflects reality a transition between different endpoints
should be possible within the same model framework.
The objective of this work is to argue on a very general level which modeling strategies are
promising or even mandatory for successful predictive modeling of radiation effects. In par-
ticular the decision between explicit (mechanistic) or implicit (empiric) simulation of complex
processes but also the choice of relevant scales of radiation damage and damage repair play
a role in this context. A balance of detail level included and the overall model simplicity is a
further aspect to be considered.
Besides point predictions, also associated uncertainties of such modeling have to be quanti-
fied. The presented work thus also emphasizes on possible approaches to assess uncertainties.
This covers not only the uncertainties of model input data and model results but also the propa-
gation into quantities relevant in applications. As an example, in particle therapy of cancer not
only thorough predictions of the enhanced effectiveness of ion radiation is needed, but also the
related uncertainties in patient treatment plans must be considered.
These two main focus points will be illustrated in this work at hand of the model framework
of the Local Effect Model (LEM) and the complementary Giant Loop Binary Lesion (GLOBLE)
model. While the former one was invented to predict the enhanced effectiveness of ion radi-
ation, the latter one is a general dose effect model originally designed for photon radiation.
Both models are based on the same assumptions, in particular regarding the spatial scales rele-
vant for lesion formation and processing. A thorough model benchmarking and the successful
widespread applicability of the models can be regarded as a strong support for the underlying
assumptions. Consequently the correct predictions made by LEM and GLOBLE shed light on the
nature of the relevant biological targets.
1.3 Outline
Integral part of this Habilitation thesis are six embedded publications which have been peer
reviewed and published in scientific journals. They are labeled and referenced as [A1-A6]
throughout the work and compiled in the last chapter of the thesis. Three of the publications
aim at model formation and applications, while the other three are concerned with uncertainty
considerations. Table 1.1 contains an overview of the publications.
The main text in chapters 2-6 of the present work includes a comprehensive framework and
puts the publications into relation and perspective of current research. The thesis is organized
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Table 1.1: Publications regarded as part of the present Habilitation thesis.
Label Title Journal & Year Ref.
A1 Calculation of the biological effects of ion
beams based on the microscopic spatial
damage distribution pattern
Int. J. Radiat. Biol. 2012 [25]
A2 Modeling cell survival after photon irradia-
tion based on double-strand break cluster-
ing in megabase pair chromatin loops
Radiat. Res. 2012 [26]
A3 Modeling cell survival after irradiation with
ultrasoft X Rays using the Giant Loop Binary
Lesion Model
Radiat. Res. 2014 [27]
A4 Sensitivity analysis of the relative biologi-
cal effectiveness predicted by the local ef-
fect model
Phys. Med. Biol. 2013 [28]
A5 Accuracy of RBE: experimental and theoret-
ical considerations
Radiat. Environ. Biophys. 2010 [29]
A6 Systematic analysis of RBE and related
quantities using a database of cell survival
experiments with ion beam irradiation
J. Radiat. Res. 2013 [30]
as follows: In the second chapter physical and biological basics for the context of the presented
research are recalled. General concepts of radiation effect modeling are introduced and dis-
cussed in chapter 3. Also the concept of the LEM/GLOBLE formalism and the spectrum of its
applications are presented. In chapter 4 uncertainty considerations are introduced. The inter-
relation of the articles [A1-A6] and their general impact in current research are briefly discussed
in chapter 5. Finally, in chapter 6 the perspectives of the presented research and possible future
developments are highlighted, in particular in the scope of current radiobiologic research and
developments in particle therapy of cancer.
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2 Physical and biological basics
In this chapter physical and biological aspects relevant for effect modeling will be recalled.
Within the standard model of radiation damage different stages are classified from damage
induction up to late consequences on the organism level. As model approaches typically are
designed for specific observables, these biologic endpoints emerging in this general picture are
discussed subsequently along with their radiation response.
Radiation action can only be understood by considering both biological and physical factors.
Hence the impact of the inherent radiosensitivity of cells and tissues as well as the radiation
quality are regarded. Finally this facilitates the definition of the relative biological effectiveness,
i.e. the effect of any radiation quality expressed relative to the response after photon irradiation,
and its application in the clinical context of cancer radiation therapy.
2.1 The standard paradigm of radiation damage
The course of radiation damage is commonly summarized within a standard model or standard
paradigm [1,2,31,32]. This is presented in Fig. 2.1 in a graphical representation. Interestingly,
this course extends over several orders of magnitudes in time from femtoseconds to years and
in space from atomic scales to meters. The associated processes cover physical interactions
over radiochemical and biological processes up to medical implications. This clearly shows why
the investigation or simulation of radiation induced biologic effects must always be research
conducted in an interdisciplinary context.
Figure 2.1: Standard paradigm of radiation damage.
The first step in the process of radiation damage is the point-like energy transfer of the ra-
diation or secondary electrons via excitation and ionization to the surrounding medium [33].
Damage to biologically relevant targets by means of physical energy deposition occurs either
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directly by these processes or indirectly by formation of reactive radicals which diffuse to these
targets. The most sensitive target for sustainable damage of tissues turned out to be the DNA
within the cell nuclei [34]. This is because it contains all genomic information, it is the basis
of protein expression and therefore responsible for cell functionality, and it is also transmitted
in each cell division from mother to daughter cells. Within the DNA, different types of damage
like single strand breaks (SSB), double strand breaks (DSB), base damages or sugar damages
of the backbone can be inflicted. Then cascades of proteins of the cell are engaged to repair
damage [35, 36]. Within so-called repair pathways different proteins have different tasks like
damage recognition, preparation for repair or actually inducing a proper DNA restoration. From
all elementary damages, DSB are hardest to repair, but it is known that even these can be re-
paired efficiently with a high fidelity, where the exact repair capability depends on cell type and
cell cycle phase [37]. Hence it is believed that lesion sites which contribute efficiently to cellu-
lar damage show composite lesions, like two DSB close to each other or DSB and other damage
types in close proximity [36]. Whether or not this complex damage can be viably taken by the
cell depends again on the repair capacity and on the particular characteristics of the damage.
In the next step of the standard paradigm unrestored neighboring breaks eventually may lead
to erroneous connections of open DNA ends [38, 39]. In the phase of mitosis of the cell cycle,
where the cell attempts to divide itself, the DNA chromatin is condensed and these lesions be-
come visible as chromosome aberrations. Most likely cell division will fail or the damage will be
transmitted to progeny of the cells. So with a radiation dose as stimulus the cells loose gradually
their functionality or proliferative capacity, i.e. their potential to divide into daughter cells. In
this perspective, DNA repair mechanisms presumably exist to prevent cell death: This becomes
clear by considering that each individual human life started from a single fertilized egg cell and
results in 1014 cells in adults by successive cell division [40], and moreover many cells in our
body are renewed from time to time. Hence retaining high fidelity cell reproduction is impor-
tant, and failure of DNA repair finally might lead to failure in functionality of entire organs or
even tissue degradation, which is the next level in the standard paradigm. In particular, the
consequences on organ or organism level are usually separated in early and late effects. The
former occur quite early after irradiation and, if not mortal, vanish after some time (such as
skin reddening or radiation disease). Late effects occur after long latency times and include
second (radiation induced) cancers and chronic irreversible normal tissue complications (such
as radiation pneumonitis or radiation effects in the central nervous system). In therapy these
side effects are limiting the dose that can be given to the tumor, as parts of the radiation field
unavoidably extents into normal tissue.
For a proper radiobiological effect modeling the key features of each step in this picture have
to be figured out and implemented in modeling assumptions. Again it becomes clear, that both
physical and biological factors have to be considered for determining a prediction of radiation
damage side by side.
A most critical issue for radiation effect modeling in this perspective is how physical alterations
of the biologic matter are translated into functional damage of cells or tissues. Most important
but still barely understood is the question what type of complex damage is most relevant. This
question is strongly connected to the relevance of different spatial scales of radiation damage
and the associated biological target, i.e. conformation unit of the DNA [41]. Moreover, repair
of lesions of different complexity implies different time scales of damage processing, bringing
in also the question for temporal aspects of damage processing. Hence the standard paradigm
comprises spatiotemporal aspects which need to be addressed for a proper understanding of
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radiation effects. This is a long standing problem in radiobiology which experiences a renais-
sance debt to both new experimental techniques and modeling approaches. The present work
makes assumptions on that within the presented modeling framework, and agreement with
experimental results support these assumptions.
From the standard paradigm a number of lessons can be learned for radiation therapy as one
of the most important applications of radiobiological research. These are summarized as the
famous 4 R’s of radiotherapy [1, 42]. They comprise repair of damage, tumor repopulation
during and after treatment, reassortment of the cell cycle after irradiation and reoxygenation of
cancerous cells. Cancer cells are often hypoxic due to lack of tumor vascularization, and thus the
indirect radiation action via radical formation is less efficient compared to normal cells, making
them more radioresistant. Again, for dedicated modeling the relevance of these processes has
to be considered and eventually to be covered by the model.
However, besides the standard picture there is some current debate about the impact of
so-called non-targeted effects like the influence of signaling from irradiated to non-irradiated
cells [43]. Likewise, the damage capacity of radiation is known to depend on the immune sta-
tus of the organism, and also alternative targets within the cell like mitochondria are discussed.
These considerations might give rise to modifications of the standard paradigm in future. At
the moment the relative importance of non-targeted effects is not clear. Concerning radiobio-
logic modeling, a change of the current paradigm might require to embed these new ideas in
established modeling concepts in cases where non-targeted effects are of relevance.
2.2 Endpoints and dose response
The standard paradigm allows to distinguish between different stages of radiation damage,
starting from the initial damage right after exposure of the DNA up to late radiation effects to
the organism. Techniques have been developed to quantify radiation effects at these different
stages by looking at corresponding endpoints. Quantification of the radiation damage for differ-
ent endpoints helps to set them into relation and to understand in detail the course of radiation
damage from one stage to the next. Here only the endpoints of relevance for the presented work
are briefly discussed, namely DNA lesion induction, cell survival as well as tumor control and
normal tissue complications. Besides these, further endpoints like formation of chromosome
aberrations, protein expression, pathway investigation of repair and of cell death, cell transfor-
mation as a first step of cancer development and many more are of interest in the field [1]. In
Fig. 2.2 the dose response curves of endpoints considered in the present work are illustrated
schematically. Temporal aspects, either implied by DNA repair mechanisms leading to tissue
regeneration or by alteration of the time course of dose delivery are represented in Fig. 2.3.
DNA damage induction and repair
In the early stages of radiation damage lesions are inflicted to the DNA. As these lesions can not
be directly observed by conventional methods - the DNA in the cell nucleus can not be resolved
even with electron microscopy - indirect experimental approaches have been developed. Two
main techniques were established: The method of gel electrophoresis discriminates between
intact, long DNA segments and smaller DNA fragments, which have been produced by DSB,
by measuring size dependent molecule migration in an electric field [44]. The DSB yield can
be derived from migration velocities. Regarding DNA at various times after irradiation, repair
kinetics can be obtained depending on the time allowed for repair prior to damage fixation.
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The second method exploits antibody staining to proteins involved in repair of DNA lesions,
letting them appear as fluorescent foci. A prominent example is the investigation of γH2AX foci
marking DSB of the DNA [45]. Again, kinetics of repair can be investigated by fixation of the
damage at different times after the irradiation.
Both methods allow to quantify different DNA lesions and among them in particular the DSB
yield, i.e. the number of initially induced DSB per Gy and cell. Depending on the cells under
investigation the determined values have been observed between 10 an 50 DSB per Gy and
mammalian cell for high energetic photon radiation [46, 47]. It has been also demonstrated
that the DSB yield is constant over several magnitudes of dose [48], as indicated in Fig. 2.2a. It
is instructive to consider some physical properties of radiation exposure: The energy deposition
associated with a dose of one Gy results with the average ionization energy of water (W-value,
[49]) of about 34 eV in about 1000 ionizations at the DNA molecule, considering that the
DNA only covers about 1 % volume of the nucleus. This means that most lesions are not DSB
but presumably less severe forms of damage like SSB or base damages with higher yields. In
contrast, more severe complex lesions, which only a fraction of all DSB is involved in, are
extremely rare but turned out to be the more effective.
Beyond the initial damage induction the temporal aspects of repair processes is also of interest.
Here, after an initial phase of damage recognition and protein recruitment [50] typically a
biphasic repair kinetics is observed [48, 51, 52], exhibiting a fast decrease of lesions at early
times followed by slower repair rates at larger times, see Fig. 2.3a. This phenomenon has
different interpretations which might go side by side as correlations: The proportion of fast and
slow repair might depend (i) on the choice of the repair pathways, (ii) on the complexity of
the damage to be removed, (iii) on the density of chromatin where the damage is induced or
(iv) on whether the two open DNA ends after a DSB are rejoined directly or connected to other
neighboring open ends [53]. Misrepaired or unrepaired lesions (persistent damage) might give
rise for either viable mutations or further consequences on the cell level.
Figure 2.2: Schematic dose response curves for (a) DSB and SSB induction, (b) cell survival and (c)
tumor control and normal tissue complication probability, reflecting radiation effects
on the DNA, cell and tissue level, respectively.
Cell survival
Considering radiation damage on the cell level suggests no unique definition of what is meant
by the death of a cell. Indeed many forms of a cell’s fate after severe damage like apoptosis,
necrosis or senescence are known, and complicated pathways lead to these forms of cell death
[54]. Clonogenic cell survival is defined as the probability of cells to keep up their proliferative
capacity. Since the seminal work of Puck and Marcus [55] the clonogenic cell survival assay
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Figure 2.3: Temporal aspects associated with repair mechanisms: (a) Repair kinetics of DNA DSB
repair, (b) elevation of cell survival by means of low dose rates or fractionated dose
delivery and (c) dependence of TCP curves on fraction number.
measures the fraction cells from in-vitro cultured cell lines to further proliferate after irradiation.
Typically, the dose response curves, also termed cell survival curves, show a shoulder in a semilog
plot for photon radiation and are described empirically by a second order curve,
S = e−(αD+βD2) , (2.1)
where S is the cell survival probability, D the dose and α and β coefficients reflecting ini-
tial slope and curvature of the survival curve, respectively. Equation 2.1 became famous as
linear-quadratic (LQ) model. Considering the complex underlying processes leading to damage
induction and processing, cell survival curves appear to be surprisingly simple in shape, c.f.
Fig. 2.2b. The interpretation of the shoulder shape is that at higher doses more severe damage
might be induced, which might be harder to repair for the cell, resulting in higher effectiveness
per dose increment (for details see section 3.3). Although the radiosensitivity of in-vitro cell
lines as measured in survival experiments might not be directly transferable to an in-vivo situ-
ation the general characteristics of cell inactivation persists. As connected tissue might change
its properties if many of the cells are damaged, cell inactivation is a strongly impacting factor
on endpoints of connected tissues, organs or the entire organism.
The temporal aspects of DNA lesion repair have direct consequences also for the shape of
cell survival curves [56–58]: When radiation is delivered in fractions (i.e. in multiple portions
with time gaps in the order of the cell cycle duration in between), the pause allows for repair
of lesions between the fractions. In the subsequent fraction the LQ shape of dose response is
repeated, indicating that repair processes have finished in meantime. Thus fractionation results
in an overall lower effect as for a single exposure with the full dose. Likewise, if radiation is
delivered protracted (i.e. with low dose rates), repair of lesions can take place already during
radiation delivery. This mitigates the formation of more complex damage compound of more
elementary lesions, and the survival curve appears straightened. Again, repair leads to a lower
overall effect. Survival curves accounting for repair are presented schematically in Fig. 2.3b.
These observations suggest the existence of sublethal damage [59, 60] which might become
lethal for the cell by means of additionally accumulated lesions, or repaired otherwise before
such additional lesions are created.
Endpoints on the tissue level
The investigation of endpoints of radiation damage on the organ or tissue level was highly
promoted by clinical investigations in the framework of cancer radiation therapy. In clinical
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endpoints generally one has to distinguish between two regions of radiation exposure, the target
region where radiation is desired to inactivate cells and the healthy surrounding tissue which
should be spared out as good as possible. Corresponding, different clinical endpoints play a role
to quantify tumor control and side reactions.
One of the hallmarks of cancer is uncontrolled proliferation [61] which needs to be stopped
for a successful cancer therapy. The inactivation of tumor cells is thus the ultimate goal of
radiotherapy of cancer. Since a tumor may grow as long as reminiscent tumor cells are not in-
activated, the probability to control a tumor is given by the probability of jointly inactivating all
tumor cells [62, 63]. This leads to a sigmoid like dose response curves of tumor control proba-
bility (TCP) as shown schematically in Fig. 2.2c. As indicated above, individual radiosensitivity
of patients as well as cell repopulation are factors also to be considered for a full understanding
of the tumor control probability. The TCP curves usually refer to local control, i.e. considering
only the primary tumor and not metastases which might have developed.
For the normal tissue the specification of the endpoint is very case specific. Generally one can
consider early or late radiation side effects, but there is no clear scale that measures damage
to entire organs. Hence scoring systems for various side effects have been developed. Then
the normal tissue complication probability (NTCP) measures the probability for exceeding a
predefined score. Again the dose response curves appear as sigmoid curves, c.f. Fig. 2.2c.
Different modeling approaches exist which take into account the dose distribution across the
considered organ and functional aspects of the organ exposed [64–67]. The dose range between
the TCP and NTCP curves is termed therapeutic window, and strategies in treatment planning
aim to maximize the width of this range, in order to carry out successful treatment with least
amount of side effects.
If tissue is exposed not instantaneously to dose, tissue regeneration has to be considered for
the overall effect. Hence again temporal aspects become important. In radiation therapy of
cancer, e.g., normal tissue can regenerate between the fractions, while tumor tissue has less
capability to do so as it was exposed to higher dose. As presented in Fig. 2.3c the overall dose to
be given for a required TCP depends on the fractionation schedule. A large number of fractions
requires a higher total dose, as the amount of initial damage per fraction is smaller and a larger
overall time is given for tissue regeneration.
2.3 Impact of cell or tissue type on the effect
The consequences of radiation do not only depend on properties of the agent (radiation type,
c.f. 2.4) but also on the biological target. Different cell or tissue types react differently to
radiation. This becomes most evident when considering targets of different sizes: Mammalian
cells are typically inactivated within a few Gy of photon radiation, while for yeast cells which
have a much smaller DNA much higher doses of hundreds of Gy are needed. This is intuitively
plausible as the probability to damage a piece of DNA goes down with its size, so the dose has
to cope up for this decrease.
But also within mammalian cells, which approximately have the same DNA content, differ-
ences between different cell types are evident. Most normal cells with an intact repair system
are quite resistive to radiation, while other cell lines appear to be rather sensitive, i.e. they
show a higher effect at a given dose. There are numerous biological reasons for this varia-
tion, ranging from different distributions in the cell cycle to different pools of available repair
proteins [68–71]
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Besides the sensitivity of cells at a given dose the entire shape of the cell survival curves is
another important parameter characterizing the reaction to radiation. Above it was argued that
the shoulder shaped dose response curves as typically seen for photon irradiation are due to
the increasing influence of more complex lesions induced at higher doses which are harder to
repair. A prominent shoulder shape therefore is an indication, that the less severe lesions at
lower doses can be effectively repaired. More straight survival curves are usually steeper even
at low doses, hence indicating a less efficient repair system. The expression of a shoulder thus
bears important information about the repair capability of the cells. This property is commonly
parameterized by the α/β-ratio, which is the dose above which the quadratic component has
more influence than the linear component [1].
This concept is also used in clinical context or for in-vivo experiments for the parameteriza-
tion of tissue reaction to radiation. Here, the repair capability becomes visible as regeneration
between fractions in fractionated radiation therapy. The α/β-ratio is then derived from the
sensitivity to fractionation [72].
Hence the α/β-ratio is a basic quantity generally used for both in-vitro cultured cells and
tissues to characterize the biological response to radiation. The following systematics becomes
evident:
• Low α/β-ratio (about 1-4 Gy): These cells are likely to have an intact repair system. Often
their α-component is low which means they are rather radioresistant to photon radiation.
In organs the cells are rather slowly proliferating and mostly differentiated. Examples
are organs of the central nervous system and slowly proliferating tumors like prostate or
tumors of the skull base. In therapy tissues of that kind are sensitive to changes in the
fractionation scheme.
• High α/β-ratio (about 4-10 Gy): These cells are rather sensitive even to photon radiation.
In organs the cells are quickly proliferating. Examples are skin and all fast proliferating
tumors.
However, one should keep in mind that the radioresponse observed in in-vitro assays is not
necessarily correlated to that of corresponding in-vivo tissues [73]. The dose response of cells
within tissues might be influenced by cell to cell communications, by their microenvironment
and metabolic factors. Likewise, the sensitivity of in-vitro cell lines is subject to change due to
culture conditions and the history of a cell line, which is why cells of equal type in different labs
are hardly comparable in their characteristic response to radiation.
2.4 Impact of radiation quality on the effect
Different radiation qualities, i.e. radiation type and energy, vary in their energy deposition
patterns in a target. Thus the local energy (or ionization density) distribution caused by the
radiation is a relevant factor for the radiation effects which are established in biological targets.
An inhomogeneous energy deposition gives rise to an enhanced formation of complex damage
as compared to a homogeneous distribution of dose. This is reasoned in enhanced local ion-
ization densities, leading to more complex damage, and explains why radiation qualities differ
in their biological effectiveness. Consequently it makes sense to characterize radiation qualities
according to their dose deposition patterns and investigate the effect with respect to this prop-
erty. This is one of the basic ideas adopted by almost all modeling concepts predicting the effect
of radiation.
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It is worth to note that all radiation qualities have one feature of energy delivery in common:
While the primary particles undergo interaction processes in the target material, as a result of
their ionization processes mostly secondary electrons are produced which deliver the main part
of the energy [74]. Hence most radiation damage locally induced is mediated by secondary elec-
trons, no matter what the primary particle is. However, the ionization density of the secondary
electrons varies considerably between radiation qualities.
2.4.1 Sparsely and densely ionizing radiation
As argued above mainly the spatial arrangement of energy transfer sites is of interest to un-
derstand the influence of the radiation quality on the observed effects. As the concept of dose
expresses by definition the deposited energy relative to the considered mass, always an aver-
aging over a volume containing that mass is involved. Hence dose is a macroscopic quantity,
neglecting the microscopic arrangement of the energy deposition sites. In the field of micro-
dosimetry researchers went one step further and investigated the spatial distribution of dose
depositions [75, 76]. The insights gained suggested to differ between sparsely ionizing radia-
tion qualities where the energy is rather distributed homogeneously across the irradiated volume
and densely ionizing radiation qualities where energy is delivered inhomogeneously to the tar-
get and only small fractions of the volume are subject to high energy depositions while others
are spared. Commonly the expression local dose refers to a rather microscopic concept of dose
where such inhomogeneities are resolved.
The most prominent example for sparsely ionizing radiation is energetic photon radiation.
This includes X-rays produced in X-ray tubes of typically more than 100 kV acceleration volt-
age, bremsstrahlung in the MeV region produced by small electron linear accelerators as often
used in clinics for radiotherapy, as well as hard γ radiation from radioactive decays. The high
energetic photons typically undergo inelastic Compton scattering and are finally absorbed by
a photoionization process at lower energies. Due to their large initial energies the interaction
lengths of the photons are quite large (ranging from centimeters to meters), which is why X-rays
can be used for medical imaging. The secondary electrons produced by the X-ray photons or in
cascades by other electrons typically have large energies. Hence their tracks will overlap, and
an overall homogeneous pattern of energy transfer points across the target with low an approx-
imately uniformly distributed ionization density is established. Combined with the notion that a
condensation of energy transfer points would result in a more localized and thus more effective
damage distribution, sparsely ionizing irradiation gives a lower bound for the biologic effect of
a given dose, and any induced inhomogeneity will result in effect enhancement.
Beams of accelerated ions or α-particles in contrast are typical examples for densely ionizing
radiation. Along the path of the primary particles lateral scattering plays only a marginal role
and secondary electrons are produced originating from the straight trajectory of the primary
particle. The secondary electrons cause further ionizations. If they have a strong radial momen-
tum component they are called δ-electrons and carry out energy with radially decreasing density
with respect to the primary particle’s trajectory. This gives rise to the formation of a track struc-
ture of ionization events around the primary particle path [74, 77–79]. Local doses attributed
to regions in the track structure can be very high, causing severe damage in the target. Hence,
as the overall energy deposition after charged particle radiation is much more inhomogeneous
as compared to a photon radiation field, it results in a higher effectiveness.
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2.4.2 Ion radiation
Energy loss
Ions loose energy when penetrating a target primarily by Coulomb interaction. This gives rise to
a gradual deceleration of the ion. For a particle of energy E the stopping power, i.e. the energy
loss along the penetration path of length x through matter is described by Bethe’s formula
[80,81], which in a very schematic, non-relativistic form can be written as
−dE
dx
= k(E)
ZtZ
2
p
E
, (2.2)
where Zt and Zp are the charge numbers of the target material and the particle, respectively,
and k(E) is a function absorbing all constants and varying slowly (logarithmically) with energy.
It becomes evident that Eq. (2.2) is a differential equation, and when neglecting the slow energy
dependence in k(E), integration and solving for dE/dx results in an energy loss increasing with
penetration depth, culminating at a singularity where the particle stops at a finite range [82,83].
An intuitive interpretation for the anti-correlation of stopping power and energy is that at lower
energies the interaction times with electron shells of target atoms and thus interaction cross
sections are larger. This again implies that energy loss is most efficient for stopping particles.
From a radiobiology point of view the absorbed energy by the target per path length is of
interest and termed linear energy transfer (LET). By its value it equals - up to negligible radiation
losses by bremsstrahlung - the stopping power. The energy released by particles slowing down
has been measured and compared to theory which has been enriched over the last century with
numerous relativistic and quantum mechanical corrections [74, 84–88]. Practically, stopping
power is available resulting from both measurements and predictions or interpolations in cases
where no measurements are available.
The connection between energy, LET and depth in water for protons is illustrated exemplarily
in Fig. 2.4. As demonstrated in panel a, the LET decreases with particle energy approximately
as LET ∝ E−0.8 over a large energy range, closely to the expected behavior LET ∝ 1/E as
derived from Eq. (2.2) when discarding the slow energy dependence of k(E). When penetrating
through matter the particle energy decreases continuously (c.f. Fig. 2.4b) with increasing energy
loss at larger depths. For an ion beam of defined initial energy the LET decreases with depth
as demonstrated in Fig. 2.4c, and the particles stop approximately at the same depth, i.e. they
have the same range. The range depends on the initial energy of the particles: The higher the
initial particle energy is, the deeper they penetrate into matter. When particles are just about to
stop, LET is high, implying a peak of energy loss right at the end of their range. As, however,
the particle deceleration is a stochastic process, the range is not exactly the same but subject to
a small distribution, giving rise to a so-called range straggling. Hence a depth dose distribution
pattern is established with a strong peak where particles are stopping, which is termed Bragg
peak.
Macroscopic dose
Considering a particle beam, all particles crossing a volume will accumulate dose to that volume.
Hence the macroscopic dose D, defined as energy deposited per mass, is connected to LET and
the particle fluence F of the beam as
D =
F × LET
ρ
(2.3)
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Figure 2.4: Connection between particle energy, stopping power (LET) and depth in water: (a)
Anti-correlation between LET and energy for protons. The dashed line indicates a
power law LET ∝ E−0.8. (b) Energy profile in water for a 160 MeV proton beam,
demonstrating the deceleration with increasing depth. (c) Variation of LET with pen-
etration depth, where the profile has been convoluted with a Gaussian function of
small width to simulate range straggling in the Bragg peak. Thus the convoluted
curve represents the depth dose profile.
in SI units, where the LET is given for the target material of density ρ [1]. This shows that for
a requested dose with high LET particles a rather low fluence is needed, while higher particle
fluxes of low LET ions are needed for the same dose.
Track structure
The LET as considered above parameterizes the entire energy loss per path length of the pri-
mary particle trajectory. The energy transferred to the target medium is carried outwards by
δ-electrons, and a dose deposition pattern forms around the primary particle track, usually
termed track structure. Figure 2.5 displays a typical example of a track structure of carbon ions.
Obviously the ion causes a large ionization density along its path, which decreases rapidly with
distance to the primary particle trajectory.
Using gas filled detectors, microdosimetric measurements of dose depositions in some dis-
tance to the ion track revealed that the radial ionization density decays as approximately r−2
with increasing radial distance r to the particle trajectory [77]. This was understood by a theo-
retic consideration of inelastic electron scattering cross sections along with relativistic electron
ballistics. Essentially, the production rate of high energetic δ-electrons is much smaller as com-
pared to lower energetic δ-electrons, so that energy deposits far from the track center occurs
less often than close to the track. Generally, the energy of the primary particle determines
largely the energy distribution of the caused secondary electrons. High energetic particles have
therefore a wide track structure where δ-electrons can migrate up to 1 cm or even more. In
the inner part of the track structure, the local doses can get very high. Due to conservation of
energy, the integration over track structure must reveal the entire energy loss, i.e. the LET [77].
These considerations imply that particles of a given species with low energy have a high LET
and moreover a narrow track structure, giving rise to very high local doses, and are thus densely
ionizing. In contrast, high energetic particles have rather low LET and a wider track structure.
However, in comparison to orthovoltage X-rays there is still enhanced inhomogeneity in dose
deposition, and the term low LET radiation is usually used in perspective of the individual prob-
lem. Typical properties of carbon ions of low and high energy, as corresponding to a therapeutic
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Figure 2.5: Track structure of a 100 MeV/u carbon ion: (a) View on a 3 µm segment of track
structure in side perspective (drawn to scale). Ionization events in distance up to 5
nm to the ion trajectory are colored in blue, ionizations caused by δ-electrons carry-
ing energy outwards in red. (b) Projection in ion propagation direction of 10 µm ion
track length. Simulations have been performed with the track structure Monte Carlo
code TRAX [89–92].
target and the surrounding areas within the radiation field (the so-called entrance channel),
respectively, are summarized in Tab. 2.1.
Amorphous track structure parameterizations
While a full description of track structure as described above involves the accurate position
and ionization or excitation energy portions of all point-like energy transfers, a more prac-
tical approach consists in an average description of these energy deposition patterns around
ion trajectories. Then the ion track can be described by an amorphous track structure [93],
which is a smooth function in space reflecting the probability for ionization events, or, in other
words, ionization density. This effective description neglects correlations of neighboring energy
depositions along individual secondary electron tracks, but is not limited in spatial resolution.
Table 2.1: Properties of therapeutic carbon beams.
Entrance channel Bragg peak
Energy (MeV/u) 290 25
LET (keV/µm) 13 77
Core dose (Gy) 1465 93000
Track radius (µm) 951 14.8
Radius at 1 Gy (µm) 0.16 0.45
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The amorphous track structure is typically visualized by the radial dose profile, where the
term dose has to be regarded as a local, microscopic dose. A simple amorphous track structure
formulation is given by
D(r) = λLET
§
rmin
−2 for r ≤ rmin
r−2 for rmin ≤ r ≤ rmax (2.4)
where the normalization factor λ is
λ=
1
piρ

1+ 2 ln

rmax
rmin
 (2.5)
and determined such that the integral
∫ rmax
0 2pirdr, i.e. the amount of energy stored in the
track structure, reflects the particle LET [94]. In Eq. (2.4), D(r) is the local dose at distance r to
the track center in the target material with density ρ. The track radius is given by rmax[µm] =
0.062 E[MeVu ]
1.7, which was revealed empirically by considering measurements in gaseous media
as discussed above and reflects that δ-electrons have a maximum possible energy. The radius
rmin labels the core radius of the track above which the 1/r
2 decrease of the dose starts. The
core region is not accessible by measurements, but quantum mechanical considerations suggest
a velocity dependent extension of that region as rmin = β rc where β is the relativistic velocity
parameter, and rc is the core radius for highly relativistic ions and is of the order of some
nanometers [94]. Figure 2.6 shows the radial track structure according to Eq. (2.4) for various
combination of ion type end energy. Notably, the local dose profile varies over several orders
of magnitude across the track. It should recognized at this point that due to some reminiscent
ambiguity in the parameterization of the track core, the presented equations set up a model,
inspired by experimental results and theoretic considerations. An overview of various suggested
amorphous track structure models is given in [95].
2.4.3 Ultrasoft X-rays
Ultrasoft X-rays are photons typically emerging from the characteristic X-ray spectrum emitted
from atomic transitions from outer to inner shells and typically cover the energy range from
about 100 eV to a few keV. Although still energetic enough to cause ionizations they differ sig-
nificantly in their properties from high energetic photon radiation in various aspects. First, due
to their low energy they interact solely via photoionization processes, while Compton scattering
plays practically no role. Hence they will be absorbed exponentially with penetration depth,
where the absorption length is in the order of a few to a few hundred micrometers in the range
of about 280 eV (carbon K shell X-rays) to about 4.55 keV (titanium K shell X-rays), respec-
tively [96]. Second, for heavier elements with occupied atomic L shells, the photoionization
will be followed by an Auger emission. This has a typical energy of 500 eV for water as consid-
ered target [97, 98] and thus has similar properties as the photoelectron. Third, the energy is
transferred to the photoelectron (except its binding energy), but as this energy is low a cascade
of only a few further ionizations might follow, and the remaining range of these electrons is low.
The ranges of the photoelectrons are about 7 nm for CK X-rays and 550 nm for TiK X-rays [96].
Consequently, essentially a few ionizations will occur restricted to a small volume of the order of
some nm to some hundred nm around the location of the photoioniztation. In this region a high
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Figure 2.6: Radial dose for various combinations of ion species and energy according to the
amorphous track structure model Eq. (2.4). Dose profiles are shown for carbon
ions (blue) with energies of 25 MeV/u (1), 100 MeV/u (2) and 290 MeV/u (3) and
protons (red) for an energy of 160 MeV (4) up to the maximum track radius. The
different tracks are similar in shape, although highly differing in absolute doses and
track extensions as evident in the double logarithmic plot.
ionization density occurs, while the gross part of the irradiated volume remains uncovered by
ionizations. To investigate the ionization patterns caused by ultrasoft X-rays it is thus sufficient
to consider the track structure of the photo- and Auger electrons. Typical ionization patterns for
1 keV electrons are visualized in Fig. 2.7. A clear correlation of ionization events along curved
electron trajectories is visible, and eventually track bifurcation occur due to the generation of
electrons by means of further ionization processes. Recently it was shown that the concept of
amorphous track structure around photo- and Auger electron tracks can be applied in analogy
to ion track structure to understand the effectiveness of ultrasoft X-rays [99].
The study of ultrasoft X-rays in radiobiology is of interest for the following reasons:
• Although photon radiation in general is regarded as low LET radiation because each parti-
cle infers just a small amount of energy, ultrasoft X-rays are densely ionizing as the energy is
distributed inhomogeneously, giving rise to high local doses in small regions. This situation
is in a way comparable with the track structure of high LET particle radiation [100].
• As has been discussed before, most radiation action is mediated by secondary electrons,
no matter what the primary radiation type is. When slowing down, eventually at the end
of any individual electron track, the electrons have a small portion of kinetic energy only,
and a cluster of ionizations is expected as for photoelectrons produced by ultrasoft X-rays.
Hence considering ultrasoft X-rays allows to study the properties of effective secondary
electron track ends, which are found in any radiation quality where higher energetic sec-
ondary electrons are involved [101].
• While ion tracks occur in a cylindrical symmetry and dose is always deposited along the
straight ion trajectory, the ionization clusters caused from ultrasoft X-rays are locally re-
stricted in all dimensions, i.e. they form bubble like regions with high ionization density.
17
Figure 2.7: Track structure of 1 keV electrons emitted at the origin (red dot) in z direction: (a)
Single electron and (b) overlay plot of 30 electrons. The blue dots show individual
ionization events. Simulations have been performed with the track structure Monte
Carlo code TRAX [89–92].
Hence ultrasoft X-rays can be exploited to study the formation of complex damage depend-
ing on the size of the ionization and lesion clusters.
Indeed it has been demonstrated that the effectiveness of photon radiation depends on energy
[102–104], and that ultrasoft X-rays have a higher effectiveness than high energetic photons
[96, 105, 106]. Historically, stimulated by the work of Goodhead and coworkers [107–109]
these experiments lead to the enhancement of the field of microdosimetry, because it became
evident that the increased effect of ultrasoft X-rays can be only understood by looking at a
nanoscopic level rather than on the µm scale only. The interpretation of these findings is, that
the spatially correlated ionizations arising from one photoionization process match the order
of the width of the DNA which is about 3 nm or first higher order DNA conformation like the
30 nm fiber [36, 110, 111], giving rise to more complex damage on these structures. This is
an example how the understanding of biologic effect is directly connected with the meaningful
biological targets in radiobiology.
2.5 Relative biological effectiveness
As has been demonstrated above, different radiation qualities differ in their dose deposition
pattern. Consequently, the spectrum of damage types induced and with that the repair capability
of the cell to that damage depends largely on radiation quality, but also on biological factors such
as the functionality of repair mechanism. To quantify the efficacy of different radiation types,
the concept of relative biological effectiveness (RBE) is introduced as the dose needed to induce
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a requested effect of some radiation quality Q relative to the dose needed for the same effect
with high energetic photon radiation:
RBE =
DQ
Dphoton
|isoeffect (2.6)
For the case of ion radiation the definition of RBE is schematically visualized in Fig. 2.8.
Figure 2.8: Definition of the RBE to parameterize the enhanced effect of high LET radiation. The
dashed line marks an isoeffect level at which the RBE is evaluated as ratio of doses
needed to reach this effect.
This definition is simple, very general and applicable to practically all end points. Referring to
energetic photons as reference radiation is most practical because orthovoltage X-ray tubes are
accessible in many labs all over the world and in radiotherapy vast experience has been made
with 60Co irradiators and clinic accelerators over decades. Furthermore as mentioned earlier
photon radiation is regarded as more homogeneously and sparsely ionizing and thus constitutes
a lower bound in effectiveness. Hence the RBE is expected to be larger than one in all other
cases.
Despite its simple definition RBE turns out to be a complicated quantity. In particular, RBE
depends on the following physical and biological factors:
• Dose and fluence: At higher doses RBE will decrease, as for the photon reference the
incremental action per Gray typically increases with dose, while this is less the case for
more inhomogeneous dose deposition. In this regard also geometric properties of the cell
nucleus play a role, as it determines the number of photons or massive particles passing
through the target cross section for a given dose. Hence the statistical properties of dose
deposition in individual cells may vary, influencing RBE.
• Particle Species and energies: For charged particles like accelerated ions the energy trans-
ferred to the medium strongly depends on the charge number and the energy of the ion
(c.f. 2.4). Typically for a given ion type RBE increases with LET and hence decreases with
energy. At very high LET only hit statistics matters, and RBE decreases again. For photons
of lower energy the limited range of photons and photoelectrons lead to inhomogeneous
dose deposition patterns. Again, RBE increases with the degree of inhomogeneity of the
ionization density.
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• Endpoint: Dose response curves of different endpoints vary in their properties (c.f. 2.2).
Hence RBE may vary between different endpoints.
• Radiosensitivity: Cells and tissues react differently to different types of damage (c.f. 2.3).
Because the types of damage induced depend on the radiation quality, this has impact on
RBE. Generally, cells or tissue types with a high α/β-ratio result in a low RBE and vice
versa.
The characteristics of RBE with respect to these factors has been matter of investigation for
several decades both for ions [112–115], and soft X-rays [96]. The entire RBE systematics is
reflected best by considering dose response curves for the radiation quality of interest and the
dose response of the reference radiation simultaneously. For high LET ion radiation and the
endpoint of cell survival, e.g., the dose response is typically steeper right from the beginning
and shows, if any, a less pronounced shoulder (see Fig. 2.2) than the dose response curve of the
reference radiation. This is plausible as the high LET facilitates the induction of more severe
lesions which are harder to repair even for lower doses - these lesions overcome the repair
ability of the cell. The efficiency of lesion repair is moreover mostly reflected by the shape of
the photon dose response curve, as discussed in section 2.2. The RBE can be evaluated from
the relative difference of both dose response curves. Thus, in regard of these complex relations,
mathematical RBE modeling must consider both the physical and biological aspects of radiation
damage and processing.
2.6 Particle therapy
The goal of any cancer radiation therapy modality is to widen the therapeutic window, i.e. to
maximize the distance of TCP and NTCP curves in dose. This allows at the end to reach a
maximum in tumor control with tolerable side effects. Finally, endpoints like the probability
of no recurrences in five years of follow up time after therapy or patient survival corrected for
other mortality reasons are investigated in clinical studies.
Typically, external radiation therapy of cancer is performed using 60Co γ-rays or X-rays pro-
duced by small clinic accelerators, typically electron linacs whose bremsstrahlung is used as
therapeutic beam. Modern techniques like intensity modulated radiation therapy or volumetric
arc therapy [116–118] combine beams irradiated from different directions to the target vol-
ume, i.e. the tumor, to achieve a maximum possible tumor conformity and low normal tissue
exposure.
The use of protons instead was proposed in 1946 [119] and exploited for therapy since the
mid fifties [120]. Also other hadrons like neutrons or pions were used or considered as particles
for therapy [5]. While therapy with neutron irradiation was (and is in few facilities) in clinical
practice for some decades but revealed comparably minor benefit, and other particle therapy
modalities such as pions did not establish for various reasons, only proton and carbon ion ther-
apy are nowadays broadly considered and implemented in dedicated treatment facilities, while
the use of helium and oxygen is under discussion for special purposes [121–124].
Ion beam therapy bears a number of advantages, but also higher effort is needed for such
therapy modalities. The beneficial properties of charged particles for therapy are more and
more acknowledged, and the current rate of new facilities founded is still growing. When
this thesis was completed more than 100.000 cancer patients have been treated with proton
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beams and more than 15.000 with carbon ions world wide. Carbon ion facilities are currently
available in Japan, Germany, Italy, and China, under construction in Austria and South Korea,
and first planning is in progress in the United States [11]. Clinical outcome clearly shows the
benefit carbon ion therapy for several tumor types [125–128], although randomized clinical
trial studies are still in progress.
The discussed properties of charged particle radiation lead directly to the advantages of par-
ticle therapy [129–131]:
• In comparison to energy deposition caused by photons, the dose profile is inverted (c.f.
Fig. 2.9(a)), which is the main rationale for hadron therapy, as it facilitates to bring in
energy deposition where it is needed: in the target region. The inverted dose profile thus
saves normal healthy tissue, while exposing the target region to high doses.
• The sharp Bragg peak allows for a good tumor conformity with relatively few channels,
i.e. beam directions relative to the patient. In treatment plans various Bragg peaks are
delivered to different depths in tissue in order to reach a homogeneous dose distribution
across the tumor, see Fig. 2.9(b). The flat dose profile is extended Bragg peak or spread-out
Bragg peak (SOBP).
• In particular for ions heavier than protons the small lateral scattering allows to design
laterally strongly confined irradiation fields.
• The high LET leads to a high RBE in the target, even increasing the ratio of dose in the
target to the entrance dose (peak-to-plateau-ratio), as can be seen in Fig. 2.9(b).
• Due to the damage complexity in the target, cell inactivation is less affected by the oxy-
genation status of the cells or different repair capabilities across the cell cycle as observed
for low LET radiation.
• As radiation damage of high LET particles is less sensitive on biological factors of the target,
inter-individual differences in radiosensitivity, i.e. the heterogeneity within patients, has
less impact on tumor control curves derived from patient cohorts. Thus the uncertainty in
doses needed to control the tumor is reduced.
• For high LET radiation, dose rate effects and sensitivity to fractionation, i.e. to the photon
α/β-ratio of the tumor tissue, is less pronounced, higher fraction doses (hypofractionation)
becomes possible (c.f. Fig. 2.2). As the target is covered by a higher dose, repair of tumor
tissue is less effective, while due to the good tumor conformity the normal tissue is still
exposed to tolerable dose levels.
On the other hand there are also a couple of disadvantages or issues to be discussed. Most of
them are matter of current research:
• Hadron therapy facilities, in particular for heavy ions, are very expensive in construc-
tion and performance. Hence an appropriate selection of patients is needed, where these
enhanced techniques are beneficial in terms of treatment results [129].
• To exploit the RBE of charged particles, it must be properly quantified prospectively. This is
nontrivial due to its rich dependencies on biological and physical aspects. Radiation effect
modeling is an essential tool for this purpose. The issue is not only the availability and
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Figure 2.9: Depth dose profiles. (a) Depth dose profiles of photons, protons and carbon ions in
comparison. The hadrons show an inverted dose profile. (b) Typical irradiation field
for carbon ions, composed of several Bragg peaks forming a spread out Bragg peak,
and resulting in a homogeneous RBE weighted dose distribution across the target
region.
performance of such models, but also of requested model input data. The quantification of
RBE and related uncertainties are a main focus of the present thesis.
• A proper patient positioning is a very delicate task. Due to the high tumor conformity and
sharp fall-off of the dose beyond the margins of the target field, mispositioning immedi-
ately results in a high dose exposure of healthy tissue. This issue is even getting more
complicated for moving targets, e.g. driven by breathing or heart beat motion [132].
• Nuclear processes like target fragmentation and for heavier ions also projectile fragmen-
tation give rise to a multiple particle type mixture of radiation qualities, which has to be
accounted for in treatment planning [133,134]
• Out-of-field leakage doses are expected from the fragments and give rise to an additional
low dose exposure of healthy tissue. An accurate dose quantification is, however, a de-
manding task. Exemplarily, much research has been performed on the exposure level of
healthy tissue in the neutron stray field [135–138]. The development of secondary malig-
nancies is of particular importance for the treatment of pediatric patients, whose expected
lifetime exceeds typical latency times for second cancer expression.
In clinical practice the doses that are given in therapy are constrained predominantly by toler-
ance doses of exposed healthy tissue. The translation of these doses between different treatment
modalities or different fractionation schedules requires an understanding of the dose response
mechanisms. For carbon ion therapy the implementation of RBE in treatment planning is per-
formed by exploiting radiobiologic models. In European facilities the LEM is used [139–141],
which is largely discussed in this work, and in Japanese facilities the Microdosimetric Kinetic
Model (MKM) is applied combined with an empiric scaling of the dose profile [142–146]. Again
it is evident that the inherent entanglement of physical and biological properties and the spa-
tiotemporal aspects of dose delivery have to be considered for determining the radiation effect.
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3 Modeling concepts and application
Everywhere in science measurements and tests are performed to finally develop an idea or a
picture how aspects of nature work. Strictly, all derived hypotheses are models, which can
be supported or refuted by experimental data. However, as complexity increases models have
to get more complex or to consider functional dependencies of the involved quantities. Here
mathematical modeling becomes relevant. Throughout this work, by the term modeling in fact
mathematical modeling is meant.
Modeling radiation effects is a matter of selecting the key features from the course of radiation
damage and the appropriate mathematical tools. A proper development of model approaches
depends on the creativity of the researcher. Model tests and benchmarking can then help to
determine the limits of a model set-up.
The goal of this chapter is to introduce different aspects and ideas followed by radiation effect
models. At first, some general considerations about requirements and constraints of mathemat-
ical effect modeling will be given. This contains also a general proposal of a set of necessary
conditions such models have to fulfill in order to be useful and practical in radiobiology. Next, a
historical view and a brief discussion of the basic strategies followed in various model demon-
strates the broad variety of developments in the field. The LQ model is the most prominent
model, although it is rather descriptive than predictive. As it is related to or even used as part
of more sophisticated models like LEM and GLOBLE, the interpretations underlying the model
will be discussed. The notion of lesion clustering on different scales is a key feature exploited in
the LEM and GLOBLE and will be motivated, before the main ideas of LEM and GLOBLE will be
considered. In this work the discussion will restrict mostly to the endpoint of survival, while in
general the presented modeling work is applicable for other endpoints and phenomena as well,
as demonstrated at the end of the chapter.
3.1 Requirements for radiation effect models
The great theories in physics like Newtonian mechanics, theory of relativity or quantum me-
chanics are all simple in the sense that they are formulated by a tiny set of basic rules or axioms,
based on which many processes in nature can be explained provided the conditions and re-
strictions under which these observations have been made are known. These theories are thus
fundamental. Complex systems obey these laws, too, but are much harder to describe. The rea-
son for this is that they contain a high number of processes which run simultaneously and may
interact, or a large number of variables and quantities to be considered for a full description.
Needless to say, cells are complex systems and their response to radiation exposure is a com-
plex situation. Trying to construct models reflecting reality by taking into account as many
aspects as possible, for instance by ab initio models describing all interactions, will be tedious
and is not feasible at the moment for practical reasons (e.g. computer power) and because not
all processes are investigated and known. On the other hand, a model which is oversimplified
may fail to reflect relevant processes. Hence a compromise of the level of detail described in
modeling has to be found.
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On a more abstract level, a mathematical model describes an observable based on input pa-
rameters and internal model parameters which implement the situation to be modeled. A higher
level of detail would thus mean to increase the number of degrees of freedom of the model and
to introduce additional parameters. If the number of degrees of freedom is too high, when fit-
ting the model to experimental data no significant parameter values can be expected any more.
In contrast, if a model has too few degrees of freedom, the model is too incomplete and the
predictive power is low [147]. The situation is visualized in Fig. 3.1. A compromising number
of free parameters has to be determined, which should reflect the information contained in the
curves to be described. For the description of shouldered dose curves for instance, two free
parameters should be sufficient, as in the simple LQ approach. This reflects the small level of
information contained in an individual set of experimental cell survival data, which adequately
can be described by a second order polynomial.
Figure 3.1: Uncertainty minimization in mathematical modeling.
Again it should be stressed that a complete picture can not be revealed by models, as underly-
ing processes are only known to some extent. In this perspective current radiobiologic modeling
is more than just an implementation of a set of rules, it is rather a prediction for the implication
of assumptions, which in turn can be tested by comparison with experimental results.
Based on the state of research a minimum set of ’must have ingredients’ and model abilities
can be proposed which is essential for predictive effect modeling. This proposed list is a very
general conjecture of the present thesis and finds support in the discussed research work of the
publications [A1-A6]:
• Characterization of the spatial distribution of ionizations: The physical properties of the
radiation as the agent triggering radiation damage must be considered.
• Target geometry: The sensitive sites have to be specified to define where ionizations can
cause further radiation damage.
• Lesion induction: From the dose distribution the induced damage has to be quantified.
• Conversion to an observable endpoint: Hypotheses or techniques have to enter into model-
ing how, depending on radiosensitivity, initial lesions are processed and how un- or misre-
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paired lesions will be converted to an observable endpoint such as chromosome aberrations
or cell survival.
• Mechanistic interpretation: The model should allow for an interpretation of its model
parameters in terms of a physical or biological meaning.
• Benchmarking: A model must be testable. Otherwise there is no way to support the model
assumptions by comparison with experimental data. Only if such benchmarks succeed, the
model can be regarded as predictive.
• Transitivity: A model which bases on justified assumptions should be able to describe
several aspects of radiation damage within the same model framework.
In particular the last point of this list is where most models which have been published in the
literature have drawbacks, or simply a spread out of application was not followed. The LEM
and GLOBLE model framework presented in this work was applied to numerous endpoints and
different observable aspects within the same framework and without changing the parameters
used for description. This is one of the most convincing arguments for the applicability of these
concepts.
3.2 Historical perspective and classification
Modeling cell survival has a vivid history, starting right from the early days of radiobiology.
Figure 3.2 gives a chronological overview of the developments. Apparently many attempts
have been made to understand the radiation response, exploiting different views on cellular
mechanisms of radiation damage processing and considering specific aspects of interest, such as
response to radiation at low or high doses, or temporal aspects of radiation delivery. The models
labeled in red allow predictions also for high LET radiation. The set-up of the GLOBLE model
goes back to article [A2], and all other models included in the figure were originally presented
in [32,142,148–172]
Successful modeling points towards a confirmation of the underlying assumptions and thus
promises a deeper understanding of radiation damage. All models listed in Fig. 3.2 are to some
extent mechanistic and to some extent empiric, which will determine the information one can
get from the models. In turn, models can only be used for predictions or interpretation of
experimental results if meaningful model parameters are available. The point of view from
which the various models have been derived from and with that the meaning of the applied
parameters is different for each model. Nevertheless, some main concepts of radiation effect
models can be distinguished. A list of concepts along with accomplishments and showstoppers
is given below, though this list may not necessarily be complete and is not meant to reflect a
classification scheme for different models:
• Target theory: A very physical view on inactivation of cells was suggested by considering a
sensitive target, which has to be hit once or a certain number of times to induce cell inac-
tivation. Likewise the joint hit probability for a number of subtargets has been considered.
The target theory was developed by Lea [148] and has widespread applications especially
for yeast cells and bacteria. However, a shortcoming was that the models predicts a vanish-
ing slope at low doses, in contrast to experimental results. Phenomenological approaches
to overcome this [149] bear of a clear justification.
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Figure 3.2: Timeline of most important descriptive or predictive cell survival model develop-
ments. Entries in red refer to models which explicitly have implemented mechanisms
to predict high LET dose response. Monte Carlo models without analytical effect
calculation have not been adopted into the figure. Also the list may not reflect all
model developments that have been presented so far. See main text for references
of the models.
• Microdosimetric model concepts: In microdosimetry the energy distribution in micrometer
sized subvolumes was experimentally investigated with dedicated proportional counters in
gaseous media [173]. Inspired by that, Kellerer et al. derived the theory of dual radiation
action [153], a modeling approach considering the distribution width of energy within
so-called microdosimetric domains whose size is one of the model parameters. The model
started from the idea of a quadratic dose response within individual domains, resulted in
a mechanistic interpretation of the LQ model and succeeded in explaining basic features
of high LET radiation effects. Later on the concept was enhanced by the Microdosimet-
ric Kinetic Model [142, 174] which also managed to explain time effects of repair, e.g.
when radiation is given protracted instead of instantaneously. Drawbacks of such model-
ing are that averages over the microdosimetric domains are carried out, prohibiting the
application to situations where a finer resolution would be required, as for example for the
radiation action of ultrasoft X-rays [109]. These considerations triggered the development
nanodosimetry, along with corresponding model work [175, 176], which could overcome
this shortcoming. A further issue, however, is the lack of a clear biologic interpretation of
the meaning of the microdosimetric domains: It was known that chromosome aberrations
are formed by lesions within µm proximity [39], but there was no interpretation about
why these lesions were not subject to repair processes within these sites. The concept of
relevant sites is also adopted in the LEM, where such interpretation was added.
• Dynamic repair modeling: This type of models considers the induction and the successive
removal of damage by means of differential equations. The development of the underlying
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concepts goes back to [32, 160] in the formulation of the Repair-Misrepair model (RMR)
and the Lethal-Potentially Lethal model (LPL), respectively. These approaches allowed in
particular to explain temporal aspects of repair. The model setup is completely general
while the assumption of different repair modes is somewhat specific. Furthermore, param-
eter determination by fitting the model to experimental data is a demanding task due to
the mathematical structure of these models.
• Transport codes in combination with a DNA damage model: A number of models, in par-
ticular for the simulation of the radiation damage of charged particles, starts to describe
the physical interaction processes by means of transport codes [177]. At the end, ioniza-
tions on the DNA are converted into DNA lesions, from which the fate of single cells will
be derived. Examples are KURBUC [178], PARTRAC [179], RITRACKS [180] or Geant-
DNA [181]. These approaches allow a detailed insight in the composition of the physical
radiation field. However, when converting ionizations into biological lesions and simulat-
ing their processing, just as in all other model concepts a number of assumptions is needed,
relativizing the level of detail exploited in the physical part of the simulation. A practical
drawback is that transport codes and track by track biological interaction models often
need extremely large computation power, thus usually generating model results of limited
statistical power.
• Amorphous track structure models: Instead of considering all physical interactions of high
LET radiation in detail, the concept of amorphous track structure considers continuous
functions of local dose as spatial probability distributions for energy transfer, c.f. sec-
tion 2.4.2. Amorphous track structure thus is regarded as the ensemble average of indi-
vidual track structures. Such averaging over individual tracks of point-like energy transfer
points allows a simple analytic description of track structure. An overview of applied mod-
els describing track structure is given in [95], and prominent examples of associated RBE
models are the Katz model [151, 182, 183] and the LEM [139, 161, 184, 185]. From a
theoretical point of view the justification of amorphous track structure is not trivial and
debated. The transition from a distribution of point-like energy transfer events to a lo-
cal dose distribution is comparable to the introduction of thermodynamic variables such
as temperature in statistical mechanics. This requires an ’equilibrium state’ of all energy
transfer events described by local dose or of all particles in motion in a thermodynamic
system, respectively. Hence the information loss by taking the average for local dose eval-
uation, where the exact positions of energy transfer points is neglected, is an important
issue to consider. Nevertheless, in contrast to microdosimetric models, in the concept of
amorphous track structure the deposited energy is not spatially averaged over µm sized
domains, but rather reflected by a probability distribution which is unlimited in its spatial
resolution.
A number of models also combine several of the concepts discussed above. For instance, the
time course of repair modeled within the MKM follows ideas closely related to the LPL and RMR
models, whereas the microdosimetric input data for the MKM are often obtained by Monte Carlo
transport codes or amorphous track structure formulations. The Katz model applies elements of
the early target theory for the effect calculation, while LEM applies the conventional LQ model.
The Repair-Misrepair Fixation model [168] exploits detailed Monte Carlo simulations of the
radiation field and a deterministic simulation of repair following the concept of the RMR and
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LPL. Consequently the question for the most successful strategies to model particular aspects of
radiation damage arises.
3.3 Interpretation of the linear-quadratic model
The most prominent model in radiobiology, probably due to its simplicity, is the LQ model. It
was introduced in the framework of chromosome aberrations by Lea [38], in the clinical context
by Fowler and Stern [186] and was later also applied to describe cell survival curves [150]. The
model is purely empiric and from a mathematical point of view just a second order fit function
to experimental data. Hence it could be used to describe experimental data, but not to predict
them.
A general interpretation derives, however, from statistical considerations: Defining lesions
which will lead to cell death as lethal lesions, only those cells will survive which do not receive
any lethal lesions by definition. If one assumes a Poissonian distribution of lethal lesions, the
probability for no lethal lesion is exp (−< L >), where < L >= αD+βD2 is the average number
of lethal lesions. Hence a basic interpretation for the exponent is found.
Several more mechanistic interpretations have been developed, and also gave rise to fur-
ther model developments. These approaches are listed below. Notably, again the importance
of spatial and / or temporal aspects of radiation damage induction and processing becomes
evident:
• In the early days of a mechanistic interpretation of the LQ model, DSB were thought to be
the most lethal lesions. In their molecular theory Chadwick and Leenhouts [154] proposed
that the linear component is due to DSB induced by one particle track and the quadratic
component due to the accidental induction of two SSB on opposing strands of the DNA in
sufficient proximity. Clearly, linear and quadratic dependence in dose would be expected
for single and two particle processes, respectively. However, considering the number of
SSB observed after irradiation (about 1000 per track and Gy) in perspective with the DNA
content of mammalian cells (about 6× 109 bp) it became clear later on that an effective
formation of additional DSB by two-track processes is unlikely. Nevertheless this approach
is of value as it tried for the first time to associate lesions directly with observed effects in
cell survival.
• Later on, experiments with delayed plating of cells after irradiation and fractionated irra-
diation led to the concepts of potentially lethal damage, i.e. lesions which become lethal
when the next critical step in cell cycle is reached, and sublethal damage, i.e. damage
which gets lethal if additional sublethal lesions occur. The interpretation is that all lesions
(α and β type) are subject to repair, but the binary accumulation of sublethal lesions only
alters the β-component [187].
• Strongly related, also effects of protracted irradiation have been considered: The stronger
β-component for acute as compared to protracted exposure (c.f. Fig. 2.2b) suggested
that pairs of (sublethal) lesions might suffer from binary misrepair which makes them
lethal. The lethal lesions should become visible as chromosome exchange type aberra-
tions, i.e. two chromosomes have a break each and recombine in a cross-wise manner.
Indeed a strong correlation between observed aberration frequencies and cell inactivation
has been found [188]. For protracted irradiation such accumulation of sublethal lesions is
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impaired as it occurs less likely due to repair taking place already during exposure. Hence
the β-component is interpreted as an misrepair interaction of independently induced le-
sions [189]. Remarkably, although damage induction and repair are processes on different
time scales, the interpretation of a shoulder reasoned by a less successful repair fidelity
at high doses and interaction of lesions are indistinguishable and identical, as higher le-
sion densities imply higher misrepair rates. However, it should be noted that despite of
a correlation between aberration frequencies and cell inactivation, so far there is no re-
lation available that would allow a reconstruction of a full survival curve from observed
chromosome aberrations or vice versa.
• For charged particle radiation the β-component is usually considered as a combined effect
of two adjacent particle tracks (hence quadratic in dose), termed inter-track effect, while
the α-component characterizes the damage each particle infers alone (hence linear in dose)
and is termed intra-track effect. Hence, for high LET particles a shoulder is typically less
visible because even within single tracks the lesion density is large, facilitating the interac-
tion of lesions or hampering their repair. Therefore, α-components typically increase with
LET of ion radiation. If a clear shoulder is visible in a dose response curve to ion radiation
it is attributed to the overlap of their tracks.
• Most models explain the quadratic component by some interaction process or lack in repair.
This means that the general notions are comparable, and indeed the LQ model follows
approximately or even exactly (as in the MKM, e.g.) from the model hypotheses. This
analogy even holds if the kinetics of lesion induction and repair is considered [58].
From a physical point of view an interaction of two lesions is associated with an interaction
range, which suggests that a coincidence of damages within the interaction range can be re-
garded as some level of complexity. This idea is also exploited in the GLOBLE model, which has
thus a strong connection to the LQ model (see article [A2]) by this link. Also the LEM makes for
low doses use of the LQ model as a parameterization of dose response curves for photons (as
model input) and ions (as model output).
While reliably representing dose response curves at low doses up to some Gy, the course of
survival curves of the LQ model at high doses is a long standing debate. Whereas target theory
as well as the dynamic repair models predict a constant final slope, the LQ model would predict
an continuously increasing bending of the dose response curve with dose. This seems to be in
contrast to some experimental and clinical findings [190–195] and attempts have been made
for according modifications of the LQ model by simulating saturation effects at high doses [139,
165,169,170,196]. However, there are also arguments why the pure LQ model in its simplicity is
sufficient to describe the data, although this would not exclude a different systematics at higher
doses not observed in the experiments and clinical studies. There is a current renaissance of
the debate about the validity of the LQ model [189, 197, 198] and the biologic mechanisms of
radiation damage [199–201] at high doses, driven by the accelerated developments of treatment
modalities like stereotactic body radiation therapy [202, 203] involving very high doses. The
modeling work associated with the LEM uses a linear extension of the survival curves at high
doses [139], which is nowadays known as the linear-quadratic-linear (LQ-L) approach.
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3.4 Levels of clustering and complexity
As early as in the formulation of the Theory of Dual Radiation Action [153] Kellerer proposed,
inspired by the observation of an approximate D−1/2 dose dependence of RBE, that "the elemen-
tary lesions are of dual nature, i.e. that they are the result of two sublesions whose production
is independent of energy concentration". In these days the duality of lesion formation was inter-
preted as the formation of exchange type chromosome aberration, and an interaction radius for
such processes in the order of a micrometer had been revealed by Lea and Neary [38,39]. Later
on the concept of clustered or complex damage was generalized in the sense that the proximity
of two lesions can be regarded as one more complex lesion.
3.4.1 Biological target size
As mentioned before, interaction of lesions requires always an interaction range and with that
a corresponding target size which allows the interaction. Hence clustering and complexity is
intimately related with the question for the biological target. Goodhead opened up this question
and demonstrated that there might be a coincidence of scales which are relevant for radiation
damage, each of which is associated to a conformation unit of DNA in the cell nuclei [41,100].
The investigation of ultrasoft X-rays clarified that solely a consideration of micrometer sized
targets as in microdosimetric concepts was insufficient and also targets on the nanometer scale,
i.e. the level of several base pairs on the DNA, have to be considered. These findings led to
the notion of complex damage, where the term complex refers to nm complexity. Such lesions
could for instance be a DSB with another DNA lesion in closed proximity. The work of Nikjoo
and coworkers [33,204] followed this track and investigated their abundance and importance.
Strongly related, also work going back to Ward [205, 206] suggested the existence of ’locally
or regionally multiply damaged sites’. Later on other levels of complexity were suggested [171,
207, 208], corresponding to larger conformation units of the DNA in the sub kbp, kbp and
Mbp range [110]. Experimental techniques have been developed relating gene loci with spatial
distance in the chromatin. Different techniques provide support for the importance of different
scales, and indeed up to now concepts like the existence of the 30 nm fiber of chromatin are
questioned by some studies [209,210].
However, as from the field of microdosimetry and investigations on chromosome aberration
the relevance of the µm scale is evident, it was proposed that aberrations can form based on two
DSB within about a micrometer distance. But again, general quantitative relationships between
DSB induction and aberration yields were not established, leaving room for further mechanis-
tic interpretation of lesion interactions on the micrometer scale. Here the LEM and GLOBLE
models propose explanations, why spatial proximity of DSB facilitates enhanced formation of
aberrations.
In a more general sense, complex or clustered damage can be defined as any proximity of
lesion within a given volume. Thus a DSB can be regarded from the viewpoint of radiochemistry
as a higher order damage as it results from ionization clusters [78], implying a composition of
two SSB. Likewise, two DSB in micrometer proximity also constitute a higher complexity than
single DSB, and might thus facilitate the formation of lethal chromosome aberrations. Recalling
that single DSB can be usually repaired with quite good fidelity these considerations are of
particular interest to reveal both the lesions and associated biological targets responsible for
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radiation damage on the cell and organ level. However, up to now the discussion of complexity
and its implications is by far not at the end and thus there is also some ambiguity in existing
definitions and conventions - it is not clear what complex damage is or what types of complex
damage are relevant.
3.4.2 SSB clustering on the nanometer scale
Paradigms for damage cluster on the nm scale were introduced by Ward as locally multiply
damaged sites who pointed out the distinct role of OH radicals for the induction of these lesions
[205, 206]. Nikjoo followed by a classification of nanoscopic damage, consisting of SSB and
DSB and these lesions by accompanying themselves, like 2 DSB, 2 SSB or an SSB and a DSB
in close proximity [33, 204]. The enhanced DSB yield of high LET radiation and of ultrasoft
X-rays could be explained by this approach. Quantitative investigations were carried out based
on Monte Carlo transport codes of secondary electrons.
In the framework of LEM a more simplistic picture was established for the calculation of DSB
yields. Its simplicity consists of only considering DSB and SSB without discriminating between
different levels of complexity of these lesions. In general, two SSB on opposite strands may
form a DSB, if they are induced sufficiently close to each other. The formation of additional
DSB is visualized in Fig. 3.3a. The model calculation starts by the yields of high energetic
photons for SSB and DSB, where the values resemble average values found in the literature for
mammalian cells. The yields are linear in dose up to at least 100 Gy [48], which means that
the lesions are typically formed by single track processes. Hence for high energetic photons,
DSB are usually induced by one electron or one ionization cluster, causing two SSB on opposite
strands of the DNA in a small volume in a correlated way. This insight was inspiration for
modeling additional DSB at very high photon doses due to the random coincidence of SSB.
They are interpreted to be formed by different tracks at high photon doses, thus resulting in
a quadratic component of the DSB yield. In [211] the model procedure is explained in detail,
and a yield ratio of the linear and quadratic component in dose of αDSB/βDSB = 8300 Gy was
found, meaning that at this value as many inter- as intratrack DSB are produced and the yield
will be doubled. To summarize the model in brief, for a given dose a random positioning of SSB
on both DNA strands was simulated and opposite breaks within intervals of 25 bp counted as
additional DSB. In the case of high ionization densities of ion tracks or at electron track ends,
e.g. after ultrasoft X-ray photoionization, the local doses are comparably high. Therefore the
concept of DSB enhancement can be applied in a straightforward manner to these situations.
In LEM, the DSB enhancement makes up one part of the higher effectiveness of ion tracks. For
ultrasoft X-rays as well as for ions, experimental values for DSB induction and cell survival could
be explained with this approach.
In comparison to other model approaches based on the Nikjoo classification like PARTRAC
or RITRACKS [179, 180] the main differences of LEM are the restriction to DSB and SSB only
and the admittance of the interaction of 25 bp instead of 10 bp. The numbers are somewhat
ambiguous as experimental indications derived from plasmid experiments only give an order of
magnitude. Hence some more research is needed, and at the moment a validation of the mod-
eling assumptions can only be gained indirectly by comparison of calculated vs experimental
yields or effects, where all model approaches are comparably successful. It should be stressed
again that the LEM approach is designed most simplistic, does not claim therefore to reflect the
real diversity of complex lesion formation on the nm scale. However, it does claim to reveal
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the right proportion of enhancement of such lesion formation for high ionization densities by
probabilistic arguments.
3.4.3 DSB clustering on the micrometer scale
Within a classical view going back to Lea and Neary [38,39] the micrometer scale is important
for the formation of chromosome aberrations, where two lesions in different chromosomes but
in close proximity of about a micrometer can result in exchange type aberrations. Evidence
is also seen in cell survival curves, interpreting the quadratic component of the LQ model to
result from these lesions by binary misrepair. This interpretation, however, is not in agreement
with a large induction rate of simple chromosome aberration composed from two breaks which
appears to be linear in dose [212], but would be expected to follow a quadratic dependence.
One can ask at this point if the theoretic considerations are incomplete or the experimental
dependencies are not revealed correctly, as aberrations are hard to quantify due to subtle time
effects and detection uncertainties.
The approach of LEM and GLOBLE here does not consider the micrometer scale as interaction
between lesions in different chromosomes, but rather clustering of DSB within subcompartments
of DNA. A rationale for this is given by the concept of chromatin loops as subcompartments of
the DNA. Chromatin loops are thought to be intervals of the 30 nm fiber of the DNA between
attachment sites to the nuclear matrix at distinct gene locations. Such loops have been proposed
by several studies [213,214] relating genomic to spatial distances and estimated to be of about
2 Mbp in length. Also other techniques point towards a relevance of DNA conformation units
of on average about 2 Mbp size, including DNA fragment size measurements [208, 215–217],
Hi-C techniques [218,219] or the phosphorylation length of γH2AX foci around damaged sites
of the DNA [220]. This is supported by theoretic arguments [221–224].
The general idea is that isolated DSB within a loop can be repaired quite effectively, while
the abundance of multiple DSB within one loop, termed as clustered DSB is more severe and
repaired with less fidelity. Such lesions would disrupt the integrity of the DNA fiber and facili-
tate a formation of chromosome aberrations which might commit lethality when the cell enters
into next mitosis. The typical size of chromatin loops would correspond to about half a microm-
eter, in line with the prior microdosimetric findings. Clustering of DSB in chromatin loops is
visualized in Fig. 3.3b.
A recent different modeling concept also foots on the idea of in-site multiple lesions as a form
of complex damage which facilitates chromosome aberration formation [171], but in this study
the kbp, corresponding to rather than the Mbp scale was exploited. In this model the yield of
clustered lesions is a fit parameter rather than a model result and thus there is limited predictive
power of such modeling. Nevertheless this approach shows that there is discussion about the
relevance of higher order clustering and about the relevant size and the corresponding target.
There is also some experimental and theoretic evidence for the existence of smaller loop scales
of about 100 kbp [225–227]. More experimental investigation could help to clarify the situation,
and in the virtue of novel techniques [218] promising results can be expected within the next
years.
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Figure 3.3: Levels of clustering in LEM and GLOBLE: (a) nanometer scale and (b) micrometer
scale.
3.5 The Local effect model
The local effect model is a model approach combining several ideas to predict the radiation
damage after high LET charged particle radiation. Its original version, LEM I, is used up to now
in carbon ion therapy facilities in Europe as RBE predicting model in treatment planning. Over
the years the model was refined and comprises in its current development stage, LEM IV, not
only the consideration of local dose distributions but also of corresponding lesion distributions.
It allows the reliable prediction of RBE for all therapy relevant particles and energies. All further
discussion will relate to LEM IV. Table 3.1 gives an overview of the model versions.
Table 3.1: Model versions of the Local Effect Model.
Model
version
Included feature Reference
LEM I Local effect calculation based on local dose [139,161]
LEM II Radical diffusion and nm interaction of SSB resulting in DSB
yield enhancement
[94]
LEM III Energy dependence of the core radius in amorphous track
structure
[228]
LEM IV Conversion of dose to DSB distributions to determine local
lesion complexity
[185] and [A1]
3.5.1 Principles
The LEM follows a number of basic strategies to estimate the high LET effectiveness. As a
proof of principle, first results of LEM IV were published in [185]. The model set-up, a detailed
mathematical implementation and further model tests are outlined in article [A1]. The main
strategies followed in LEM are:
• The simple amorphous track structure model introduced in 2.4 is used to determine the
local dose at any distance r to the primary ion’s trajectory. The model reveals a 1/r2
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dependence of local dose up to a finite range given by the maximum energy of δ-electrons.
In the core, a maximum dose is proposed to assure a proper normalization of the radial
local dose profile according to the LET.
• The yield of DSB based on LET is derived using the concept of nm clustering of SSB as
outlined in [211,229].
• A spatial distribution of DSB in cells is derived by a stochastic Monte Carlo sampling from
the local dose distribution. The nuclei are considered as cylindrical objects with homoge-
neous DNA distribution. The arrangement of DSB after an ion passing a nucleus is sketched
in Fig. 3.4.
• Proximity of DSB is evaluated to determine clustered DSB, defined as more than one DSB
within chromatin loops, which are modeled as cubic subcompartments of the nucleus.
From this the proportion of clustered to isolated DSB is evaluated and taken as a parameter
quantifying the complexity of the damage milieu within the nucleus.
• A photon equivalent dose providing the same degree of complexity is determined and the
associated photon effect calculated from the photon dose response parameters. The ion
effect is determined as a fraction of this effect scaled by the total DSB number, as for ions
not the entire cell is exposed with the same lesion complexity. Notably, thus the ion effect
is determined as an extrapolation form the photon dose response curve.
Figure 3.4: Set of DSB induced by a high LET carbon ion passing through a cylindrical model cell
nucleus of 5 µm radius and 500 µm3 volume. Along the particle track a high density
of lesions becomes visible, while far off the center only eventually a DSB produced by
a high energetic δ-electron occurs.
Summarizing, the main concepts of LEM are the exploitation amorphous track structure, of the
coexistence of both nm and µm scales for lesion induction, and the extrapolation of the photon
dose response to the high LET response scaled by the complexity of the lesion distribution. A
basic insight justifying this step is, as described in [185], that the local radiation action is usually
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mediated by means of secondary electrons and therefore the local response does solely depend
on the local ionization density, regardless of the radiation quality causing these ionizations.
The course of different steps in LEM is visualized in Fig. 3.5. Although the general concept is
kept most simplistic as it works usually with average quantities and essentially only uses the
photon dose response parameters as variable input parameters, the practical implementation in
a computer code is somewhat tedious, because for instance the proper compartmentization of
the nuclei in chromatin loops has to be arranged. The full mathematical framework and steps
towards such an implementation are presented and discussed in article [A1].
Figure 3.5: General set-up of LEM: Starting from an amorphous track structure parameterization
of the local radial dose profile of individual particles passing through the cell, an
overall dose distribution across the entire nucleus and from that a lesion distribution
is derived by means of a Monte Carlo calculations. Next, lesions within box shaped
chromatin domains are scored, and isolated (blueish boxes) and clustered (reddish
boxes) DSB are counted. Their proportion is calculated as a representative quantity
characterizing the average degree of complexity of lesions. Then a photon dose is
determined where a lesion pattern after photon irradiation would produce the same
average degree of complexity. Finally, the associated effect after photon irradiation
of that dose is determined and reflects, weighted with the volume fraction covered
by ion induced lesions, the effect of the ion. From this the RBE can be immediately
calculated.
It should be stressed that the LEM has both mechanistic and empiric properties. It is mecha-
nistic, as the distribution of lesions gives a clear interpretation of the complexity of initial lesion
distributions. It is empiric as the complicated biologic processes involved in damage processing
and repair is only implicitly considered in the photon dose response, parameterized by the LQ
parameters. This allows taking into account repair without explicit modeling, using the reaction
to photon radiation as template. Another remarkable property of the LEM approach is that the
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assumption of the coexistence of two spatial scales directly enter in two separate contribution
to RBE, one originating by the pure number of DSB and the other by the interaction of DSB.
In comparison to most other high LET dose response models the biggest advantages of LEM are
a true consideration of nm resolution within the amorphous track approach, a clear paradigm
of relevant targets and target sizes and effect computations based on a few assumptions and
using a minimum sized set of parameters only. It has been thoroughly benchmarked against
in-vitro and in-vivo data. It is used successfully in its original version for treatment planning in
carbon ion therapy in the treatment facilities in Heidelberg, Marburg, Pavia, and Shanghai, and
will also be used in the facility in Wiener Neustadt in future. As proposed before, a successful
application to a broad range of different situations, as outlined in the next section, is one of the
most intriguing arguments for the model approach.
3.5.2 Applications
Since the model set-up was completed the LEM IV was applied for different purposes. Here,
published and ongoing work is listed in order to demonstrate the widespread applicability of
the model, both in radiobiology research and the clinical context.
Applications in radiobiology
• Spatial measurement of dose distribution in tissues have been performed by means of
biodosimetric methods. LEM predictions based on the amorphous track structure approach
are in good agreement with radial distribution of DNA damage in tissue along individual
ion tracks [230]. Before only physical measurements of track structure carried out in
gaseous media were available. These studies thus confirm the validity of the radial track
structure approach for biological applications.
• Due to gradual repair of induced damage protracted dose delivery will result in a smaller
effectiveness than instantaneous dose exposure for photon irradiations, while this effect
is less obvious for high LET radiation. The impact of temporal aspects of dose delivery
for high LET radiation was investigated with LEM and is in agreement with experimental
data [231].
• The distinction of damage classes of isolated and clustered DSB along with the track struc-
ture model in LEM allows a description of damage induction and repair kinetics after high
LET irradiation. A further assumption in this context was, that clustered damage is likely to
be subject for a slower repair than isolated DSB. A mechanistic description and prediction
of kinetics of DNA damage after high LET irradiation was developed. The repair of isolated
and clustered DSB were identified with the slow and fast component of damage repair (c.f.
Fig. 2.3a) and compared to experimental data, where agreement was found [232,233].
• An enhanced effect of high LET ion radiation is due merely to the inhomogeneous ion-
ization pattern. This was shown by dedicated microbeam experiments where low LET
protons showed en effect enhancement solely by focusing the beam to sub micrometer di-
mensions [234]. Experimental results for cell survival can be precisely described by the
LEM. The experiments serve as a direct evidence for the relevance of micrometer lesion
interaction. In comparison to the effect of carbon ions of comparable LET but higher ion-
ization density also the effect of interactions on the nanometer scale is demonstrated. The
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experimental results are revealed by LEM with good accuracy. This research is conducted
within the BMBF founded project ’LET Verbund’, and a corresponding publication is in
preparation.
• To understand normal tissue radiation injury, the LEM has successfully predicted the RBE
for side effects after spinal cord irradiation in in-vivo systems [235]. This proves that also
endpoints on the organ level can be described by LEM and is a proof of principle on the
way to clinical application.
Clinical applications
• As LEM I is the model version still used for clinical applications, a comparison of clinical
results and treatment planning based on LEM I with the improved model version LEM IV
was needed. For TCP of chordoma as well as for NTCP of temporal lobes after irradiation
of craniosacral tumors it was found, that both model versions describe the clinical results
adequately [236,237].
• The determination of RBE for clinical purposes is important for a proper treatment plan-
ning, but the RBE depends on the model used. Hence comparing treatment plans where
the RBE was derived with different models needs a mapping of the different RBE concepts.
To understand clinical studies from Japanese ion beam treatments a translation of their
clinical doses into European RBE weighted doses was necessary. The LEM helped to derive
such translation recipes [238,239].
• LEM was used to predict the dose dependence of RBE and to demonstrate the tissue type
dependence of RBE at high doses. These findings are of relevance in therapy planning of
modern regimens using high doses in few fractions (hypofractionation) such as in stereo-
tactic body radiation therapy [240].
• In proton therapy conventionally an RBE of 1.1 in the entrance channel and the target
is used by recommendations of the ICRU [241]. This is standard in proton facilities all
over the world, while radiobiological studies clearly demonstrate higher RBE values at the
distal part of extended Bragg peaks. Hence the question arises what impact a more explicit
consideration of RBE in treatment planning would change and if possibly side effects of
the therapy could be reduced. One aspect of the higher RBE is a shift of the biologically
relevant range of the proton beams into the normal tissue. A quantification of the range
dependence on tissue type and dose was possible with LEM [242]. This topic is of large
current interest in medical physics, and clinical results are expected in the near future
which will allow further comparison of the predictions with clinical data.
• LEM simulations are usually carried out with some approximations, shortening the Monte
Carlo runs needed for convergent RBE results. However, for larger doses as of interest
in hypofractionated regimens, systematic model errors increase. There a more time con-
suming full simulation was performed [A1], considering the exact stochastic nature of
hit statistics of ions on cell nuclei. By modifications of the treatment planning system
TRiP [140,243] a usage of thereby calculated RBE information was enabled [244].
• Second cancer risk after particle therapy is an important topic of current research. A
comparative study of carcinogenic risk after proton and carbon therapy was performed
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by applying the LEM for the calculation of cell inactivation and adopting some ideas of
LEM also for the simulation of carcinogenic trigger mechanisms. The cancer risks were
exemplarily evaluated at hand of Hodgkin’s Lymphoma patient plans [245]. These model
approaches may become helpful for understanding and predict late side effects of radio-
therapy and build a bridge between radiobiologic considerations and radiation protection.
• LEM was applied to assess benefits in ion therapy comparing protons, helium and carbon
ions as different therapy relevant ion species [121]. As particle therapy is still to be con-
sidered as an emerging form of therapy, optimization with respect to benefit is a vivid field
of research.
• One problem in hadron therapy treatment planning is intrafractional organ motion. For
a quantification of the consequences of motion, the biological radiation action has to be
considered in the target and normal volumes. Again, LEM can be applied for a proper
analysis [246].
The list demonstrates that the relevance of biophysical modeling covers aspects of clinical
applications, radiation protection as well as basic cell biology research. The methods used for
these investigations all use LEM as introduced in [185] and article [A1].
3.6 The Giant Loop Binary Lesion model
Based on experiences made with LEM the idea arose to go one step further in the interpretation
of the concept of distinguishing between two lesion types only for the effect prediction, namely
of isolated and clustered DSB, and to associate these with individual lethalities. A straightfor-
ward application to photon irradiation led to the development of the GLOBLE model. Like LEM,
GLOBLE is a very simple model approach based on a minimum of assumptions and parameters.
3.6.1 Principles
The GLOBLE model exploits a small number of assumptions, which makes it to a very simple
photon model, based on a mechanistic interpretation. The details of the model development and
first applications as a proof of principle are outlined in article [A2]. The underlying concepts
are listed below:
• As for LEM, chromatin loops of 2 Mbp DNA are regarded as interaction regions of DSB.
Again the distinction between isolated and clustered DSB is made.
• For high energy photon radiation dose is deposited quite homogeneously across cell nu-
clei. Henceforth to good approximation the number of isolated and clustered DSB can be
calculated simply by Poissonian statistics.
• To convert the abundance of lesions with an effect, each isolated and each clustered DSB is
associated with a inactivation probability of the entire cell. These two probabilities are fit
parameters of the model and are considered as parameters of the individual radiosensitivity
of the cells under investigation.
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With this conceptual basis the cell survival probability S can be expressed as
S = e−(niεi+ncεc) , (3.1)
where ni and nc are the dose dependent number of initial isolated and clustered DSB, respec-
tively, and εi and εc are the corresponding cell inactivation probabilities of those lesions. For
photon radiation at high energies the number of unaffected chromatin loop domains, ni and
nc can be determined from Poissonian statistics for the DSB distribution. As demonstrated in
Fig. 3.6 this results for low doses in a linear increase of ni and a quadratic increase of nc with
dose. At very high doses, which are not accessible experimentally, essentially all domains are
expected to have more than one DSB. Consequently, in terms of cell survival a transition from
an iDSB- to a cDSB-dominated damage regime is expected.
Figure 3.6: Number of unaffected chromatin loop domains, domains with exactly one DSB (iDSB)
and with more than one DSB (cDSB) vs dose, assuming Poissonian statistics for the
DSB distribution.
The model derivation and mathematical details are presented in article [A2]. There it also has
been demonstrated that the simple approach along with the mechanistic interpretation allows
to understand the dose response curves of repair deficient cell lines as well as an observed anti-
correlation of α- and β values of the linear-quadratic model for various cell lines. Most inspiring,
however, are the numerical values of the model parameters which revealed that isolated DSB
are lethal to about 1 %, while clustered DSB typically are lethal in 20 % of all cases for cell lines
with an intact repair system. These numbers are only indications as their exact values depend on
the particular cell line under investigation, but reflect the general idea of different lethalities of
different levels of lesion complexities. Although only considering lesion interaction in chromatin
loops as closed compartments this approach does not forbid an impact of eventual formation
of chromosome aberrations: Unrepaired clustered DSB facilitate the formation of aberrations
which then determine cell death. The associated probabilities are implicitly contained in the
lethality coefficients of the GLOBLE model.
It should be mentioned that the mathematical structure of the GLOBLE model as proposed in
Eq. 3.1 - even without the mechanistic interpretation of chromatin loops and lesion clustering
- is the most simple model distinguishing between less and more harmful lesions. Hence one
can be faithful that the GLOBLE is a quite basic concept with a justification simply based on
mathematical arguments. On the other hand one has to recall that the model parameters are
average quantity over a cell population, which includes for instance different cell cycle stages of
changing radiosensitivity in the case of asynchronous cells.
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3.6.2 Applications
In the following published and ongoing work related to GLOBLE is listed:
• As outlined in article [A2], GLOBLE allows to understand the relation of wild type cells and
derived cell lines of these with defects in the repair system, impairing DSB repair. The latter
usually show a steep dose response curve [247], which suggests that even isolated DSB can
not be repaired properly, and thus are comparable in effect to clustered DSB. Assuming
that the lethality εi of iDSB is equal to the lethality εc of cDSB allows to understand the
radiosensitive behavior of repair deficient cell lines.
• The GLOBLE was applied to explain the enhanced radiation action of ultrasoft X-rays.
Based on the enhanced DSB yields and the dose response properties after high energetic
photon radiation an accurate prediction of survival curve after irradiation with ultrasoft
X-rays was found. Remarkably, also an mechanistic explanation could be given why in
this case the RBE is not dependent on dose. Hence with GLOBLE also the entire shape of
survival curves can be predicted, both for high energetic photons and ultrasoft X-rays. In
article [A3] the whole model framework and the results are described and discussed. It be-
came evident that both levels of inhomogeneity have to be taken into account, namely the
localized ionization clusters due to the small range of secondary electron tracks as well as
the decreasing dose profile across cell nuclei due to photoabsorption. In a following work
the calculation of the yield based on the nanometer interaction of SSB is modeled, com-
pleting the full understanding of the radiation damage of ultrasoft X-rays. A publication is
in preparation [99].
• As for high LET radiation qualities, the time course of repair was investigated at hand of
γH2AX kinetics after photon irradiation. Experiment data could be adequately described
by the kinetics predicted with GLOBLE [248]. The model procedure involved a proposed
correlation of iDSB and cDSB with slow and fast repair components of biphasic repair
kinetics. The applicability of biphasic repair as proposed within the GLOBLE model was
shown to be justified at hand of a data collection [53].
• The GLOBLE model was successfully enhanced by a kinetic simulation of lesion induction
and repair for protracted irradiation [249, 250], thereby simulating dose rate effects of
photon radiation. Here the idea was that after induction of an isolated DSB a lesion can
either be repaired or accompanied by induction of a further DSB, converting it into a
clustered DSB. The kinetics could be described by formation and decay rate equations,
strongly inspired by simulation of occupation states of laser media. This approach was
later on also applied within LEM to high LET radiation qualities [231], demonstrating
the strong link between these two model approaches. This work also demonstrates how
mathematical modeling techniques of a field of pure physics can be transferred to the
different context of radiobiological problems.
• An enhancement of GLOBLE led to the discrimination between the inactivation probabili-
ties associated with different pathways of DNA repair after irradiation [251]. This allowed
a cell cycle dependent description of cell survival curves.
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All these applications are based on the model introduced in article [A2]. Despite of the sim-
plicity of the GLOBLE approach the most obvious characteristics of photon irradiation experi-
ments can be explained and the full dose response curve appropriately be calculated.
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4 Accuracy and uncertainty considerations
Every measured quantity is subject to uncertainty. Moreover, variability is an ubiquitous phe-
nomenon in biology. For most observables large uncertainties are rather the rule than the
exception. For the application of radiation effect models a number of questions arise in this
context:
• Experimental and clinical outcome is only reproducible in the sense of average values of
the observable. This is due to inherent uncertainties related to damage processing and
induction, but also to the variation in the inter-individual radiosensitivity cells and patient
populations. What is the impact on biophysical modeling, if model parameters are subject
to errors?
• What is the desired accuracy of such modeling, if the quantities to be described are anyway
subject to large uncertainties?
• How can one separate the limits of a model, inducing systematic errors of the model results,
from the potentially also systematic uncertainty of experimental data used to benchmark
models?
Research on such questions in radiobiology is still a byproduct rather than a focus. Although
some methodological problems of e.g. retrieving parameters of the LQ model from in-vitro or in-
vivo data or the propagation to the RBE have been pointed out [252–255], usually few effort is
made to account for such problems. However, interest has increased by the growing importance
of modern radiation therapy modalities, where precise therapy planning is required.
From a clinician’s perspective the relevance of uncertainty associated with effect modeling is
embedded in a whole list of other uncertainties faced in practical treatment. These include:
uncertainties of the CT image evaluation, uncertainties in the target delineation, positioning
uncertainties, uncertainties in stopping power and beam properties, limited accuracy of dosime-
try, uncertainties due to target motion and changing target volumes during the treatment due
to tumor growth or regression [256]. Nevertheless in particular for carbon ion therapy where
the RBE is large, uncertainties in the biological planning are significant and translate into un-
certainties of doses to be delivered. Hence they need to be addressed properly. But also in
proton therapy, where so far biological treatment planning is only applied within a fixed RBE
of 1.1 [241], there is evidence in particular from in-vitro experiments for higher RBE values in
the Bragg peak area [257], and the uncertainty due to the RBE at distal ends of applied fields is
known and discussed [242,256,258,259].
Although far from having a complete picture, the present chapter summarizes results that
have been gathered on uncertainties of parameters and quantities of relevance for LEM. First,
different types of uncertainty occurring in RBE modeling are discussed. Next, to understand
the influence of parameter uncertainties in LEM a sensitivity analysis has been performed and
will be presented in the next section. Then the possible induction of artificial systematic uncer-
tainties by means of preparation of raw data is demonstrated. Having the need for caution in
the interpretation of experimental data in mind, finally the investigation of uncertainty in cell
survival data is covered in detail.
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4.1 Types of uncertainties in RBE
Different types of uncertainty related to RBE modeling with LEM exist. A rough classification
with reference to subsequent sections is given below:
• Experimental quantities used for input parameters of the model are subject to uncertain-
ties. This comprises inter-individual variabilities between cells or patient populations un-
der investigation. The uncertainties will propagate to uncertainties in the modeling results.
They are considered in section 4.2.
• Starting from raw data, derived quantities like the α/β-ratio are often considered. By
calculating these quantities bias errors can be induced by nonlinearities in the uncertainty
propagation. This issue will be discussed in section 4.3. In modeling, the α/β-ratio is often
used as input parameter. The impact of such bias errors has consequently to be accounted
for.
• Experimental quantities used for model benchmarking are subject to uncertainties, which
will be elucidated in section 4.4. These will determine how decisive model tests can be.
• The model will have, in particular due to its simplicity, limits. These can be apparent as
systematic model errors like over- or underestimation of effects in some situations. Limits
of LEM are briefly discussed in section 5.2.
Moreover, the LEM applies a Monte Carlo code to derive DSB distributions in nuclei. However,
as Monte Carlo routines converge as 1/
p
N with the number of runs N to the asymptotic value,
this error can be made arbitrary small by sufficient runtime. For published results usually a
Monte Carlo error of lower than 1 % is assured. Hence this origin of uncertainty can be discarded
for further discussion.
It is worthwhile to note at this point that the different origins of uncertainties consist a gen-
eral difficulty when the predictive power of different models should be compared: As models
typically refer to different sets of input parameters, different levels of uncertainties are involved
and would have to be separated from the model inherent uncertainties. This is in general not
feasible, and there is no clear recipe how to compare models under non-comparable bound-
ary conditions. Hence most model comparisons actually suffer from some non-comparability,
meaning that a fair and equal treatment of the models to be compared cannot be guaranteed. A
comparison of LEM to other models has therefore been followed only qualitatively by comparing
the model ingredients and underlying concepts. Solely on the level of clinical applications model
comparisons have been performed based on established procedures for patient treatments with
carbon ions, where the goal was to set predicted RBE values in relation rather than assessing
the performance and accuracy of the underlying models [236,238,244]
4.2 Parameter sensitivity analysis
In conventional photon therapy a dose accuracy of 5 % in the target region is recommended
and should be guaranteed by a proper quality assurance [260]. Due to the various sources of
uncertainty, in carbon ion therapy this level of accuracy is not feasible. Although there are no
official recommendations an uncertainty of the RBE weighted dose of about 10 % is regarded
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as tolerable. Hence one of the important tasks is to quantify the RBE uncertainty and to make
sure that RBE predictions are sufficiently accurate.
A first step to quantify uncertainties of predicted RBE is to investigate how the LEM propagates
uncertainties of its input parameters. In practical applications, the input parameters may vary
due to inter-individual differences between cells under investigation or different patients to
be treated [261–263]. As LEM maps the effect after photon irradiation onto that after ion
irradiation in a non-trivial way there is no analytic way of performing such an analysis. Hence
a sensitivity analysis was performed starting from typical input values for both monoenergetic
irradiation and for irradiation of a spread out Bragg peak as for clinical purposes. The sensitivity
analysis demonstrates here the change of the RBE as model output stimulated by a change in
one of the input parameters. The sensitivity analysis of LEM IV is presented in article [A4] along
with an exemplary demonstration of how sensitivities can be converted into an RBE uncertainty
estimate for clinical purposes based on plausible input parameter variabilities. Related work has
been published focusing at particular input parameters of LEM IV [264] and impact on tumor
control probability using LEM I [265].
The study of article [A4] showed within a systematical sensitivity analysis that the calculated
RBE is most sensitive on the photon dose response parameters which are used as input for the
RBE calculations. Therefore the associated uncertainties of the RBE are present already in the
response to photon radiation. Moreover, the uncertainty in extended Bragg peaks decreases in
comparison to monoenergetic radiation of comparable dose averaged LET. The reason is that
across a SOBP a mixture of radiation qualities exist, leading to a damping of the uncertainties,
but also a reduction of RBE. For proton therapy, where the RBE at distal ends of fields might
be harmful as it is not taken into account in treatment planning, such a reduction is desired
and could be realized by techniques like LET painting [266–268]. However, for carbon ion
radiation a high RBE is beneficial as it provides a higher ratio of RBE weighted dose in the
peak compared to the entrance channel. Hence a compromise between that high RBE and
associated tolerable uncertainties has to be found. For this more radiobiological and clinical
studies will be needed, and the provided methods in article [A4] will be helpful for a quantitative
assessment of uncertainties. In the context of the current discussion of personalized medicine
[269] such studies appear very promising and could facilitate a full exploitation of RBE for
clinical treatments in future.
4.3 Uncertainties induced by data processing
In radiobiology the application of Gaussian error propagation is often inappropriate for two
reasons. First, the distribution of the data is often not Gaussian, and second, the uncertainties
of data are often of the same order as their mean, prohibiting a series expansion of the influence
of deviations up to first order only. Consequently, more advanced techniques like simulated error
propagation by Monte Carlo methods have to be applied for such quantities [270].
This becomes of particular importance, when based on measured data composite quantities
are derived, like the α/β-ratio or RBE values as a ratio of two doses. As concluded in article
[A5], caution is needed in the interpretation of RBE values reported in the literature, as these
values might be systematically too large. The same argument applies again to α/β-ratios if they
are directly derived from dose response curves. The reason for such a bias error is due to the
properties of ratio distributions, as shall be outlined briefly in the following:
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The distribution of ratios of random variables is an interesting statistical problem. For two
Gaussian random variables X1 and X2 with realizations x1 and x2, respectively, the ratio X1/X2
is a new random variable which follows a long tailed distribution. In particular this implies
(x1/x2) > x1/x2. So the ratio x1/x2 of individual realizations is likely to be too large as com-
pared to (x1/x2).
Article [A5] focuses on this issue and revealed that under the assumption of Gaussian distri-
bution of numerator and denominator of the ratios the result will be distributed with a long tail,
making large values more likely. This is demonstrated at hand of RBE values calculated from
dose response curves, but the same argument also applies to α/β values, c.f. 4.4. A further
complication is that the assumption of Gaussian distribution is not necessarily true and that in
addition correlation between both quantities of the ratio might play a role.
Suggestions to overcome these difficulties are to consider, if possible, as many data as possible
to obtain an impression of independent experimental results. Furthermore, if the uncertainties
of the numerator and denominator quantities can be estimated, Monte Carlo error propaga-
tion allows to construct the theoretic ratio distribution and to assess the bias error induced.
Generally, as outlined in article [A5] it is suggestive to use median values instead of average
quantities because the median is less sensitive on the shape of the distributions. With these
techniques bias errors can be quantified and taken into account. The work nicely shows that not
only experimental results in terms of mean values, but also the underlying distribution have to
be considered in order to fully understand characteristics of derived quantities. In article [A5]
the necessary mathematical framework is provided for a profound error propagation.
4.4 Uncertainty and variability in observed experimental radioresponse
For tests of RBE models experimental data of ions over a wide LET range are needed. In ad-
dition, for LEM photon dose response data are needed as input parameters, where again a
quantification of uncertainties is of interest. To follow the goal of obtaining a global view on
available data and to quantify their uncertainty, for the endpoint of cell survival a data base
has been established, containing over 800 combinations of survival curves for both low and
high LET irradiation taken from the literature. It was termed Particle Irradiation Data Ensemble
(PIDE) inspired by a data collection of energy levels in nuclear physics [271]. The PIDE con-
tains besides the cell survival data, parameterized within the parameters of the LQ model, also
relevant physical and biological information such as the cell types, particle species, energies and
LET values and several more. It was introduced in article [A6], where also first evaluations
were presented. The PIDE is the largest data base, while other data collections exist, focusing
on certain aspects of dose response curves [257,272,273]
The data base was made available for the research community and can be retrieved over the
GSI website [274]. Currently the data base has about 100 subscribers who use it for their own
research. Ther are already some publications showing results derived from PIDE [6, 124, 275–
281]. The most important features of PIDE are compiled in the following list:
• PIDE contains 845 pairs of cell survival curves (for photons and ions). These were taken
from 74 publications.
• The cell lines used comprise sensitive and resistant cells, normal and tumor cells, cells
in asynchronous populations and synchronized in particular cell cycle phases, and human
and rodent cells. All properties are tabled in the data base.
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• Irradiation conditions comprise monoenergetic beams as well as irradiation within spread
out Bragg peaks. Various ions at different energies have been used, resulting in different
LET values. Again, all properties are tabled in PIDE.
• Only experiments have been adopted into the data base which fulfill certain quality criteria,
like irradiation under track segment condition where the LET does not vary considerably
along the track segment through the cell nucleus.
Currently PIDE is being updated by including also raw data, i.e. the measured cell survival
probabilities for each dose point, instead of only providing the LQ parameters. The benefit
will be a more justified comparison between data sets of different labs or different researchers.
A generic problem is that at different institutions various ways of e.g. normalizing survival
data to the number of cells irradiated are applied. Likewise, error bars given for the raw data
are determined by various strategies. Moreover, the number of data points underlying each
survival curve differs, but has a strong impact on the precision of the derived parameters. Hence
accessibility of the full sets of raw data will facilitate a reanalysis of all data with the same
techniques.
One first insight confirmed by PIDE is that dose response after ion irradiation is rather robust
against changes in the cell’s radiosensitivity, while the photon dose response underlies a much
larger variability. Hence uncertainties in RBE go back to uncertainties in the photon dose re-
sponse curves to a large extent, in line with results from the sensitivity analysis, c.f. section
4.2. To demonstrate the large variability of photon parameters, Fig. 4.1 shows the distribution
of α/β-ratios of photon dose response curves listed in PIDE for V79 hamster cells. The large
spread of the values goes back to intra-individual and inter-individual uncertainties: Any cell
damage and subsequent damage processing is a probabilistic process and is consequently asso-
ciated with an inherent, also termed intra-individual uncertainty. Moreover, when comparing
independent experiments, ’copies’ of the cell lines in various labs differ in their history, which
might give rise to changes in their radiosensitivity. Also, different ways of analyzing raw data
and obtaining LQ parameters for the same cell line contribute to inter-individual differences. As
discussed in the previous section, a systematic distortion by means of calculating ratio quantities
(c.f. article [A5]) plays a role on top. Evidently, simply taking the calculated α/β values from
one experiment is insufficient for a characterization of a cell line. Rather a set of experiments
along with the distribution of the dose response parameters should be considered. The solid
line in Fig. 4.1 indicates a calculation of the ratio distribution of α and β , taking the uncertainty
of these parameters in the underlying experiments into account.
A number of further investigations have been carried out at hand of the PIDE and were pre-
sented in article [A6]:
• A precision analysis of the characteristics of RBE on its determining factors was provided.
This confirms long-standing findings in radiobiology with a high statistical performance:
RBE decreases with dose and decreases with the photon α/β-ratio. It increases with LET
up to a maximum RBE, where the overkill effect causes RBE to drop for higher LET values.
A profound particle specificity was determined in the increase of RBE vs LET and the
position of the RBE maximum. The scatter of data allows to refine and better quantify
these statements by appropriate statistical methods such as moving averages.
• An uncertainty and correlation analysis of the LQ photon parameters was provided. It
turned out, that for independent experiments the photon α and β parameters are anti-
46
Figure 4.1: Distribution of the α/β -ratios derived from V79 cell survival experiments tabled in
the PIDE. The solid line is a theoretic distribution function computed by methods
discussed in articles [A5] and [A6]. A strong curtosis and thus a long tail of the
distribution becomes evident. Hence simply considering individual α/β values or cal-
culating means might induce bias artifacts.
correlated. While within individual experiments such anti-correlation is expected by means
of the χ2 minimization fit procedure, for independent experiments the reason is not obvi-
ous. An explanation is found within the GLOBLE model and outlined in article [A2]. The
key idea is that the effect due to iDSB depends on α while the effect of cDSB depends on a
linear combination of α and β . If the GLOBLE model is the correct photon dose response
model this predicts the observed anti-correlation.
• The course the β-parameter of ion radiation in dependence on LET is largely debated
(see [282] and references therein). While no statistical significant conclusion has been
found so far, the results of the PIDE strongly indicate that RBE decreases for high LET
values. Presumably the reason is that particle energies and hence track structure widths
go down with increasing LET, impairing overlap of different tracks. A smaller inter-track
effect implies a smaller β value of ion radiation dose response.
Generally, characteristics of RBE and related quantities can be experimentally explored with
a high statistical power using the PIDE. A comprehensive view on the available data allows
moreover to develop measures for the spread of existing data as well as to identify ranges of
missing or scarce data, encouraging future experiments.
While of high interest for model benchmarking, such a data base is of limited benefit for clin-
ical purposes. There, α/β-ratios have to be derived from fractionation studies for the clinical
endpoint of interest. Usually the available data is scarce which is why for the development of
RBE information for therapy purposes all available information has to be regarded and inter-
preted in the more complex clinical context. However, characteristic properties of uncertainty
propagation in LEM as an RBE predicting model can also be investigated by means of in-vitro
data only, and results can then be transferred to the clinical situation as indicated in article
[A6].
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5 Discussion of the articles A1-A6
Aim of this chapter is to put the articles [A1-A6] into relation to each other and to briefly discuss
the main accomplishments. While each article contains an individual discussion part the focus
is here the common view on the effect model concepts and the uncertainty considerations.
5.1 Effect modeling: Articles A1-A3
At the moment, the LEM is used for description of charged particle radiation damage while the
GLOBLE model is applicable for photon radiation qualities. However, both models share most
of their underlying assumptions and concepts as evident in articles [A1] and [A2]:
• Both models carry out effect simulations in two stages: At first the distribution of radiation
induced DSB is simulated and interpreted in terms of isolated and clustered DSB, and
then from the lesion pattern the effect is derived. While the first step follows mechanistic
concepts, the second step is empiric, as knowledge about the photon dose response curve
(for LEM) or the lethality of iDSB and cDSB (for GLOBLE) is needed as reference. Hence
both models can be categorized as semiempiric.
• LEM and GLOBLE make both use of the conjecture that one class of critical targets of DNA
damage are chromatin loop domains. This is a distinct feature not used in other modeling
approaches and an interpretation of damage complexity.
• Both approaches can express cell survival based on the DSB induction. Hence two dif-
ferent endpoints are linked, one referring to initial damage and the other at more distant
consequences after all repair processes have ended. In contrast, most other modeling work
focuses at remaining damage after repair processes only.
• The models are capable to describe both spatial and temporal aspects of DSB induction
and repair. They exploit assumptions on the spatial scales of radiation damage (DNA size
and chromatin loop size, nm and µm scale) and temporal scales (two components of DNA
repair with repair times of about 15 minutes and 2 hours), and comparison to experimental
results supports the assumption of the existence of these scales.
• Both models can be regarded as a synthesis of concepts which have already found appli-
cation in other modeling approaches: Similar as in microdosimetry, interaction sites are
considered in which lesion accumulation leads to more complex damage [283, 284]. In
LEM the exploitation of amorphous track structure and using the photon dose response as
a reference radiation is similar to the concept of the Katz model [151]. The explicit model-
ing of DSB distributions is comparable to the output of Monte Carlo transport codes or in
combination with a DNA model on top [179,285]
Inspired by these similarities between LEM and GLOBLE, a unification of both approaches
should be feasible by using the GLOBLE dose response instead of the LQ model as input for LEM.
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This has not yet been accomplished, and the reason are differences in the photon dose response
curves of the GLOBLE and the LQ models at higher doses. As pointed out in section 3.3, the
shape of dose response curves at high doses is still under debate. Further work is needed to
verify or falsify current approaches and might help to unify the concepts of LEM and GLOBLE.
One of the most remarkable insights one can gain from the modeling concepts of LEM and
GLOBLE is that space and time to certain extent act in a similar way regarding radiation damage:
Radiation effects are the higher, the more condensed radiation is delivered in both space and
time. Inhomogeneous, acute irradiation is thus more effective than homogeneous, protracted
irradiation of same dose. Hence a spatiotemporal symmetry becomes evident. On the level of
radiation effects, RBE parameterizes the degree of ionization inhomogeneity in space, while the
dose and dose rate effectiveness factor (DDREF) is a related quantity (mostly used in quantifying
carcinogenic potential of radiation) parameterizing the effect modification for deviations from
instantaneous irradiation delivery [286–288]. Furthermore, the enhanced effect of ion radiation
results from different contributions, corresponding to the underlying spatial scales of radiation
damage.
Current research exploiting microbeam irradiation of cells with a specified number of ions
focuses at a generalization of the RBE interpretation in terms of the underlying spatial scales
and the characterization of the underlying ionization patterns [234]. At the time when this
thesis was completed, experimental results are in full agreement with the proposed coexistence
of µm and nm scales, and a corresponding publication is in preparation. These findings are
complementary to the study of ultrasoft X-rays (c.f. article [A3]), where primarily the nm scale
is of relevance and strongly underpin the list of necessary ingredients of RBE models as proposed
in section 3.1.
At the level of model application it is very convincing that with a fixed set of model parameters
shared by LEM and GLOBLE different endpoints and phenomena in radiobiology can be modeled
within one consistent picture. Figure 5.1 visualizes the various applications of the models. The
broad utilization of the LEM / GLOBLE formalism is an important support for the underlying
model ingredients and is hardly accomplished by any other competing modeling approach. The
simultaneous applicability to a wide range of phenomena is a strong support of the consistency
of the model concepts and the underlying assumptions.
5.2 Uncertainty considerations: Articles A4-A6
The emergence of uncertainty in radiobiologic data partially goes back to the probabilistic nature
of interaction of radiation with matter. Inter-individual differences in the radiation response
contribute additionally to the overall uncertainty, as outlined in article [A6]. In a physical
perspective this means that the biologic targets of radiation exposure are not fully identical.
Moreover, derived experimental quantities might suffer from bias errors which further enhance
the uncertainty, c.f. article [A5].
On the theoretic side, any model that is simple and only uses a few parameters has limits
of validity. To test a model, it should be challenged, and only as long no disagreement with
data can be found, it can be taken as valid. Disagreement will reveal model limits. However,
in the last step the uncertainty of the experimental data used for benchmarking needs to be
taken into account as well. Radiobiologic models might use experimental data as input param-
eters and thus will transport the associated uncertainties to their predictions, as discussed in
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Figure 5.1: Overview of possible applications of the LEM and GLOBLE models for various sce-
narios, endpoints and phenomena. The top line boxes specify the various radiation
qualities and biologic endpoints for which model calculations can be performed. The
center line refers to the effect calculations which might consider specific aspects of
dose response, involving spatial and / or temporal aspects of damage induction and
processing. The calculations are aiming at the topics presented in the bottom line,
summarizing the main fields of model application.
article [A4]. Further systematic deviations between model predictions and data then arise from
insufficiencies in the models.
Having these different sources of uncertainties in mind, a number of lessons can be learned
for testing radiobiological models:
• To reveal the model limits and uncertainties induced by the model, the fluctuation proper-
ties of experimental data used within the model and for comparison of model predictions
need to be known.
• The accuracy a model is aiming at is limited by the accuracy of the experimental data used
for model benchmarking.
• In the clinical context, radiobiological models are used in a framework of specified pro-
cedures with impact to radiation delivery to the patient. Uncertainty might either arise
from treatment planning which accounts for this framework, or the underlying biological
models. Hence model tests are frequently performed on the basis of in-vitro assays which
are much less demanding in its interpretation.
• Model parameters used as constant numbers might actually turn out to be representative
values of distributions. A sensitivity analysis as presented in article [A4] gives insight in
the key parameters which induce most uncertainty by using average values. For LEM it
turns out that in particular photon dose response parameters are the largest source of
uncertainty, while uncertainties of the internal model parameters have less impact on the
predictions.
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LEM and GLOBLE are designed based on various concepts, abstractions and assumptions.
Both models have been applied to situations, where comparison to experimental data was con-
sidered in order to perform model tests. It thereby was confirmed that the GLOBLE model
reliably predicts the shape of dose response curves and that LEM gives accurate predictions for
RBE values for all therapy relevant ions and energies. The only detected exception of this state-
ment is the entrance channel for very high energetic ions, in particular for protons, where RBE
values are slightly underestimated of the order of 10 %. The reasons for this are presumably
that in the physical beam model of extended peaks target fragmentation is not yet taken into
account. Furthermore, it is not clear if for high energetic ions, where the production cross sec-
tions of secondary electrons is low, the application of amorphous track structure is fully justified.
Research towards these questions is on the way.
Besides of these considerations one has to keep in mind that LEM and GLOBLE usually work
with average values. For instance, if a population of cells consists of several subpopulations,
deviations between the predicted and experimentally determined effectiveness might be ex-
pected [289]. This issue could be overcome by a component-wise application of the model. In
this perspective the GLOBLE model has been used successfully for the description of the cell
cycle dependence of radiation effects. A similar issue might arise due to a broad distribution
of cell nuclear sizes [290], where also a multiple simulation for different size categories would
allow for a better theoretic assessment.
Summarizing, in the current field of applications there are only minor systematic deviations
between the presented model work and experimental observations. The techniques presented
in this thesis show how point predictions of radiation effects and associated uncertainties can
be derived. In most parts of the parameter space the LEM and the GLOBLE model result in pre-
dictions with are correct within the accuracy of data used for benchmarking. This has important
implications for therapy, where the uncertainty of patient treatment plans might be assessed,
but also for novel applications such as biodosimetry, where measured radiation effects may be
used to reconstruct the absorbed dose by backward application of effect models.
To further highlight the predictive power of the presented model work, model benchmarking
is a continuous process which will also be followed in future research. The combination of large
data collection as presented in article [A6] with uncertainty analysis tools as outlined in articles
[A4] and [A5] and discussed above is promising to gain further insight in the conceptual limits
of LEM. At the end, hypothesis testing of model predictions would make up a statistically sound
procedure to further verify or falsify the model capabilities of LEM and GLOBLE and with that
the underlying concepts.
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6 Perspectives
Although there is a vivid history in radiobiology modeling the current expansion of particle
therapy triggers further developments and requires for progress in this field. Also other reasons
like intended space travels to Mars or the Fukushima accident gave rise to more dedicated
research in modeling radiation effects. This outlook section lists a number of topics where more
research seems reasonable with respect to the formulation and benefit of radiobiological models.
Notably, some of these go back to very basic questions in radiobiology, where still after decades
final answers are lacking, while others resulted in emerging fields of research, mostly facilitated
by means of recent clinical or experimental technological developments.
Open questions in radiobiology
• What does track structure at extremely high and low energies look like? The radial
1/r2 decay of ion track structure is well established by measurements in gaseous media for
a wide range of ions and energies. However, systematic measurements in denser biologic
material were just gained recently by means of biodosimetry [230,291]. However, the track
structure extension is less known for very small (< 1 MeV/u) or very large energies (>1
GeV/u). Here further track structure investigations will be needed and parameterizations
have to be established.
• What is the biological effect of ion radiation at extremely high energies? While at
moderate and therapy relevant energies the radiation action of ion radiation is fairly well
investigated, there is little knowledge about extremely large energy. Those energies will
be available at the FAIR facility in some years from now [292]. By nuclear fragmentation
processes, low energetic secondary ions are expected to give rise to a high LET component
of the radiation field, thus enhancing the RBE. As possible fields of applications, usage of
those beams has been proposed for theranostics, i.e. therapy and radiography at the same
time [5,293].
• What are the geometric sizes and size distributions of the relevant targets for damage
induction? Considering the combination of elementary lesions to more complex lesions
has turned out to be crucial to propagate the induced lesion pattern to a biological out-
come. While the µm and nm scales seem relevant, the coexistence of further relevant
target sizes cannot be excluded [36, 41]. A better knowledge of the relevant target sizes,
the associated size distribution and biological interpretation would be desirable. Lesion
statistics on the relevant targets could then help to understand radiation damage on a
more mechanistic basis.
• What is the relevant complex damage and what is the microscopic composition of
lethal lesions? Although it becomes more and more clear that the notion of complex
damage as neighbored lesions combined of more basic lesions is of relevance on both
the µm and nm scale, the exact nature and formation of those processes remain under
discussion. At the moment it is not clear what lesions ultimately determine cell lethality.
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Establishing a more detailed correlation of observed chromosome aberrations or remaining
damage at late times with cell survival [188, 294] could help to better point out which
lesions actually commit lethality.
• What are preconditions for the amorphous track structure concept? Reflecting the
spatial distribution of ionization events by the ionization density or local dose in biophysi-
cal models requires a locally homogeneous distribution of these events. Hence the level of
detail that has to be included in track structure needs to be considered case by case. For
instance, while for ion irradiation the amorphous track structure around the primary parti-
cle’s (the ion’s) trajectory is evaluated, for ultrasoft X-rays it is more suggestive to consider
amorphous track structure around the photoelectron, because the ultrasoft X-ray photon
does not transfer its energy gradually to the surrounding medium [99].
• To what extent can biologic soft matter replace physical detectors and vice versa?
While physical dose measurements aiming at microdosimetric quantities are usually car-
ried out in gas filled detectors in order to obtain a good experimental resolution, bio-
dosimetry might be an alternative way for radiation effect detection in more dense media
directly instead of employing density scaling approaches [230]. In turn, availability of
physical detectors mimicking dose response of biologic matter would be desirable to ob-
tain experimental data not subject to biology inherent uncertainties.
• What are the physical properties of particle beams apart from carbon, and what are
the associated biological benefits? For various reasons in heavy ion therapy also other
ions than carbon are discussed with respect to their therapeutic benefit. The fundamental
characterization of helium and oxygen beams for instance are of great interest, in particular
concerning scattering properties, projectile and target cross sections and LET distribution
depending on depth, but also their biological effectiveness [121–124,295,296].
• What elements of repair processes have to be considered in modeling? DNA repair
processes are rich multistep processes, which in turn could give rise to remaining lesions.
To remove base damages, base excision repair is able to induce further DSB, when running
into mitosis. In the same context, the meaning of stalled replication forks with respect to
lethality is unclear [297,298]. At the end, this may alter the relevant lesion yields, whose
uncertainty needs to be reduced.
• What is a convenient and unbiased method for comparing radiation effect models?
Models differ in their underlying concepts as well as in the type of input data they need.
As the latter might be not available to equal precision for two model approaches to be
compared, it is nontrivial at the moment to disentangle limits in predictive power induced
by the model limits or the accuracy of the input data used. Even sophisticated statistical
concepts like the Akaike information criterion [299] which is based on entropy measures of
information content do not account for different data quality of the free model parameters.
• What is the systematics of clinical RBE? While the general dependence on dose and
radiation quality is known to be comparable to what is known from in-vitro experiments,
the connection of biologic parameters such as the α/β-ratio in the transition from the
in-vitro to the clinical context remains unclear [68, 300]. Furthermore the availability of
tissue reaction parameters is still scarce, or available parameters are associated with large
uncertainties.
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• What is the proportion of targeted and non-targeted effects? Since about a decade
there is pronounced research on the contribution of intercellular signaling and related
processes, which may lead to radiation consequences of unirradiated cells or tissues. How-
ever, at the moment there is no clear picture about the relevance and quantification of
these effects with respect to targeted effects. Some first model attempts try to clarify the
picture [301–303], but experimental data are subject to broad variability, making model
verification very subtle.
Open questions in a clinical context
• What determines normal tissue complications? There is no consistent understanding of
side effects in healthy tissues after radiation therapy. This is due to a number of reasons:
No evident mechanistic picture exists of how radiation induced lesions impact connected
tissue, possibly consisting of different subunits and comprising many different cell types.
Moreover, radiation damage would have to be related to organ functionality, i.e. an observ-
able endpoint has to be selected, which is somewhat ambiguous. Finally, typically there is
no uniform radiation exposure over the normal tissue organs, so the volume effect (i.e. the
influence of inhomogeneous exposures) has to be considered [304, 305], but again exist-
ing models and model parameters are applicable to limited extent only [64, 65]. Progress
in this point would allow for a change of paradigm from target field to side effect opti-
mized treatment planning [306]. This question is also of particular interest in the scope of
new suggested treatment modalities involving extremely high local doses delivered with
microbeams [307–312].
• What is the risk for second cancers after radiotherapy? Due to the lack of broad epi-
demiological and clinical data, there is only few information about second cancer forma-
tion for conventional radiotherapy [313,314] and almost none for particle therapy [315].
In particular for the treatment of pediatric patients optimizing treatment planning in re-
gard to second cancer risk would be of great importance [316]. While a number of models
of cancer induction and formation exist [317, 318], their justification and their perfor-
mance is unclear [287,319]. For instance, model parameters are mostly derived from low
dose epidemiology studies [320]. Hence a better understanding of processes of radiation
induced carcinogenesis with photon and ion irradiation and development of associated risk
models is desirable [321].
• What is the dose response at high doses? While for low doses the framework of the
LQ model is a reasonable parameterization for dose response, at higher doses this is more
and more questionable. This is of particular importance with respect to hypofractionated
regimens or stereotactic body radiation therapy, where high doses are delivered within
one or a few fractions. The biological mechanisms of damage at high doses, presumably
targeting at tissue vascularization, and the applicability of the LQ model is still under
discussion (c.f. the outline in section 3.3).
• What is the interaction of radiation and chemotherapy? Currently, most patients re-
ceive chemotherapeutic drugs and radiation in a combined therapy regimen. While there
is some evidence for cytostatic drugs that they act additively in combination with radiation
when applied to in-vitro assays [322,323], this remains unclear when interaction between
radiation and the immune system is involved in the clinical context [324]. If radiation
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dose and drug concentration could be optimized within one consistent picture this would
help to exploit the possible advantages of such combinations [325–330].
• Do we need to consider a variable proton RBE? As in proton therapy up to now RBE
is assumed to be 1.1 in the entrance channel and target region, neglecting a potential
impact of a variable RBE [257]. In a family of empiric effect models assuming a linear
dependence of RBE on LET [258,331] as well as with LEM [242] the impact of a variable
RBE was considered and quantified. In particular at the distal end of extended Bragg peaks
an enhanced effect is predicted [256]. However, the translation of such enhanced effects
in clinically observable endpoints is unclear [332].
• What is the role of stem cells in human cancers? It has been hypothesized that for
tumor control it is not necessary to inactivate any cancerous cell, but rather any radiore-
sistant cancer stem cells which have the self-renewal ability, keep up tumor growth and
promote metastasis [333]. While the definition and characterization of cancer stem cells
is still matter of debate, they are smaller in number, but at the same time show a higher
radioresistance as compared to non-stem cancer cells [334]. Further knowledge about can-
cer stem cell biology promises an enhanced understanding of TCP curves, and potentially
provide mechanisms on how to inhibit further differentiation [335–338]. This opens new
potential for models encouraging NTCP/TCP oriented treatment planning.
• What is the optimal choice of safety margins surrounding the target? Safety margins
embedding the target are applied in the clinics to account for uncertainties in positioning
and treatment planning as well as to include parts of the tumor with infiltrating growth
which are invisible in the computer tomography images. However, due to the good tumor
conformity achieved with modern techniques like Volumetric arc therapy or ion therapy,
conventionally chosen large margins can be challenged. This is in particular of interest for
pediatric patients, where probably smaller margins scaling with the organ size would be
more appropriate and reveal less side effects [339].
• How can one account for the personalized radiosensitivity of patients? The strong
heterogeneity in local tumor control among patient populations suggests to search for
biomarkers to obtain a person specific radiosensitivity. Convenient markers would allow
to design personalized tumor dosages. The correlation of such markers with the response
of the tumor or normal tissue to radiation and an according implementation in radiation
effect models paves the way to patient specific NTCP optimized treatment planning [340–
342].
All these points have a potential impact to radiation effect modeling and therefore in appli-
cations of radiobioloy models, as e.g. therapy treatment planning. Answers to these questions
could be exploited in therapy to either broaden the therapeutic window or facilitate to design
more patient specific tailored treatment plans. This highlights the importance of mathematical
modeling in current and future research and underlines the need to combine physical concepts
with emerging biological and clinical insights. Finally, it should be noted that the list given above
is not complete but rather reflects a selection of current research interests in the field. While in
the present thesis mainly applications of biophysical modeling for cancer therapy are followed,
further questions related to modeling open up from different perspectives, e.g. considering
radiation protection on earth and for astronauts in space or radiation therapy of non-cancer
diseases.
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7 Reprints of selected publications
7.1 Article 1: The mathematical framework of the Local Effect Model
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Introduction
Local Effect Model: Basics
The ‘Local Effect Model’ (LEM) in its earlier versions (Scholz 
et al. 1997, Elsässer and Scholz 2007, Elsässer et al. 2008a) 
aims at deriving the biological effects of ion radiation directly 
from the response of cells or tissues to photon radiation, thus 
efficiently exploiting the large data base collected with con-
ventional radiation. The effectiveness of particles is calculated 
based on the microscopic local dose distribution pattern of 
ion traversals within the cell nucleus, assuming that equal 
local doses should lead to equal local effects, independent 
on the radiation quality. Typically, the local dose around 
single ion tracks is determined by an amorphous description 
of the radial dose distribution (Elsässer et al. 2008b). For a 
local dose dloc, in the earlier versions of the LEM the local 
biological effect is derived directly from the corresponding 
photon dose response curve denoted as Sg(D), where S rep-
resents the survival at dose (D). This response curve is repre-
sented by the linear-quadratic (LQ) parameters ag and bg for 
the specific biological endpoint under consideration, which 
are known from experiments or clinical data.
Since the linear-quadratic description is only valid for 
low and intermediate doses (Astrahan 2008), a correction 
for S(D) was introduced in order to account for a transition 
to an almost linear shape at higher doses D  Dt, where Dt 
denotes the ‘threshold’ dose for the transition. In addition, 
the induction of DNA single-strand breaks in close vicinity 
( 25 bp) can lead to additional DNA double-strand breaks, 
thus further enhancing the biological effects at very high local 
doses ( 1000 Gy) (Elsässer and Scholz 2007). In analogy to 
the cell survival dose response curves, similar considerations 
also apply to other endpoints that can be characterized by a 
linear-quadratic dose response such as local tumor control 
or normal tissue complications (Karger et al. 2006).
Local Effect Model: Generalization
A key feature of the approach described above is the direct 
link of the local dose deposition pattern to the photon dose 
response curve describing the observable endpoint under 
consideration. For the extension recently reported (Elsässer 
et al. 2010), we have introduced an intermediate step, based 
on the premise that the biological response of a cell to radia-
tion is primarily linked to the initial DNA damage distribution 
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Abstract
Purpose: To present details of the recent version of the ‘Local 
Effect Model’ (LEM), that has been developed and implemented 
in treatment planning for the ion beam therapy pilot project 
performed at GSI Helmholtzzentrum für Schwerionenforschung 
in Darmstadt, Germany.
Materials and methods: The new version of the model is based 
on a detailed consideration of the spatial distribution of the 
initial damages, i.e., double-strand breaks (DSB). This spatial 
distribution of DSB is obtained from the radial dose profile of the 
ion track using Monte Carlo methods. These distributions are 
then analyzed with regard to the proximity of DSB. This version 
of the model also facilitates the calculation of full dose response 
curves up to arbitrary high doses, thus allowing to thoroughly 
check the approximations previously used to estimate the 
quadratic term (b-term) for the linear-quadratic description of 
dose response curves.
Results: The accuracy of the model predictions is demonstrated 
by good agreement of the relative biological effectiveness (RBE) 
as a function of the linear energy transfer (LET) with experimental 
data obtained for V79 cells after carbon irradiation. The b-values 
predicted by the full simulation tend to be larger as compared to 
the approximation in the intermediate LET range.
Conclusion: The new version of the model allows a more 
mechanistic description of the biological effects of ion radiation. 
The full simulation is a prerequisite for tests of the validity of the 
approach at high doses, which are of particular interest for 
application in hypofractionation studies.
Keywords: Biophysical model, local effect model, double-strand 
break (DSB) distribution
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induced by radiation rather than the local dose distribution 
itself. We assume that the microscopic spatial distribution 
of DNA damage, namely double-strand breaks (DSB) and in 
particular their local density, represents the relevant measure 
determining the fate of a cell after radiation insult. Further-
more, in line with the general concepts of the LEM, we assume 
that similar DSB patterns should lead to similar effects, inde-
pendent of the radiation quality leading to these patterns.
In order to assess the similarity of DSB distributions, 
specific measures have to be defined. In the LEM, these are 
related to the structure of chromatin organization in the cell 
nucleus. It is assumed that so called ‘giant loops’ of DNA 
(Yokota et al. 1995, Solovjeva et al. 1998), comprising about 
2 Mega base pairs (Mbp) DNA length, represent the critical 
structure of the DNA (Johnston et al. 1998, Ostashevsky 1998). 
We then distinguish two types of damages, namely that either 
only a single DSB (‘isolated DSB’ [iDSB]) is induced in such 
a loop structure or two or more DSB (‘clustered DSB’ [cDSB]) 
are induced. It is hypothesized that cDSB lead to a signifi-
cant higher probability of, e.g., cell killing as compared to 
iDSB, since for iDSB the DNA on both sides of the DSB is still 
attached to the nuclear matrix, and thus repair is expected 
to be facilitated in general in this case. In contrast, for cDSB 
one or more DNA fragments can be removed from the loop, 
which are not any longer attached to the nuclear matrix and 
thus correspondingly difficult to repair (Figure 1).
Assuming that damage induced in different DNA loops 
can be considered to act independently, the total number of 
loops with iDSB and cDSB, respectively, represents a mea-
sure of the clustering of the DSB induced by a given dose 
deposition, as defined by the cluster-index C:
C
N
N N
cDSB
iDSB cDSB
=
+
,
where NcDSB and NiDSB represent the number of loops with 
isolated and clustered DSB, respectively.
The calculation of the spatial DSB distribution is based on 
the local dose derived from the radial dose profile described 
above and used already for the previous versions of the LEM. 
Assuming a homogenous distribution of the DNA within the 
nucleus as a first approximation, the mean number of DSB 
in a given small subvolume of the nucleus can be derived 
from experimental photon data, which indicate that the 
yield of radiation-induced DSB is approximately 30 DSB/Gy/
cell. Based on the local average number of DSB, spatial DSB 
distributions are then determined by means of Monte-Carlo 
techniques, i.e., actual DSB distributions are determined by 
considering the amorphous track structure pattern as the 
probability density distribution of DSB. A potential enhance-
ment of the DSB induction resulting from a combination 
of SSB in close vicinity ( 25 bp) as a consequence of the 
extremely high local doses in the track center is also taken 
into account (Elsässer and Scholz 2007). Furthermore, indi-
rect effects of radicals are taken into account by smearing 
out the radial dose profile according to the typical diffusion 
length of radicals (Elsässer and Scholz 2007).
Figure 2 schematically illustrates in a two-dimensional 
representation the analysis of the DSB distribution pattern 
according to the method described above. The outer square 
represents a cell nucleus; the inner small squares represent 
the subvolumes covered by individual DNA loops. Assum-
ing a homogenous distribution of DNA within the nucleus, 
the amount of DNA contained in a loop (approx. 2 Mbp) can 
be attributed to a subvolume of the nucleus, based on the 
knowledge of the total DNA content (approx. 6  109 Mbp 
in mammalian cells) and the typical volume of the nucleus 
(approx. 500 mm3). The cell nucleus thus contains about 3000 
loops of 2 Mbp size; therefore, the boxes drawn in Figure 2 
are only schematic and not to scale.
In order to determine the number of isolated and clus-
tered DSB, the cell nucleus is divided into cubic shaped 
subvolumes with 540 nm side length, corresponding to the 
volume covered by a 2 Mbp DNA content when assuming 
a homogenous distribution of DNA within the nucleus. The 
number of DSB in each subvolume is determined according 
to the local dose distribution within the subvolume and the 
subvolumes are then classified as isolated DSB or clustered 
DSB if exactly one DSB or two or more DSB are induced in a 
subvolume, respectively.
As indicated in Figure 2b, typically the overall distribution 
of DSB induced by a charged particle traversal largely differs 
from the random distribution after photon radiation (Figure 
2a) because the DSB are induced essentially along the tra-
jectory of the particle; however, the analysis of the number 
of iDSB and cDSB can be done exactly as for photons. The 
damage induced by a particle traversal can thus be inter-
preted as a cut-out of the distribution induced by photons at 
a macroscopic dose where the cluster index for photons (Cg) 
is identical to the cluster index for the ion traversal (CI); this 
condition Cg  CI defines the ‘photon equivalent dose’ Deq. 
Technically, by means of the Monte Carlo simulation average 
values for Cg and CI are obtained, from which the equivalent 
dose is derived. Knowing this equivalent dose, the effect of a 
single particle traversal can be obtained by appropriate scal-
ing of the effect induced by photons at D  Deq. Based on the 
Figure 1. Illustration of the impact of isolated DSB induction (a) and 
clustered (b) DSB induction within a single DNA loop. In (b), the 
simplest case of a cDSB is indicated for the case of 2 DSB (black circles). 
If more than 2 DSB are induced (additional grey circles), the situation 
remains similar as for 2 DSB, since it is characterized by potential loss 
of large DNA pieces and remaining pieces attached to the nuclear 
matrix.
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assumption of stochastic independence of the effects result-
ing from lesions induced in different loop domains, the scal-
ing is simply based on the total number of iDSB and cDSB 
after photon and ion irradiation, respectively.
For the schematic representation in Figure 2a, the dam-
age induced by the particle traversal on average would thus 
be 1/10 of the damage induced by photons, when averaging 
over a large number of individual representations. More gen-
erally, the scaling factor k according to the condition of an 
equal cluster index can be determined by:
 = = ( )( )ln 
ln 
S
S
N N D
N
Ion iDSB, Ion cDSB, Ion Ion
i
( )
( )
D
D
Ion
eqγ
+ 
DSB, cDSB, N Dγ γ+ ( )( )eq
Here, DIon denotes the dose deposition by a single particle 
traversal, SIon(DIon) and Sg(Deq) denote the survival after ion 
radiation at dose DIon and photon irradiation with the photon 
eqivalent dose Deq, respectively. N with the corresponding 
subscripts represents the numbers of isolated and clustered 
DSB after ion and photon radiation, respectively.
Figure 2. Schematic representation of the DSB distribution after photon radiation (a) and a single particle traversal as indicated by the arrow (b) 
through a cell nucleus (large square), composed of domains (small squares) representing giant DNA-loops. Different grey values represent different 
types of DSB. For simplicity, only 2-dimensional distributions are shown. The size of the squares representing the loop domains is not to scale. (c): 
Schematic illustration of the occurrence of intertrack effects by interaction of DSB from different tracks. Tracks are assumed to be perpendicular to 
the plane shown; circles indicate the radius of the individual tracks as defined by the maximum range of secondary electrons perpendicular to the 
trajectory. In order to facilitate the visualization of intertrack effects, DSB of interacting tracks are marked with different symbols.
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almost identical, which can be expected since these are fully 
represented by the action of individual, single particles. 
Systematic differences between the two approaches are 
observed for the bI-term. Here, the full simulation in general 
predicts larger bI-values as compared to the approximation, 
so that the drop of the bI(LET)-curve is significantly shifted 
to higher LET values. Furthermore, there is an indication of 
even an increase of the bI-term at intermediate LET values 
around 30 keV/mm for carbon ions. Further preliminary 
studies revealed that the potential enhancement of the 
bI-term above the photon reference value seems to be more 
pronounced for lighter particles like protons.
Discussion
The generalization of the LEM based on the concept of iso-
lated and clustered DSB in DNA giant loop domains has been 
shown to significantly enhance the quantitative agreement of 
the model predictions with experimental data (Elsässer et al. 
2010). This refers in particular to the simultaneous representa-
tion of the effectiveness of light and heavier ions with the same 
level of accuracy. For the application to V79 cells as shown in 
Figure 3, a tendency of underestimation is observed in the 
intermediate LET range. However, this deviation seems to be 
specific for V79 cells and does not represent a general feature 
of the model, since, e.g., for other cell lines like HSG the corre-
sponding discrepancies are much less pronounced (Elsässer 
et al. 2010). This could be due to the fact that at present, key 
parameters such as, e.g., the loop or domain size are assumed 
to be identical for different cell lines, but actually differences 
might be expected depending on the cell or tissue type.
As we have shown in this paper, the generalization of the 
LEM also facilitates the direct calculation of the b-term of the 
dose response by explicitly modeling the intertrack interac-
tion mechanism within a full Monte Carlo simulation.
This feature is closely related to the interpretation of 
‘clustered damage’ in terms of interaction of DSB over Mbp 
genomic distance or micrometer geometrical distance, 
This procedure allows calculating the effect of a single 
particle traversal, defining the effectiveness at low doses and 
thus the aI term of the linear-quadratic representation of 
the dose response curve. The bI-term can then be estimated 
according to the approximation described in (Krämer and 
Scholz 2006). This approximation has been introduced since 
full simulations of dose response curves would be unfea-
sible for applications in the framework of treatment plan-
ning; this was mainly due to the extremely time consuming 
calculations.
Local Effect Model: Full simulation
In extension of what has been reported by Elsässer et al. 
(2010), we here show for the first time that within the frame-
work of the most recent implementation of the LEM as 
described above, the full simulation of dose response curves 
is largely simplified.
This is due to the fact that now the biological effect of inter-
est is determined from the initial DSB distribution pattern, i.e., 
a discrete number of events has to be summed instead of inte-
grating over continuous functions of local dose distribution 
patterns. The pattern induced by a combination of particle 
traversals can be deduced with good accuracy from the pat-
tern within individual tracks, since the yield of DSB is linearly 
dependent on the dose up to doses of several hundred Gy, 
which typically occur only within a narrow region of approx. a 
few ten nm in the track center (Elsässer and Scholz 2007). Thus, 
the induction of DSB is not affected significantly by intertrack 
effects. These intertrack effects become visible only when 
analyzing the spatial distribution of DSB in terms of cDSB, 
because for cDSB distances in mm dimensions are relevant, so 
that even without direct overlap of the tracks interactions of 
the DSB induced by two tracks in mm distance might occur. 
Figure 2c schematically depicts this type of intertrack effect.
Results
Figure 3 shows a comparison of model predictions with 
experimental data for inactivation of V79 cells after carbon 
irradiation as published by Furusawa et al. (2000). This 
comparison is based on the single particle approximation as 
described above. The general shape of the relative biologi-
cal effectiveness (RBE) as a function of linear energy transfer 
(LET) curve as well as the dose- and survival dependence 
of the RBE are reproduced reasonably well. The tendency of 
an underestimation in the intermediate LET range at higher 
doses, i.e., the RBE for 10% survival (RBE10), could at least 
partially be due to the approximation used for the derivation 
of the bI-term in the single particle approximation.
In order to further investigate the accuracy of the single 
particle approximation, the full simulation of dose response 
curves has been implemented. We first focus here on the dis-
cussion of the general differences between the single particle 
approximation and the full simulation based on a ‘hypotheti-
cal’ cell line, characterized by the linear-quadratic photon 
parameters aγ and bγ typical for in vitro cell lines. Figure 4 
compares the corresponding predicted linear-quadratic 
parameters for ion irradiation, aI- and bI, for the  simulation 
of carbon ion irradiation at different LET. The aI-values are 
Figure 3. Comparison of model predictions with experimentally 
determined RBE values for cell killing obtained after carbon ion 
irradiation of V79 Chinese hamster cells as reported by Furusawa et al. 
(2000). RBEa represents the RBE for the linear a-terms, i.e., the initial 
slopes of the dose response curves; RBE10 represents the RBE at 10% 
survival level. Input photon parameters for calculation: ag  0.184 Gy1, 
bg  0.02 Gy2, Dt  17 Gy, Radius of the cell nucleus RNucleus  4.7 mm.
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respectively. This definition of clustered damage signifi-
cantly differs from that used, e.g., by Nikjoo et al. (2001) and 
Ottolenghi et al. (1995); they focus on ‘local’ cluster effects 
characterized by combination of damages over distances 
of a few basepairs only, representing what has been termed 
‘locally multiply damaged sites’ by Ward (1994). In that 
respect, the most recent implementation of the LEM shares 
more similarities with approaches based on ‘regionally mul-
tiply damaged sites’ due to the consideration of interaction of 
DSB over significantly larger genomic distances, in line with 
experimental data indicating an excess of DNA fragments in 
the 10 kbp–1 Mbp size after ion irradiation (Radulescu et al. 
2004). Our approach is also consistent with the findings by 
Friedland et al. (2006), who analyzed clusters on a local and 
regional scale and found a better correlation of regional clus-
ters with experimental data of RBE for cell inactivation.
Underestimation of the RBE in the intermediate LET 
range, as visible in Figure 3, is probably due to the underes-
timation of the b-term in the single particle approximation, 
on which the predictions were based. More detailed studies 
of these effects are currently ongoing, based on the approach 
described above, which already indicated that the beta-term 
in the full simulation approach is systematically higher as 
compared to the single particle approximation.
For light particles like protons, even a simultaneous 
increase of aI and bI might occur with increasing LET, which 
is in contrast to conclusions that in general the bI term tends 
to decrease with increasing LET. But at least for neutrons 
reports indicate a clear increase of the quadratic compo-
nent for neutrons, bN, as compared to the corresponding 
component for photon radiation, bg (Jones 2010). The dif-
ference between the full simulation and the approximation 
also depends on the specific ag- and bg-values used as input 
for the model calculations; a detailed analysis, however, is 
beyond the scope of the present manuscript.
For the application of the model in treatment planning, 
the higher bI-term will have significant impact mainly for 
higher dose levels as relevant for hypofractionation studies; 
we checked that at lower doses around 2–3 Gy the approxi-
mation method is sufficiently accurate.
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A new, simple mechanistic dose-response model for cell
survival after photon irradiation is presented. Its ingredi-
ents are motivated by the concept of giant loops, which
constitute a level of chromatin organization on a megabase
pair length scale. Double-strand breaks (DSBs) that are
induced within different loop domains of the DNA are
assumed to be processed independently by the cell’s repair
mechanism. The model distinguishes between two classes of
damage, characterized by either a single DSB or multiple
DSBs within a single loop. Different repair fidelities are
associated with these two damage classes from which
lethality of damages and consequently the survival proba-
bility of cells is derived. Given the giant loop chromatin
organization and the assumption of two damage classes
represent the main pillars of this new approach, we propose
to call it the Giant LOop Binary LEsion (GLOBLE)
approach. In this paper, we discuss the motivation and the
formulation of the model as well as some basic implications.
First applications to experimental data obtained with 250
kV X-rays exhibit that the model is able to reveal important
features of the dose-response curves describing cell survival.
These comprise a linear-quadratic behavior at lower doses
and a transition to a straight dose-response relationship at
high doses. We establish relationships to the parameters a
and b of the linear-quadratic model and discuss possible
generalizations. When expressed in terms of the linear-
quadratic model, we demonstrate that our new model
predicts an intrinsic anticorrelation between b and a, in
line with an analysis of a large set of experimental data that
is based on survival curves for more than 150 cell lines.
 2012 by Radiation Research Society
INTRODUCTION
Precise knowledge and characterization of the dose-
response curves is a prerequisite for optimal application of
radiation in radiotherapy. During the past decades, the
linear-quadratic model (LQ-model) has been demonstrated
to be a powerful tool for the understanding and prediction of
the essential biological responses that are relevant for
therapy such as fractionation and dose-rate effects (1, 2).
However, evidence has accumulated that shows that the LQ-
model has certain limitations in the high-dose region. It has
also been shown that the curvature of the dose-response
curve is less pronounced at high doses than predicted from
the shape of the dose-response curve at lower doses (3, 4).
This is of particular clinical relevance for application of
hypofractionation schemes and/or radiosurgery. Several
solutions have been proposed to overcome this problem
(5–8); however, these are more empirical approaches not
aimed at a detailed consideration of the potential underlying
mechanisms.
DNA double-strand breaks are considered to be the
damage responsible for most end points such as chromo-
some aberrations and cell killing. However, due to the high
number of DSBs induced by radiation at sublethal doses of
only a few Gy, it is immediately obvious that a single DSB
is not lethal in general, indicating that most of the induced
DSBs can be rejoined or repaired correctly. It is therefore
assumed that the spatial distribution of DSBs is a major
factor in determining e.g. lethality (9–13). However, no
unique strategy has emerged from these approaches
allowing for the development of an improved model for
the dose-response curves that would be able to overcome
the drawbacks of the LQ-model mentioned above.
Fortunately, many experimental studies have been
performed to better understand and characterize the factors
that determine the fate of DSBs after radiation insult. The
studies related to the relevance of the chromatin organiza-
tion with respect to the reparability of DSBs are of particular
interest for the work described below. For example,
chromatin loops with a size of several megabase pairs have
been identified as structural subunits that are termed ‘‘Giant
Loops’’ (14–16). Using a different experimental technique,
Johnston et al. (17) came to similar conclusions and they
1Address for correspondence: GSI Helmholtzzentrum fu¨r Schwer-
ionenforschung, Department of Biophysics, Planckstrasse 1, D-64291
Darmstadt, Germany; e-mail: m.scholz@gsi.de.
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identified chromatin loop structures with megabase pair
size. In addition, it has now been shown that the
phosphorylation of the H2AX histone in approximate 2
Mbp regions surrounding a DSB is possibly related to these
giant loop structures and represents a further hint to the
relevance of megabase pair chromatin structures for the
response of a cell to radiation damage (18).
Assuming in a first approximation a homogenous
distribution of DNA within the cell nucleus of 500 lm3
volume, the amount of about 2 Mbp of DNA corresponds to
an average cubical subvolume with approximately 0.5 lm
side length. High-LET radiation is expected to induce
multiple DSBs within such regions/subvolumes with high
probability. We therefore implemented the quantification of
the frequency of DSB within these subvolumes in the Local
Effect Model (LEM) (19) and showed that it allows for the
accurate prediction of the cellular response to high-LET
radiation (20, 21).
In the present study, we investigate in more detail the
implications of the chromatin loop approach for the shape of
the photon dose-response curve itself. A new survival
model emerges that is discussed in relationship to the
conventional LQ-model and with respect to experimental
photon dose-response curves. The main purpose of this
investigation is to describe the principles of the model and
to discuss its basic general features to allow testing of the
capabilities of the model. Detailed comparison to experi-
mental data and analysis of the corresponding model
parameters will be treated elsewhere.
METHODS
The strategy for the derivation of the dose-response curve based on
a mechanistic interpretation of DSB induction in megabase pair giant
loops is presented below. In a first step, we restrict ourselves here to
the description of in vitro cell survival, which does not imply that the
approach is principally limited to this case. Furthermore, the stochastic
nature of cell inactivation is represented by describing cell inactivation
in terms of the number of the mean number of ‘‘lethal events’’
NlethalðDÞ which are induced by irradiation with dose D. This number
of lethal events is an average quantity representative for a large
number of cells irradiated under the same conditions with dose D in
such a way that the survival probability can be obtained by:
SðDÞ ¼ e NlethalðDÞ ¼ eeðDÞ: ð1Þ
where in the last step, the number of lethal events is identified with the
effect e and it is assumed that the actual number of lethal events is
Poisson distributed. The basic assumption of the approach proposed
here is that chromatin domains of approximately 2 Mbp size represent
the key structure that determines the cellular radiation response. In
agreement with the findings previously reported in refs. (16) and (22),
we assume that the chromatin is organized in giant loops and are
attached to the nuclear matrix at distinct points in approximately 2
Mbp distance. The response of a cell is expected to critically depend
on the number of DSBs induced in each of its loop structures, as
schematically illustrated in Fig. 1.
Two cases are distinguished here:
1. A single, individual DSB is induced in a loop. In this case, repair
or rejoining of this loop is facilitated due to the fact that the
damaged site can be accessed from both sides of the DSB for
repair proteins. Furthermore, since the DNA ends are still close
together, both nonhomologous end joining, as well as homolo-
gous recombination, are likely to be successful.
2. Two or more DSBs are induced in a loop. In this case, loose
fragments can be produced by ‘‘cutting out’’ pieces of DNA from
the loop. These fragments are no longer connected to the nuclear
matrix and can easily diffuse away from its original position.
Obviously, this case can be expected to represent a much more
severe damage to the cell, since the DSB ends of the loop
segments that remain attached to the nuclear matrix can be far
apart, and the mechanism of nonhomologous end joining might
fail. Two DSBs are sufficient to represent such a significant
challenge to the cell, and inducing more than two DSBs does not
contribute further to the complexity of the damage because only
more fragments are produced.
In line with the terminology introduced in refs. (20) and (21), these
two cases are termed ‘‘isolated DSB’’ (iDSB) and ‘‘clustered DSB’’
(cDSB). This definition of clustered damage significantly differs from
that used by Nikjoo et al. (23) and Ottolenghi et al. (12) as they
focused on ‘‘local’’ cluster effects characterized by the combination of
damages over distances of a few base pairs, which represents what has
been termed ‘‘locally multiply damaged sites’’ by Ward (24). Our
definition shares more similarities with approaches that are based on
‘‘regionally multiply damaged sites’’ due to the consideration of
interaction of DSBs over significantly larger genomic distances, in line
with experimental data indicating an excess of DNA fragments in the
10 kbp–1 Mbp size after ion irradiation (25).
Different effects can be attributed to the classes of iDSB and cDSB,
respectively. In the first case, DSBs are likely to be repaired. The
average number of lethal events of one iDSB is represented by ei. The
average effect of one cDSB is assumed to be much more severe,
represented by a number of lethal events ec and according to the higher
severity ec  ei. Both ei and ec are smaller than 1 and can be regarded
as a measure of the probability for an iDSB or a cDSB to be lethal,
respectively.
FIG. 1. Schematic representation of the chromatin giant loop
structure [adapted from Yokota et al. (16)] and the consequence of
isolated or clustered DSB within loops. For simplicity, only the
essential topology of the chromatin loop structure is shown: the actual
conformation of individual loops includes additional complicated 3-
dimensional folding.
386 FRIEDRICH, DURANTE AND SCHOLZ
64 7 Reprints of selected publications
The fact that ei and ec represent average quantities allows the
treatment of all iDSBs and cDSBs in the same way. However, the
effect of a single DSB may depend on the position in the genome
where it occurs. For example, an iDSB in a single copy crucial gene
might be lethal, whereas it might be well tolerated in a region of
repetitive sequences. Similarly, the effect of a cDSB will depend on
whether it contributes to a complex rearrangement or to a deletion.
Therefore, the model can be considered as mechanistic only in the
sense of the above mentioned average quantities, but not with respect
to the full details of all steps involved in DNA damage processing.
If the average number of chromatin loops with isolated DSB is
termed ni and the average number of loops with complex DSB is
termed nc, the survival probability can be written as
S ¼ eðnieiþncecÞ: ð2Þ
Equation (2) represents the most general formulation of the
approach and comprises the assumption that lesions in different
chromatin loops are processed independently. For photon radiation,
under certain simplifying assumptions, the number ni and nc can be
easily obtained. Therefore, we assume that the yield of initial DSB is
given by aDSB¼ 30 DSBs per Gy and per cell, independent of the cell
type. This value reflects experimental data obtained for hard X rays
and c rays. In principle, the value can be easily adapted to e.g., higher
values as observed for low energetic soft X rays (26). However, in the
case of soft X rays, other factors such as significant attenuation have to
be taken into account and we will analyze this in more detail
separately.
Assuming a genome size SG, this can be used to determine the
number of DSBs per chromatin loop, assuming that all loops are
characterized by the same size SL. Thus, the whole genome contains NL
¼ SG/SL loops, and the induction frequency of DSB is YLoop ¼ aDSB/NL
per Gy and per loop. From this average number, using Poisson
statistics, the number of loops containing zero DSB (n0), exactly one
DSB (ni) or two or more DSBs (nc) can be determined as a function of
the dose D from:
n0 ¼ NLeYLoopD
ni ¼ NLðYLoopDÞ  eYLoopD
nc ¼ NL  n0  ni: ð3Þ
Inserting these values into Eq. (2) allows for the determination of
the complete dose-response curve. An implicit assumption behind
Eqs. (2) and (3) is that the number of lethal events as well as the
number of isolated and clustered DSBs are Poisson distributed.
However, for a given total number of DSBs, the corresponding
possible numbers of iDSB and cDSB are not independent but are
anticorrelated. Therefore, Eqs. (2) and (3) might not be strictly valid in
particular at high doses. This becomes clear when the cell survival
based on the assumptions of the GLOBLE is derived from a
probabilistic view, where the parameters ei and ec are the probabilities
for an iDSB or a cDSB to lead to cell death. Consequently, each
isolated domain, e.g., does not lead to cell death with probability (1 –
ei), and the probability for a cell to not be killed by ki of these is (1 –
ei)ki. Hence, the survival can be calculated as
S ¼
X
ki
X
kc
qðki; kcÞð1 eiÞkið1 ecÞkc : ð4Þ
which immediately evaluates to Eq. (2) if and only if the probability
function q(ki,kc) for finding exactly ki iDSB and kc cDSB factorizes
into two Poissonian distributions with average values ni and nc. This
factorization is an approximation because iDSB and cDSB are not
induced independently, but have a correlation by the total number of
DSBs induced. We have thus performed a Monte Carlo evaluation of
the survival according to Eq. (4) and compared the results of the
Monte Carlo approach with the results of the analytical calculations
based on Eqs. (2) and (3).
RESULTS
General Features
The general features of the model will be discussed based
on the assumption of a genome size of SG¼63109 bp and a
chromatin loop size of SL¼ 2 Mbp. The number of loops is
thus NL ¼ SG/SL ¼ 3,000 per cell. The corresponding
numbers of isolated and clustered DSBs, respectively, are
shown in Fig. 2 together with the resulting cell survival
curve that is based on ei ¼ 0.0036 and ec ¼ 0.18, which
represents a ratio of R¼ ec/ei¼ 50. As expected, the number
of iDSBs rises almost linearly at lower doses. In contrast,
the number of cDSBs is characterized by a highly nonlinear,
initially quadratic increase with dose, which is due to the
fact that simultaneous induction of at least 2 DSBs within
the same loop is required to form a cDSB. This nonlinearity
FIG. 2. Panel A: Number of isolated DSBs (iDSB) and clustered
DSBs (cDSB) as a function of dose; the number of cDSB is scaled by
a factor of 10 to allow a direct comparison of the dose-response curves
for iDSB and cDSB. Input parameters: SG ¼ 63 109 bp, SL ¼ 2 Mbp.
Panel B: Corresponding cell survival curve based on eI¼0.0036 and ec
¼ 0.18.
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is also reflected in a trend toward a maximum of iDSBs at
higher doses. As shown in Fig. 2B, the parameters chosen
here represent a typical shape of in vitro cell survival
curves.
When comparing different cell lines that differ mainly in
their repair capacity, we assume that complex double-strand
breaks (as defined in the Methods section in the sense of
multiple damaged loops) are either unrepairable or mis-
repaired with a high probability for any cell type. This does
not necessarily lead to a lethal event, as a certain level of
remaining damage might be tolerable for a cell. In a first
approximation, these assumptions translate into the hypoth-
esis of a constant value for ec (that can be smaller than one),
independent on the specific cell line. As a consequence,
differences in sensitivity could then be fully attributed to the
differences in the repair capability of isolated DSBs and
expressed in the corresponding variation of the parameter ei.
Figure 3 depicts survival curves based on ec ¼ 0.18 and ei
values of 0.06, 0.0072 and 0.0036, corresponding to ratios R
¼ ec/ei of 3, 25 and 50. The theoretical curves are compared
to experimental data obtained for XRS, CHO and V79 cells,
which represent cells of similar origin, but with different
repair capacity; these data cover almost the full range of
sensitivities found in larger sets of data for different cell
lines.
The variation of R as a single variable allows for the
correct reproduction of the overall difference in sensitivity
as well as the transition from a significantly shouldered to
an almost purely exponential survival curve. Note that the
shoulder here occurs as a consequence of the enhanced
lethality of cDSBs compared to iDSBs, along with the
increasing abundance of cDSBs with increasing dose. The
model therefore accounts for different levels of severity of
DNA lesions in a very simple way.
To further investigate this impact of the R value on the
shape of the dose-response curves, the corresponding slopes
of the curves are plotted as a function of the dose over a
large dose range up to 70 Gy in Fig. 4. Since the increase of
this slope with the dose is a measure for the b term of the
dose-response curve within the LQ model, it follows that
cells characterized by a small R value are expected to show
smaller b values compared to cells with higher R values.
Interestingly, according to this model the slope is expected
not to continuously increase, but to exhibit a maximum and
a consequential decrease toward higher doses. The dose
value, at which the maximum level is reached, depends on
the assumption of both the R values as well as the loop size
SL and the loop DNA content, respectively. For larger loop
sizes, the maximum is observed at lower doses compared to
smaller loop sizes (Fig. 4B). For these loop sizes, at one
specific dose at approximately 40 Gy, all curves cross and
therefore become independent on ei. Note that the total
systematics can be understood by a thorough investigation
of Eq. (3).
Purely linear-quadratic behavior would correspond to
straight lines, where the intersection with the y-axis and the
slope correspond to the linear-quadratic parameters a and b,
FIG. 3. Comparison of model predictions with experimental data
reported by Weyrather et al. (46). Model parameters: SG¼ 63 109 bp,
SL¼ 2 Mbp; ei and ec as given in the legend for the different cell lines.
FIG. 4. Slopes of dose-response curves as a function of dose for SG
¼ 6 3 109 bp, ec ¼ 0.18, and ei ¼ ec/R. Panel A: SL ¼ 2 Mbp,
corresponding to NL¼3000. Panel B: SL¼5 Mbp, corresponding to NL
¼ 1,200. Straight black lines in the dose region 0–10 Gy represent
linear fits to the low-dose region.
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respectively. As indicated by the fits to the dose region of
up to 10 Gy, all curves shown in Fig. 4 can be approximated
with sufficient accuracy by straight lines in this region. This
indicates that the new approach is consistent with a linear-
quadratic behavior in the low-dose region, and significant
deviations are expected only in the dose region typically
above 10 Gy. Therefore, the link between the new model
and the LQ-approach will be analyzed in more detail in the
following section.
Comparison to a Monte Carlo Based Approach
As mentioned in the Methods section, Eqs. (2) and (3) are
based on the implicit assumption that ni and nc are Poisson
distributed, which is an approximation due to the potential
anticorrelation of ni and nc for a given number of DSBs, in
particular at high doses. We therefore have compared results
based on Eqs. (2) and (3) with a full Monte Carlo
calculation based on Eq. (4), the results are summarized
in Table 1. The deviation between the Monte Carlo
calculation and the analytical description are completely
negligible at 10 Gy. Additionally, at dose values of 50 Gy
for four of the 5 parameter combinations, the deviations are
below 5%. Only for the parameter combination using a
comparably high value for ec, the difference is about 15% at
50 Gy. However, according to a preliminary analysis of a
larger set of different survival curves, these high ec values
are unlikely. Therefore, the analytical description using Eqs.
(2) and (3) can be considered as sufficiently accurate
approximation over the whole relevant dose range.
Relationship to the LQ Model
While in the widely used LQ model the effect e is linked
with dose via:
e ¼ aDþ bD2 ð5Þ
in our new approach this relationship reads according to
Eq. (2)
e ¼ niðDÞei þ ncðDÞec ð6Þ
where the dose dependence of ni and nc is nonlinear, c.f.
Eq. (3).
From Eq. (5) it becomes evident that the linear and quadratic
coefficients can be obtained from the limits of the first and
second derivatives of the effect –lnS with respect to dose
a ¼ lim
D!0
dðlnSÞ
dD
; b ¼ 1
2
lim
D!0
d2ðlnSÞ
dD2
: ð7Þ
Applying these relationships to Eq. (6), we obtain
transformation formulas between the LQ parameters and
the parameter set (ei, ec) as:
ei ¼ aaDSB ð8Þ
and
ec ¼ 2 NLbþ aDSBaa2DSB
 
: ð9Þ
While the linear component a is directly linked to the
lethality of iDSB, the probability for a cDSB to be lethal is
given by a linear combination of both a and b.
Based on the hypothesis that the choice of a fixed,
constant value of ec is consistent with experimental results,
Eq. (9) suggests a coupling of the linear-quadratic
parameters a and b:
b ¼ ec
2
 a
aDSB
 
 a
2
DSB
NL
¼ ec
2
a2DSB
NL
 a  aDSB
NL
¼ c1  c2a:
ð10Þ
with constants c1 and c2.
This equation has important implications concerning the
linear-quadratic parameters a and b and its correspondence
to the parameters of the new model:
 When analyzing a large group of different cell lines that
are characterized by different values a and b, it suggests
a linear anticorrelation of b and a: i.e., the higher the a
value, the lower the b value should be.
 Maximum values bmax should be achieved for cell lines
exhibiting very small a values, and in the limit of a!0
the value of bmax is fully characterized by the lethality of
a cDSB, the overall DSB yield and the number of loops.
bmax ¼ eca2DSB
2NL
ð11Þ
 The slope c2 of the anticorrelation is solely dependent on
the ratio of the DSB yield and the number of loops.
c2 ¼ a2DSB
NL
ð12Þ
 A b value of zero is expected for the condition.
a ¼ ecaDSB
2
ð13Þ
TABLE 1
Ratio of the Predicted Mean Number of Lethal Events
Derived from a Full Monte Carlo Simulation According to Eq.
(4) Compared to the Analytical Description Based on Eqs. (2)
and (3) for Different Combinations of Input Parameters ei and
ec and a Constant Number of Loops NL ¼ 3,000
ei ec
NLethal;MC=NLethal;analytical
10 Gy 50 Gy
0.05 0.2 1.005 1.030
0.05 0.1 1.003 1.014
0.05 0.5 1.019 1.177
0.01 0.2 1.003 1.031
0.10 0.2 1.008 1.040
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 Negative b values are predicted with the new model for
high values of a. This feature will be discussed in more
detail below.
The above mentioned parameters of ec¼ 0.18, aDSB¼ 30/
Gy and NL¼3,000 result in bmax¼0.027 Gy2 and a slope c2
of 0.01 Gy1, i.e., a b value of zero is expected for an a
value of 2.7 Gy1.
To compare these model predictions to experimental data,
we have compiled linear-quadratic parameters characteriz-
ing the sensitivity to high-energy photon radiation of more
than 150 cell lines, as reported by Fertil and Malaise (27),
Steel et al. (28) and Friedrich et al. (29). The experimental
data are shown in Fig. 5A, together with a straight line fit
and the corresponding 95% confidence intervals. Despite
the large spread of the experimental data, there is a clear
indication of an anticorrelation between b and a as
suggested above, which is fully in line with the trend
discussed by Fertil and Malaise (27). The corresponding fit
parameters of Eq. (9) are c1¼ 0.0496 0.0029 Gy2 and c2¼
0.031 6 0.0048 Gy1.
Figure 5B depicts the theoretically predicted anticorrela-
tion as described above (thick line) in comparison to the
mean values of b, averaged over a intervals as indicated by
the horizontal bars, and the corresponding error of this mean
values as indicated by the vertical bars.
The order of magnitude of the predicted values for bmax, as
well as the slope c2 are in reasonable agreement with the
experimental data. However, with the parameters used for
the comparison shown in Fig. 3, the average values for
larger collections of different cell lines seem to be
systematically underestimated. Based on Eq. (11), we have
calculated the same anticorrelation for different loop
numbers ranging from 3,000 down to 1,300; a value of
about NL ¼ 2,000 is in the best agreement with the average
values for the large data ensemble.
DISCUSSION
General Aspects
In this study, we present a simple approach to model cell
survival curves after photon irradiation, which is based on
the knowledge of the spatial distribution of initial DSB on
the level of so called giant chromatin loops. These loops
represent DNA length in the order of some Mbp and in
geometrical terms regions of about 0.5 lm size. An essential
feature of the model is the classification of DNA DSB in
only two different classes, namely iDSB, representing loops
containing exactly one DSB, or cDSB, representing loops
which contain two or more DSBs. The same lethality is
attributed to all cDSBs, independent of the actual total
number of DSBs contained in the loop. Since the
development of the new model was essentially motivated
by the experimental results concerning the giant loops and
only two classes of lesions are considered, we propose to
call the new approach the Giant LOop Binary LEsion
(GLOBLE) approach.
An important feature of the model is its compatibility with
the LQ-approach in the low dose region. Here, Eqs. (8) and
(9) allow for the unique translation of the linear-quadratic
parameters a and b into the new parameters representing the
lethality of isolated and clustered DSBs, respectively. At the
same time, however, the model is able to represent the
deviations from a pure LQ-behavior that is typically observed
at high doses (3, 4). This refers to a less pronounced bending
at high doses, which is in agreement with the trend predicted
by the model as shown in Fig. 3. At present, this agreement
has to be assessed as only qualitative. However, as the main
purpose here is to describe the key features of our new
approach, the full and detailed comparison to experimental
FIG. 5. Panel A: Anticorrelation of b and a as observed in
experimental data reported by Fertil and Malaise (27), Steel et al. (28)
and Friedrich et al. (29). Lines represent a linear fit with the
corresponding 95% confidence intervals. Panel B: Comparison of
predicted and experimentally observed anticorrelation of b and a for
different values of NL. Data points represent mean values over
intervals indicated by the horizontal bars and the corresponding errors
of the mean are represented by the vertical bars.
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data is beyond the scope of the present paper and will be
addressed in future projects.
Determination of Input Parameters
The GLOBLE approach is largely based on input
parameters that can be determined experimentally. The
initial yield of DSBs, aDSB, has been measured for a wide
variety of cell lines, and there is general agreement that this
initial yield of DSB is largely independent on the specific
cell line under investigation, see e.g. (30). The size of
chromatin loops has also been determined experimentally to
be in the order of 1–2 Mbp (22), and different cell lines are
characterized by similar loop sizes in a comparably narrow
range. However, it should be taken into account that using a
single constant value for the loop size possibly represents an
oversimplification. Therefore, analysis of the impact of an
underlying loop size distribution represents an important
next step for the application of the model. However, it
remains open at the moment how accurately this distribution
can be determined, and reasonable assumptions about the
size distribution might replace the corresponding experi-
mental information in a first step.
The link between c-H2AX foci and chromatin loops as
discussed by Rogakou et al. (18) could help to develop
experimental methods for the measurement of the size
distribution. If actual chromatin loops can be identified with
the regions of c-H2AX phosphorylation, measurements of
foci size as reported in ref. (31) can give useful information
about the loop size distribution.
The relevance of large scale chromatin organization for the
understanding of radiation effects is also emphasized by other
model approaches. Eidelman and Andreev (32) use subunits of
1.3–3.3 Mbp for modeling interphase chromosomes. Friedland
et al. (33) assume rosette-like structures of about 0.5 Mbp size,
composed of smaller loops with approximately 70 kbp each. In
a more recent article, Friedland et al. (34) reported that a
structure of the cell nucleus composed of approximately 6,000
subunits consisting of rosette-like structures based on multiple
100 kbp loops, corresponding to a DNA content in the order of
Mbp for each subunit. A similar approach is followed by
Nikjoo and Girard (35), subdividing chromosome domains
into ‘‘factories’’ of approximately Mbp size, that also consist of
rosette-like structures composed of multiple loops of approx-
imately 100 kbp size. Ponomarev and Cucinotta (36) use a loop
size of 120 kbp without specifically assuming higher order
structures based on multiples of these loops. However, the
approaches mentioned above have been mainly developed for
the modeling of initial DNA damage distributions, and none of
them has been applied to predict cell survival after photon
radiation. According to the concept presented in this paper,
correlation of DSBs on the 100 kbp scale would not be
sufficient to explain the shouldered shape of the dose-response
curves, and thus the results are clearly in favor of the relevance
of Mbp structures.
The length scale corresponding to Mbp structures, which
is in the order of micrometers, is also fully in line with the
typical interaction distances discussed in the framework of
chromosome aberration induction, as discussed in more
detail below. Whether or not the organization of these Mbp
structures as a random walk or a rosette-like structure would
make a difference in respect to the model remains to be
elucidated.
Anticorrelation of b and a and of Negative b Values
Mechanistically, the decrease of the curvature of the dose-
response curve toward higher doses can be explained within
the GLOBLE framework by the local ‘‘effect saturation’’
within individual loops. As described above, the same
lethality ec is attributed to all types of cDSBs independent of
the actual number of DSBs induced in the loop. Therefore,
the highest efficiency is expected if exactly 2 DSBs are
induced within a loop. If more than 2 DSBs are induced, the
relative contribution to lethality per DSB is correspondingly
reduced. This feature also explains the anticorrelation
between b and a as shown in Fig. 5.
As mentioned above, we hypothesized that the variation
of sensitivity could be mainly attributed to the variation of
the lethality of iDSBs, whereas it is assumed that cDSBs
should have the same lethality for all cell lines in a first
approximation. The onset of saturation effects, i.e., the drop
of the incremental increase of lethal events per dose
increment, critically depends on the difference of lethalities
between iDSBs and cDSBs. If iDSBs are much less lethal
than cDSBs (i.e., ei  ec), saturation will occur only if, on
average more than 2 DSBs are induced per loop. If,
however, iDSBs are similarly lethal to cDSBs (i.e., ei ’ ec),
as in the case of XRS cells, then saturation might already
occur in the case of 2 DSBs, and thus the cDSB lethality per
DSB is also reduced.
This effect is compatible in principle with a negative
bending of the dose-response curve that corresponds to
negative b values. However, this has no meaningful
interpretation in the framework of the standard LQ-model.
The GLOBLE approach thus represents a framework for an
explanation of such an unexpected shape of dose-response
curves as indicated by the negative b values in Fig. 5, and as
discussed in depth by Denekamp et al. (37).
The Role of Damage Interaction
As in many other models, the curvature of the dose-
response curve can be traced back in the GLOBLE approach
to the accumulation and interaction of damage in the most
general sense. However, no assumptions concerning a
physical interaction are made here because the individual
DSB of a cDSB do not necessarily have to come close
together. The mere existence of 2 or more DSBs at the same
time in the same loop is assumed to lead to a higher lethality
due to the assumed less efficient repair of such damage.
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Additionally, since interaction of DSBs over micrometer
dimension is considered, the GLOBLE approach is thus
consistent with experimental results that indicate the
relevance of that length scale for the interpretation of
chromosome aberration data (38). This also was the origin
of the microdosimetric approach, that specifically investi-
gates energy deposition in volumes of micrometer dimen-
sions (39).
Consistent with the terminology discussed by Bedford
(38), iDSB can be considered to be similar to the class of
sublethal damage, whereas cDSB share similarity with the
class of potentially lethal damage. However, in our case,
both classes cannot be strictly distinguished, and are
attributed only to different levels of potential lethality.
Evidence for Two Classes of Damage
An important feature of the model is that only two classes
of damages are distinguished. At present, this classification
is based on the hypothesis that an isolated DSB within a
chromatin loop is easier to repair compared to clustered
damages that consist of multiple DSBs within a loop. Based
on rejoining studies, it has been proposed that the kinetics of
the process can be characterized by two different time
constants: a fast and a slow component. In line with the
findings reported by Johnston et al. (40), it is tempting to
identify the fraction of fast repairable damage with the iDSB
and the fraction of slowly repairable damage with the cDSB.
One can easily estimate using Eq. (3) and the constants
given above that a dose of 45 Gy [which was used for the
rejoining studies reported in (41)] results in about 860
iDSBs and 225 cDSBs. With an average multiplicity of
slightly above two at this dose, these 225 cDSBs represent a
total amount of approximately 450 DSBs. If individual
DSBs within a cDSB are considered to be resolvable in the
assay used to measure rejoining, the iDSB thus represent a
fraction of approximately 65% of the total damage induced,
whereas the cDSB represent a fraction of 35% of the
damage induced. The order of magnitude of these estimated
fractions is in reasonable agreement with data reported by
Nun˜ez et al. (41), indicating that for a set of 6 different cells
lines, the fraction of damage attributable to the slow
rejoining process is in the order of 20–30%. Similarly,
Dahm-Daphi and Dikomey (42) found a fraction of 22 6
5% at 60 Gy, and Stenerlo¨w et al. (43) report fractions of
17–45% after 100 Gy for 3 different cell lines. The value
reported by Stenerlo¨w et al. (44), where the fraction of slow
repair after 100 Gy was found to be only 7%, seems to be
exceptionally low in this respect.
In contrast, when using more sensitive assays such as the
c-H2AX assay that requires doses of only a few Gy, a slow
component of DSB removal is almost undetectable within
experimental uncertainties (45). This result is in line with
estimates using Eq. (3) and results in a fraction of less than
5% cDSB for doses below 5 Gy.
Kinetic Extension of the GLOBLE Approach
The possible identification of iDSB and cDSB with the
fast and slow component of rejoining immediately suggests
a kinetic extension of the GLOBLE approach. In principle,
this can be easily implemented by using the appropriate
differential equations, finally allowing the application of the
approach to model e.g., dose-rate effects. First tests have
already been carried out in this direction.
Potential Applications in the Framework of the Local
Effect Model
The Local Effect Model (LEM) in its current implemen-
tation (20, 21) is based on the transfer of the known photon
dose-response curve to derive the dose response to high-
LET radiation. For the application of the model, the photon
dose-response curve has to be known up to very high doses
in the order of 100 Gy because of the extremely high local
energy deposition in the center of a particle track. Since
these data are not directly experimentally accessible, a
simple approximation is used in the LEM, based on the
assumption that the linear-quadratic shape of the dose-
response curve turns into a purely linear shape at doses
above a certain threshold dose Dt. This approach is in line
with the independently developed approach as reported by
Astrahan et al. (5) which is based on experimental findings.
Since the new GLOBLE approach presented here predicts a
continuous transition toward shallower slopes at high doses,
it could allow a more accurate description of the dose-
response curve that is based on parameters solely
determined in the low-dose region according to Eqs. (8)
and (9). The GLOBLE representation of the photon dose-
response curve will thus be tested in the LEM framework as
an alternative to the currently used linear-quadratic-linear
approach.
Furthermore, the extrapolation to these extremely high
doses might not be necessary since a similar approach to the
one presented here could be directly used for dose
deposition patterns and their corresponding spatial DSB
distributions as induced by high-LET radiation. As soon as
the number of iDSBs and cDSBs are known for any type of
radiation quality, the same parameters ei and ec that
represent the photon dose-response curve can be used to
derive the corresponding survival level after light or heavier
ion irradiation. This would allow for the description of the
dose-response curve based solely on the knowledge of the
number of iDSBs and cDSBs that are independent of the
radiation quality that lead to these numbers. In mathematical
terms, this corresponds to the assumption that Eq. (2) is
universally valid for any radiation quality.
SUMMARY AND CONCLUSION
Starting from only a few assumptions, it was possible to
set up the GLOBLE model as a new survival model that
explicitly distinguishes between the effects related to
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simple, isolated DSB and clustered DSB damage to the
DNA, respectively. The spatial extent relevant for more
severe lesions of the order of half a micrometer (corre-
sponding to ;2 Mbp) has been identified in microdosim-
etry, the analysis of chromosomal aberrations and in c-
H2AX staining of DNA lesions. This scale now can be
interpreted with the concept of chromatin giant loops in a
biological context. Though being very simple, the GLOBLE
can conveniently explain several properties of cell survival
after photon irradiation, such as the systematics of survival
of repair-deficient mutants and their corresponding wild-
type mother cell lines, or the observed negative correlation
between the linear and quadratic coefficients of the LQ
model. This is promising as the latter is not an inherent
feature of conventional survival models. However, in the
same way we are aware that the pathways of DNA damage
recognition and repair are very complex, the current
implementation of the GLOBLE represents a simplification
of the underlying processes. For example, we do not
distinguish here between nonhomologous end-joining
(NHEJ) and homologous recombination (HR), which differ
in their fidelity to correctly repair DSBs. Nevertheless, there
is room to extend the model in this direction by attributing
different average numbers of lethal events to iDSBs
processed by NHEJ and HR, respectively.
However, such extensions can only be addressed after
thoroughly testing the current implementation, where the
primary goal would be to check whether there is a consistent
set of constants (such as the loop domain size) that allow
consistent description of survival data. Another important
further step will be the extension to high-LET charged
particle radiation, where the abundance of cDSB is
enhanced due to the extremely inhomogeneous localized
dose distribution in micrometer dimensions. Finally, for
applications such as radiotherapy (with photons or high-
LET radiation) the GLOBLE might be of interest because it
seems to overcome the shortcomings of the conventionally
used LQ model at high doses.
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We present an application of the Giant LOop Binary
LEsion (GLOBLE) model to the case of cell killing after
irradiation with ultrasoft X rays. The model is based on the
analysis of DSB clustering on the level of chromatin
organization on a megabase pair length scale; it distinguishes
between two classes of damage, characterized by either an
isolated, single DSB (iDSB) or multiple, clustered DSB
(cDSB) within a single giant loop. These corresponding
fractions of iDSB and cDSB depend on the total number of
DSB and thus on the dose as well as the yield of DSB per Gy
per cell. Based on the increased yield of DSB with decreasing
photon energy as reported in the literature, we demonstrate
that according to the model this increased yield of DSB is
sufficient to explain the increased RBE of ultrasoft X rays.
Further assumptions as e.g., a higher lethality of individual
DSB induced by ultrasoft X rays compared to high-energy
photons, which might be a consequence of the more localized
energy deposition, seem not to be a prerequisite. Since the
model is also suitable to take into account local dose
variations within the cell nucleus, we further analyze the
impact of attenuation of low-energy photon radiation when
penetrating a cell layer. We show that the inhomogenous dose
distribution resulting from attenuation further increases the
effectiveness and particularly affects the beta-term of the
corresponding dose response curve. Finally, we compare and
discuss the mechanisms of increased RBE as observed after
ultrasoft X-ray irradiation with those observed after high-
LET ion beam irradiation.  2014 by Radiation Research Society
INTRODUCTION
Precise knowledge and characterization of the effective-
ness of different radiation qualities is of utmost importance
for applications in radiation protection as well as in
radiation therapy. Biophysical models represent an impor-
tant tool to test hypotheses about mechanisms of radiation
action and are also of high practical relevance for
applications e.g., in treatment planning in ion beam
radiotherapy (1, 2).
Thorough validation of models is required for this type of
application because of the precision criteria that typically
have to be fulfilled in this field. Based on ideas originally
implemented to model high-LET radiation in the framework
of the Local Effect Model (LEM) (3, 4) we recently
demonstrated that the general features of photon dose-
response curves can be predicted by the spatial pattern of
initial DSB induced by ionizing radiation (5). This pattern is
characterized with respect to a level of chromatin
organization called ‘‘giant loops’’ (6–9), which represent
DNA segments of approximately 2 Mbp length attached to
the nuclear matrix. We define two types of DSB, the first is
a single, isolated DSB (iDSB) induced in the giant loop, and
the second is a clustered DSB (cDSB), where two or more
DSBs are induced in the giant loop. Assuming that due to
their higher complexity cDSB represent a more severe
damage than iDSB, we assigned different lethalities to the
classes of iDSB and cDSB, respectively. We showed that
essential features of photon dose-response curves e.g., the
linear-quadratic behavior at low and intermediate doses as
well as a transition to more straight dose-response curves at
higher doses can be predicted by this classification of DSB
(5). The application of the model, termed the ‘‘Giant LOop
Binary LEsion’’ model (GLOBLE), to the case of photon
radiation requires the assumption of a random distribution
of DSBs within the critical target, i.e., the cell nucleus; and
this condition is clearly fulfilled for high-energy photon
radiation such as 250 kV X rays or 60Co c rays.
Ultrasoft X rays represent a further test case for the
model, since they exhibit an increased effectiveness as
compared to high-energy photons [e.g. see refs. (10–12)].
Potential mechanisms of this higher effectiveness might be
due to the higher yield of DSB and/or to the local
heterogeneity of the dose distribution because of the
significant attenuation of low-energy photon radiation.
In this article we therefore analyze to what extent the
GLOBLE model is consistent with the experimental results
1 Address for correspondence: GSI Helmholtzzentrum fu¨r Schwer-
ionenforschung, Dept. of Biophysics, Planckstrasse 1, D-64291
Darmstadt, Germany; e-mail: m.scholz@gsi.de.
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obtained for cell killing after ultrasoft X-ray irradiation.
Furthermore we use the model to specifically investigate the
role of the target shape and geometry, which has been
proposed to influence the biological effectiveness observed
after ultrasoft X-ray irradiation. In addition, we discuss the
potential differences between the RBE effects for ultrasoft
X rays and charged particle radiation. Finally we compare
the GLOBLE model with other models developed to explain
the effects of ultrasoft X rays. The main purpose of this
investigation is to show a proof-of-principle and to discuss
the basic, general features of the model; a thorough
systematic comparison to the numerous reports of experi-
mental data and modeling approaches would be beyond the
scope of this contribution.
METHODS
Basics of the GLOBLE Approach
The basic assumption of the approach which has been previously
published by Friedrich et al. (5) is that chromatin loops of
approximately 2 Mbp size represent the key structure determining
the cellular radiation response in agreement with the findings reported
by others (6–9, 13). In this model the response of a cell is therefore
expected to critically depend on the number of DSBs induced in such
a loop structure.
The average number of lethal events assigned to iDSB and cDSB is
represented here by ei and ec, respectively. According to the higher
severity of cDSB compared to iDSB, in general ec .. ei. As it turns
out, both ei and ec are smaller than one and can be regarded as the
probability for an iDSB or a cDSB to be lethal, respectively.
According to the definition of cDSB, dose-rate effects are expected
to significantly affect the consequences of the time sequence in which
DSB are induced, since repair of the first DSB might have happened
before the second DSB is induced. These dose-rate effects have been
neglected for the analysis shown here; however, we have demonstrat-
ed recently that GLOBLE in principle is well suited to reflect the dose-
rate dependence of radiation effects (14).
If the average number of chromatin loops with isolated DSB is
termed ni and the average number of loops with clustered DSB is
termed nc, the survival probability can be written as:
S ¼ expðnieiþncecÞ ð1Þ
Eq. (1) represents the general formulation of the approach and
comprises the assumption of independence of the loops, i.e., the
lethality of lesions in one loop is fully determined by intra-domain
effects and thus by the number of initial DSBs induced within an
individual loop and it does not explicitly depend on the damages
induced in the neighboring domains. This does not exclude the
interaction of DNA ends from different domains and thus e.g., the
formation of chromosome aberrations as a consequence of misrepair
or misrejoining processes. Lethal events as the result of domain
interactions are comprised in the mean values ei and ec.
For photon radiation with a homogenous dose distribution, the
numbers ni and nc can be obtained from the initial DSB yield.
Therefore, we assume that for hard X rays and c rays the yield is given
by aDSB ¼ 30 DSB per Gy and per cell, consistent with experimental
data reported elsewhere (15, 16) and independent of the cell type.
Assuming a genome size SG, this can be used to determine the
number of DSBs per chromatin loop, assuming that all loops are
characterized by the same size SL. Then, the whole genome contains
NL¼SG/SL giant loops, and the induction frequency per loop is YLoop¼
aDSB/NL per Gy. From this average number, using the Poisson statistics
the average number of loops in a cell nucleus containing zero DSB
(n0), exactly one DSB (ni) or two or more DSB (nc) are determined as a
function of the dose from:
n0 ¼ NLexpYLoopD
ni¼ NLðYLoopDÞ  expYLoopD
nc¼ NL  n0  ni ð2Þ
Inserting these into Eq. (1) allows determining the complete dose
response curve.
As discussed in ref. (5), the assumption of independent Poisson
distributions for ni an nc leading to Eq. (1) represents an
approximation, since actually, at least at very high doses, they are
correlated. However, as demonstrated by a comparison with a Monte
Carlo approach, the approximation underlying Eq. (1) is accurate
enough for the dose range to be discussed here.
Adaptation to Ultrasoft X Rays
Essentially three aspects have to be considered for the application of
the GLOBLE model to ultrasoft X rays:
 The increased yield of DSB induction The attenuation of X rays within the target The target geometry
The increased yield can be represented by the corresponding RBE
value, i.e.,
aDSB;UX ¼ RBEUX  aDSB;c ð3Þ
where aDSB,US and aDSB,c denote the yield of initial DSB after ultrasoft
X and c irradiation, respectively. Qualitatively, the increased yield can
be explained by the pronounced clustering of ionization events as a
consequence of the low energy and thus the limited range of
photoelectrons emitted by ultrasoft X rays.
According to the basic assumptions of the model, the lethalities
attributed to iDSB and cDSB, respectively, are hypothesized to be cell
specific constants and should be independent of the radiation type.
Attenuation of ultrasoft X rays within the target at depth x is
described by the attenuation length kUX:
DðxÞ ¼ ex=kUXDð0Þ ð4Þ
In contrast to high-energy photon radiation, where at least for thin
monolayers of cells attenuation can be neglected, in the case of
ultrasoft X rays the target geometry can – depending on the
attenuation length – affect the local dose distribution within the target
and thus the expected effect. Therefore, the target thickness has to be
specified, and in general we assume a cylindrical shape of the cell
nucleus with given volume VNucl, radius RCyl and height HCyl. For
comparison, we also consider a spherical shape with the same volume
VNucl, but correspondingly different radius RSph. Dose values are
always given as mean dose values across the thickness of the target,
i.e., the cell nucleus. Additional layers of cytoplasm are not considered
and taking into account that these thin layers are more or less
symmetrical above and below the cell nucleus, in a first approximation
the mean dose across the assumed nuclear thickness should represent
the mean dose across the whole cell.
Along with the decrease of the local dose with penetration depth
due to attenuation, the probability to induce iDSB or cDSB varies with
depth accordingly. Therefore, the target volume is virtually divided
into slices with 0.5 lm thickness, corresponding to the typical
dimension of the volume covered by a giant loop. Depending on the
target geometry, the number of loops contained in each slice is
determined and the numbers ni and nc determined separately for each
slice according to the local dose deposited in that slice. The total effect
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is then calculated by summing up the contribution of lethal events as
defined by Eq. (1) from all slices.
RESULTS
Comparison to Experimental Data
The model requires the DSB yield as input for the
prediction of cell killing. de Lara et al. have measured DSB
induction and cell killing simultaneously (10); this data set
is thus ideally suited to test the GLOBLE model. The
increased yield of DSB is implemented by assigning an
RBE for DSB induction according to the data published by
de Lara et al. and the parameters are summarized in Table 1.
The RBE values for DSB induction are assumed to be valid
for all cell lines. Since de Lara et al. performed their
experiments with V79 cells, we take the corresponding
values for ei and ec from our previous publication (5) to
characterize the lethality of iDSB and cDSB, respectively,
for all radiation types. The cell line specific lethalities ei and
ec, are listed in Table 2, together with the values for the
other cell lines as described below. Figure 1 shows the
comparison of the GLOBLE prediction for high-energy
photons, Ti-K soft X rays and C-K soft X rays with the
experimental data. For high-energy photons and Ti-K X
rays, a very good agreement is observed over the whole
dose range. For C-K X rays, the model predictions are in
agreement with the experimental data at least for the range
from 100% to 1% survival, however at lower survival levels
deviations become significant because of the saturation
effects. These saturation effects are frequently reported for
irradiations with extremely low-energy photons and are
typically attributed to shielding effects.
Because attenuation plays a major role for very low-
energy photons, the target geometry might influence the
dose-response curve. Therefore, we compare curves for the
standard geometry, which is a cylindrical nuclear shape to
curves based on a spherical nucleus with the same nuclear
volume in Fig. 1. In this case, the predicted curve is
shallower for C-K X rays, whereas the curves for Ti-K X
rays and high-energy photons remain unaffected. This can
be attributed to the fact, that in a spherical volume the
number of domains per layer in the nucleus varies with
depth, whereas in a cylindrical geometry this number is
constant. Consequently, in the spherical geometry in the
layers close to the entrance, where the proportion of cDSB
compared to iDSB is highest, the number of domains is
smaller and thus the predicted effect is lower. However,
calculating the mean dose in accordance with the procedure
reported for the experimental data, does not consider this
variation of the lateral extension of the target. Consequently,
the effectiveness seems lower in the case of spherical
volumes. In reality, cell nuclei have a more ellipsoidal shape
and thus the corresponding prediction of the model would
be between the extreme cases of cylindrical and spherical
geometry.
Since for C-K X rays only a few data points are available
in the low-dose region, which is not affected by saturation
effects, we also compared the model predictions to the data
reported by Raju et al. (12) (Fig. 2). Although they also
used V79 cells for their studies, the dose-response curve
after high-energy photon irradiation slightly differs from the
one reported by de Lara et al. Consequently, to represent
this dose-response curve correctly, the parameters ei and ec
have been adapted based on the linear-quadratic parameters
and the transformation formula given in Eq. (6) in the article
by Friedrich et al. (5). These correspondingly adapted
values for ei and ec (see Table 2) have then been used to
model the dose-response curve after ultrasoft X-ray
irradiation. Since DSB induction was not measured by
Raju et al., we use the same RBE values for DSB induction
as reported by de Lara et al. Again, a very good agreement
between model predictions and experimental data is
observed. In particular, the pronounced shoulder predicted
by the model in the low-dose region fits to the experimental
data. For higher doses, Raju et al. (12) observed a saturation
as de Lara et al., although at a lower survival level. This was
simulated in the model by introducing a constant offset for
the survival level as given in the Fig. 2 legend, representing
a small fraction of cells receiving no dose due to shielding
by other cells.
Finally, a set of experimental data reported by Goodhead
et al. (17) for irradiation of human fibroblasts has been used
for comparison with the GLOBLE model. Here, the shape
of the dose response after high-energy photon irradiation
significantly differs from the curve observed for V79 cells.
This is reflected in the difference of the parameters ei and ec
as summarized in Table 2. As already discussed by
Friedrich et al. (5), the higher sensitivity can be modeled
TABLE 1
Characteristic Features of Different Ultrasoft X Rays with
Respect to DSB Induction [taken from de Lara (10)] and
Attenuation [taken from Nikjoo and Lindborg (36)]
Radiation
quality
Energy
(keV)
RBEDSB
(from de Lara et al.)
kUX
(lm1)
C-K 0.28 2.7 180
Al-K 1.49 1.9 7.9
Ti-K 4.55 1.4 1.9
TABLE 2
Input Parameters for the GLOBLE Model for the Different
Cell Lines used for Comparison with Experimental Data
Author Cell line ei ec
de Lara et al. V79 0.0036 0.210
Raju et al. V79 0.0048 0.163
Goodhead et al. HF19 0.0315 0.150
Notes. Despite de Lara et al. (10) and Raju et al. (12) using the same
cell line (V79), they report slightly different sensitivities already for
high-energy photons and thus need to be characterized by corre-
spondingly different parameters. For details see text.
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by a corresponding increase of ei with ec remaining in the
same order of magnitude. Again, since no direct information
about the RBE for DSB induction after ultrasoft X rays is
available for HF19 cells, we used the same parameters as
reported by de Lara et al. Comparison of the model
predictions with the experimental data as shown in Fig. 3
shows good agreement.
The Impact of Attenuation
It has been intensively discussed whether or not the
increased biological effectiveness is a consequence of the
extreme attenuation of e.g., C-K X rays in combination with
the nonlinearity of the dose-response curve observed for
high-energy photon radiation. This could be particularly
relevant for V79 cells, which are characterized by a larger
FIG. 2. Comparison of model predictions for Co-250 kV X rays, Al-K and C-K ultrasoft X rays with experimental data for V79 Chinese
hamster cells reported by Raju et al. (12). Effects of shielding of the cells are illustrated for 1% shielding in the case of C-K and 0.1% shielding for
Al-K.
FIG. 1. Comparison of model predictions for Co-c, Ti-K and C-K ultrasoft X rays with experimental data for V79 Chinese hamster cells
reported by de Lara et al. (10). For C-K, in addition to the standard cylindrical geometry of the cell nucleus calculations are shown for a spherical
shaped nucleus (dashed line). For Co-c and Ti-K, the corresponding lines would lie exactly on top of the curves shown for the cylindrical
geometry. For C-K, also the effect of shielding 1% of the cells is shown.
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cell height compared to the fibroblasts used e.g., by
Cornforth et al.
We therefore analyzed in more detail the impact of
radiation attenuation on the predicted cell survival. The
GLOBLE model is ideally suited for such an analysis since
cell killing is determined by summing up the number of
lethal events in individual domains; inhomogeneities of the
dose deposition can thus be easily taken into account.
Figure 4 illustrates the impact of attenuation by artificially
switching on and off the attenuation in a cross-wise manner,
i.e., for C-K X rays the attenuation was neglected, but the
high RBE for DSB induction was kept. Vice versa, an
artificially high attenuation coefficient as observed for C-K
X rays has been attributed to Ti-K X rays, but again keeping
the RBE for DSB inductions as reported by de Lara et al. for
Ti ultrasoft X rays. As expected, attenuation has a
significant impact if the attenuation length is in the order
of micrometers, i.e., within the dimension of a typical cell
nucleus, since this implies a significant dose gradient along
the penetration depth of the ultrasoft X rays.
The increased effectiveness related to the strong attenu-
ation can be explained by high local dose at the entrance
side of the radiation, which increases the probability to
induce cDSB in the first layer of loops. Due to the nonlinear
increase of the probability of cDSB as a function of dose
these high local doses lead to an over proportional increase
of lethality, as reflected by the steeper slope of the
corresponding survival curves.
Despite the fact that a significant impact of attenuation is
predicted, it is by far not sufficient to fully explain the
increased effectiveness of ultrasoft X rays.
Since the effects of attenuation will depend on the
thickness of the critical target, we compared the corre-
sponding predicted survival curves for three different
heights of 2, 6 and 10 lm in Fig. 5a, where the nuclear
volume has been kept constant and the cross section has
been adapted accordingly. As expected, the curves get
steeper with increasing thickness of the nucleus. However,
this effect is only pronounced for cells showing a distinct
shoulder in the case of high-energy photon irradiation,
which can be traced back to a large difference in the
lethality of iDSB and cDSB. If the high-energy photon
dose-response curve is already almost linear – correspond-
ing to high values of ei – almost no impact of attenuation is
predicted even for very thick cells. This is demonstrated in
Fig. 5b on the basis of the ei and ec parameters used for
fibroblasts (cf. Fig. 3). A local, microscopic inhomogene-
ity of the dose distribution is thus expected to have impact
on the dose response curve only if the corresponding high-
energy photon dose-response curves are nonlinear.
Comparison of Ultrasoft X Rays and Ion Beams
In line with the experimental data the model predicts a
significant bending of the dose-response curves in the
region down to 10% (Fig. 2), which is a striking difference
to what is typically observed after high-LET irradiation,
e.g., carbon ions showing similar RBEa. Apart from the
saturation effects observed at lower survival levels, this
indicates that the increased RBE of ultrasoft X rays
represents a dose-modifying factor, whereas for high-LET
radiation typically a drop of RBE with increasing dose is
observed (18). Both the GLOBLE as well as the LEM are
able to reproduce these features, as it is demonstrated by the
comparison shown in Fig. 6. The curves for high-energy
photons and C-K soft X rays are identical to the ones in Fig.
1; the curve for carbon ions is determined using the LEM,
that is also based on the concept of DSB classification into
FIG. 4. Effect of attenuation on the dose-response curves for C-K
and Ti-K ultrasoft X rays. The impact of attenuation is demonstrated
by either artificially switching off the attenuation effect for C-K (thick
dashed line) or artificially attributing a stronger attenuation as for C-K
to the Ti-K X rays (thin dashed line). Simulations are performed with
parameters for V79 cells; RBEDSB values are kept unchanged in both
cases.
FIG. 3. Comparison of model predictions for Co-c, Ti-K, Al-K and
C-K ultrasoft X rays with experimental data for HF19 human
fibroblast cells reported by Cox et al. (26) and Goodhead et al. (17).
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iDSB and cDSB (3, 4). The LET was chosen so that the
RBE for the initial slope of the survival curves, RBEa, is
identical for carbon ions and C-K soft X rays. The
comparison clearly demonstrates the quite different shape
of the dose-response curves, despite the fact that the
identical RBEa values would indicate a similar radiation
quality.
DISCUSSION
Concept of Lesion Distribution Approach
Both the LEM and the GLOBLE model are based on the
premise that the initial DSB distribution pattern deter-
mines the radiation response, where the pattern is
characterized by the number of iDSB and cDSB induced
by the radiation field. In the GLOBLE model the
observable effect can be determined based on the
lethalities ei and ec that are attributed to iDSB and cDSB,
respectively; the lethalities are assumed to be independent
of the radiation quality leading to the DSB. Based on the
knowledge of the increased yield of DSB after ultrasoft X-
ray irradiation and the lethalities ei and ec derived from
high-energy photon radiation, the GLOBLE model can
predict the cell killing effects of ultrasoft X rays with high
accuracy down to survival levels of approximately 1%,
that are not affected by shielding effects. This is consistent
with the assumption that the quality of lesions, in
particular of iDSB and cDSB, does not significantly differ
between low-energy and high-energy photon radiation,
and that it is mainly the different yield and thus the
corresponding number of iDSB and cDSB that actually
determines the effect. This conclusion concerning lesion
quality is further supported by experimental results
indicating that the rejoining kinetics after high-energy
photon irradiation and ultrasoft X-ray irradiation is almost
identical (10). Furthermore, a recent approach to model
rejoining kinetics based on the two classes of iDSB and
cDSB is consistent with these findings (19).
The role of the increased yield of DSB after high-LET
irradiation has been discussed to be relevant for the
explanation of the increased RBE in a modeling study
reported by Carlson et al. (20), although that model was not
able to explain the decrease of RBE typically observed for
higher LET values above approximately 150 keV/lm. The
authors further conclude that the local lesion complexity as
characterized in nm-dimensions seems not to be a major
factor determining radiation effectiveness, which is in
agreement with the concept on which the current analysis
is based.
Therefore, although lesion severity does not change with
respect to individual iDSB, an increase of lesion severity on
the micrometer level that is relevant for cDSB results from
FIG. 5. Comparison of the impact of the cellular height on the
predicted dose-response curves for parameters representing signifi-
cantly shouldered dose-response curve after high-energy photon
radiation (ei¼ 0.0038, ec¼ 0.18) (panel a) and parameters representing
an almost straight-dose-response curve (ei ¼ 0.032, ec ¼ 0.15) (panel
b). RBEDSB was set to 1.0 for the calculations.
FIG. 6. Comparison of GLOBLE predictions for C-K ultrasoft X
rays and LEM predictions for carbon ions at 44.2 keV/lm,
characterized by the same RBEa
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the inhomogeneous dose distribution with depth in the case
of C-K soft X rays. Here, the high local dose at the entrance
region of the nucleus induces cDSB with a higher frequency
than expected on the basis of the mean nuclear dose,
because the induction of cDSB depends in a nonlinear way
on the dose. Nevertheless, as demonstrated in Fig. 4, the
impact of the dose attenuation on the increase in effect is
comparably small, although clearly visible, compared to the
impact of the higher yield of DSB.
Role of Target Geometry and Dimensions
It has been hypothesized that target geometry in
combination with the strong attenuation might represent
a major cause for the increased effectiveness of ultrasoft X
rays (21, 22). In particular the experimental data reported
by Cornforth et al., for fibroblasts that are characterized by
a substantially minor thickness in contrast to other cells
indicate an RBE very close to 1. Whereas this result would
be in favor of the hypothesis that attenuation is responsible
for the high RBE, it is at variance with the observed higher
yield of DSB after ultrasoft X rays. Assuming that the
increased yield of DSB is valid for fibroblasts as for V79
cells (which is in line with the general observation that the
initial DSB induction does not vary significantly between
cell lines), it would be difficult to understand why
fibroblasts should not respond to a higher yield with a
lower survival, too. However, no DSB induction were
measured in the AG1522 fibroblasts after ultrasoft X ray
irradiation, and thus it might be speculated that for some
unknown reason the DSB induction is actually less
enhanced compared to other cell lines.
In comparison to a homogeneous dose deposition to a
cell nucleus, for irradiation with soft X rays with an
absorption length in the order of micrometers the deposited
energy is concentrated at the entrance and decreasing
exponentially with increasing penetration into the nucleus.
Intuitively, domains far away from the entrance are barely
affected by ionization events and hence do rarely house
iDSB, while domains close to the entrance are likely to
show a more dense damage pattern, leading to iDSB or
even cDSB more regularly. This suggests that only a
reduced number of domains are accessible to the radiation,
but get affected more severely in turn. Indeed a Taylor
analysis for cylindrical cell nuclei irradiated with small
doses of some Gy shows that absorption can be modeled
by simply replacing the number of loops by a lower
effective loop number, decreasing with absorption
strength.
This notion of a reduced domain number with an
enhanced proportion of cDSB compared to iDSB implies
important consequences for the dose-response curve. While
without such absorption a dose-response curve is expected
to be a simple dose rescaled copy of the corresponding
high-energy photon curve (i.e., it has dose modifying
property), absorption will break this similarity. At the
entrance where local doses are high, it becomes more likely
that any two photoelectrons induce DSB into the same
domain, thus giving rise to enhanced damage clustering and
to a higher bending of the dose response curve at high
doses. In the LQ model this results in an increased beta
term.
Comparison to the Microdosimetric Approach
The experimental data obtained after ultrasoft X-ray
irradiation have challenged theoretical considerations on the
mechanisms of radiation action, namely the microdosimetric
approach. The key argument here as raised by Goodhead
(23) was, that the typical range of photoelectrons released
by ultrasoft X rays (a few nm) is incompatible with the
target dimensions of micrometer size, which is the basis of
the microdosimetric approach. According to the model
discussed here, these different dimensions are not in
conflict.
The extreme localization of energy deposition in nm
dimensions can be considered to be the cause for the
increased yield of DSB, as indicated by Goodhead (24). The
clustering of ionization events may lead to a higher
probability to induce to SSB close together on opposite
DNA strands, resulting in the increased yield of DSB. This
increased yield is not directly modeled in the approach
presented here, but information about RBEDSB is taken from
the experimental data and it is assumed that the spatial
distribution of DSB is still random, as for higher energy
photon radiation. Due to the short track length of
photoelectrons, all DSB are induced independently of each
other. Interaction processes get involved as soon as the
doses are sufficiently high to induce a significant number of
cDSB, characterized by multiple DSB within a loop.
However, no physical interaction of the DSB or overlap
of the dose depositions by different photoelectrons is
required to lead to an interaction; instead the interaction is
mediated by the target structure, because the mere
simultaneous existence of two DSBs in one loop is assumed
to lead to a lower survival probability compared to the
product of survival probabilities for two independent
iDSBs.
Thus, processes in nm as well as lm dimensions are
relevant for the explanation of the increased effectiveness of
ultrasoft X rays: the nm dimension is relevant for the
increased induction of DSB, the micrometer dimension is
relevant for the increased effectiveness of cDSB.
The Relevance of Two Damage Classes
According to the results discussed above, in the
framework of the GLOBLE model the increased effective-
ness of certain radiation types may result from two different
processes:
1. The increased yield of DSB
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2. The concentration of DSB, leading to a deviation from a
random distribution
Both obviously play a role for ultrasoft X rays, although
here the increased yield represents the dominant factor and
the concentration of DSB seems to be a comparably minor
correction leading to a further increase in the case of very
low-energy photon radiation.
The discussion can be extended to the case of high-LET
particle radiation, where it is much more likely that the
concentration of DSB along the particle trajectories, will
become dominant. This effect might be further enhanced by
an increased yield of DSB, which is a consequence of the
higher probability to induce SSB close together due to the
high local dose within the particle track center (25).
Interestingly, in terms of Eq. (1) the increased effective-
ness can be either attributed to a simultaneous increase of ni
and nc or a shift in the balance between ni and nc for ultrasoft
X rays and ions, respectively. Thus, for a given survival
level, there are different potential linear combinations of ei
and ec, which can be attributed to this effect.
This also explains the different shape of dose response
curves for ultrasoft X rays and ion beam radiation, even if
the RBE for the initial slope is identical (see. Fig. 6).
For soft X rays, the increased DSB yield seems to play the
major role, and the nonrandomness of DSB distribution due
to attenuation is only expected to play a role in the case of
very low-energy photons with correspondingly strong
attenuation. This explains why for ultrasoft X rays the
increased effectiveness exhibited dose-modifying features,
since as a consequence of the random distribution for a
given number of DSB the same spatial patterns of
microscopic DSB distributions are produced by high- and
low-energy photons. The situation is entirely different for
ion irradiation. Here, the nonrandom distribution of DSB is
the dominant factor, caused by the track structure and the
corresponding high local dose along the trajectory of the
particle. As a consequence, DSBs are induced essentially
along the trajectory, leading to a highly ordered distribution
of DSB and resulting in a much higher probability for the
induction of cDSB and thus a higher lethality. Therefore, in
the case of ultrasoft X rays the increased initial slope of the
dose-response curve is due to an increased number of iDSB
with comparably low lethality, whereas in the case of ion
irradiation the increased slope can be attributed to a
comparably small number of cDSB, that however exhibit
a much higher lethality compared to iDSB. In addition,
according to the model assumptions, cDSB induced within
individual particle tracks are not susceptible to inter-track
effects, because increasing the number of DSB in a loop that
already contains 2 or more DSBs does not further enhance
lethality. Therefore, only iDSB induced within individual
tracks can contribute to inter-track effects, and consequently
the dose-response curve for ion irradiation is straighter. In
contrast, since predominantly iDSB are induced by
individual ultrasoft photons, all DSB can contribute to
inter-track effects.
Similarly, for ultrasoft X rays a pronounced dose-rate
effect would be expected similar to that of higher energy
photons as described by Herr et al. (14). In contrast, since in
the case of high-LET radiation cDSB are primarily formed
by single ions, they are always produced simultanously and
thus not susceptible to dose-rate effects.
The model prediction concerning the different shape of
dose response curves after ultrasoft X-ray irradiation and
high-LET irradiation is fully in line with the experimental
results reported by Cox et al. (26). They compare survival
curves for irradiation with Al-K X rays and 20 and 50 keV/
lm He ions. Whereas both survival curves for He-ion
irradiation are almost linear, the curve for Al-K X rays
shows a significant bending, although the initial slope is
similar to that for 20 keV/lm He-ions.
Comparison to Other Models
Several other modeling approaches have been reported in
the literature for application to the case of ultrasoft X rays.
Although a thorough comparison to these other approaches
would be beyond the scope of this article, we will address
here some conceptual aspects that might indicate directions
of future work.
The experimental results obtained with ultrasoft X rays
particularly challenged ideas on which the theory of dual
radiation action (TDRA) (27) is based. The major
inconsistency was related to the length scales involved;
since extremely low-energy ultrasoft X rays such as C-K
rays deposit their energy within nanometer ranges, this was
concluded to be incompatible with the length scales relevant
for the TDRA (23). A generalized version of the TDRA
[called GTDRA (28)] and the appropriate accounting for the
heterogeneous energy deposition caused by attenuation was
then reported to be able to account for the peculiar energy
deposition pattern of these low energy X rays (29, 30). The
major impact of the attenuation has been reported to
potentially lead to an increased b term, which otherwise is
assumed to be constant in the TDRA and GTDRA.
Interestingly, the approach shown here is consistent with
the increase of beta as a consequence of the attenuation
across the cell nucleus, as shown in Fig. 4. However, in
general our approach predicts an increase of beta also in the
case of negligible attenuation, which is even more
prominent. This is a consequence of the dose modifying
properties that result from the general scaling of the DSB
yield by a common factor RBEDSB,USX. If attenuation is
negligible, the RBE for survival RBESurv should be constant
and identical to RBEDSB,UX for any given survival level.
With that, the linear quadratic parameter can be derived
from:
aSurv;UX ¼ aSurv;c  RBEDSB;UX ð5Þ
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bSurv;UX ¼ bSurv;c  RBE2DSB;UX ð6Þ
Therefore, if the dose-response curves for conventional
high-energy photon radiation already show a shoulder, the
inter-track contribution should be particularly prominent for
ultrasoft X rays, which is in line with the experimental data
shown in Fig. 2.
Since the model reported by Stewart et al. (31) is able to
predict the experimentally observed increase of the DSB
yield with decreasing photon energy, it might be helpful in
further applications of the approach presented here.
An increase of the b term with the square of the number
of DSB is also predicted by the model developed for
application to high-LET radiation by Carlson et al. (20).
However, the model is only able to predict an increase with
LET, whereas it fails to predict the decrease typically
observed at LET values above approximately 150 keV/lm.
Another approach based on microdosimetric consider-
ations has been proposed by Hawkins and adapted to the
case of ultrasoft X rays [microdosimetric kinetic model
(MKM) (32, 33)]. In this model, the increased effectiveness
of low-energy photons is attributed to an increased
probability to induce two potentially lethal lesions caused
by one event, and the increase of b is attributed to the
increased yield of potentially lethal lesions (33). Whereas
the latter is consistent with our findings, if DSB are
considered to be the potentially lethal lesions (although this
is not explicitly stated so by Hawkins), the first aspect is
incompatible with the approach presented here. It would
require the induction of two DSB by a single-low-energy
photon, and based on the average yields and the number of
photons per Gy the probability of a single photon to induce
one DSB is substantially smaller than 1, and therefore the
simultaneous induction of two DSB thus seems to be very
unlikely. However, of course this cannot be ruled out based
on these simple considerations and further analysis will be
required for the detailed comparison of these approaches.
Obaturov et al. have presented a modeling approach
applicable to a wide range of radiation qualities, which
resembles our approach in that it also uses a compartmen-
talization of the cell nucleus in about 3,000 subunits, called
‘‘membrane attached superstructural units’’ (MASSU) (34,
35). The model also allows for a variation of the b term,
depending on the repair probability of potentially lethal
damages before first postirradiation mitosis. However, the
model does not allow prediction of the variation of b with
radiation quality, but it rather empirically accounts for such
a variation.
As discussed above, in the MKM as well as in our model
the increased yield of potentially lethal damages or DSB,
respectively, leads to an increased b term for ultrasoft X
rays. A question we have not specifically addressed here is
the mechanism leading to this increased yield. Instead, we
made use of empirically determined RBE values for DSB
induction as reported by de Lara et al. Further work thus is
required to clarify in how far this increased yield of DSB
can be predicted on the basis of an amorphous track
structure approach as reported by Elsa¨sser et al. (25). There,
the increased yield of DSB after charged particle track
traversals has been modeled by specifically considering the
increased probability to induce two SSBs in close vicinity,
finally leading to a DSB. Based on this concept, it might be
possible to model the increased DSB yield of ultrasoft X
rays based on their extremely confined energy deposition
pattern.
A commonality of models based on pairwise lesion
interaction, e.g., the TDRA or the MKM is the prediction of
a pure linear-quadratic shape of dose-response curves. In
contrast, as discussed in detail by Friedrich et al. (5), a
specific prediction of the GLOBLE model resulting from
the concept of DSB clustering in chromatin loops is a
transition to a more straight form of the dose-response curve
at high doses as well as an intrinsic anticorrelation between
the LQ-parameters b and a. Experimental results are in
agreement with both of these predictions and thus are
further supportive of the concept on which GLOBLE is
based.
SUMMARY AND CONCLUSIONS
We have compared predictions of the GLOBLE model
with experimental data obtained after irradiation with
ultrasoft X rays. We showed that within the framework of
the GLOBLE model the increased yield of DSB is sufficient
to explain the increased RBE for cell killing, assuming that
the lethality of DSB is independent of radiation quality.
Analyzing the impact of attenuation of ultrasoft X rays
within the target, it could be demonstrated that this
attenuation only plays a minor role for the increased
effectiveness compared to the increased yield of DSB with
decreasing photon energy. In a comparison with cell killing
effects after high-LET ion-beam irradiation, we could also
explain why ultrasoft X rays exhibit dose-modifying
properties and nearly dose-independent RBE values,
whereas for high-LET radiation a significant dose depen-
dence is typically observed, even at the same RBEa. Since
the model predictions are fully consistent with the
experimental results, we take this as further support of the
general concepts on which GLOBLE is based.
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Abstract
The relative biological effectiveness (RBE) is a central quantity in particle
radiobiology and depends on many physical and biological factors. The
local effect model (LEM) allows one to predict the RBE for radiobiologic
experiments and particle therapy. In this work the sensitivity of the RBE on its
determining factors is elucidated based on monitoring the RBE dependence on
the input parameters of the LEM. The relevance and meaning of all parameters
are discussed within the formalism of the LEM. While most of the parameters
are fixed by experimental constraints, one parameter, the threshold dose Dt , may
remain free and is then regarded as a fit parameter to the high LET dose response
curve. The influence of each parameter on the RBE is understood in terms
of theoretic considerations. The sensitivity analysis has been systematically
carried out for fictitious in vitro cell lines or tissues with α/β = 2 Gy and
10 Gy, either irradiated under track segment conditions with a monoenergetic
beam or within a spread out Bragg peak. For both irradiation conditions, a
change of each of the parameters typically causes an approximately equal or
smaller relative change of the predicted RBE values. These results may be used
for the assessment of treatment plans and for general uncertainty estimations
of the RBE.
(Some figures may appear in colour only in the online journal)
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1. Introduction
The RBE is used to quantify the enhanced effect of ion beams in comparison to low LET
radiation such as x-rays or gamma rays. For applications in radiobiologic research as well as
in ion radiotherapy the precise characterization of RBE is of importance. Many experimental
and clinical studies have been carried out to reveal the RBE under various conditions (Ando
and Kase 2009, Gerweck and Kozin 1999, Friedrich et al 2013). However, as the RBE depends
on several factors whose versatile combinations cannot be investigated solely by experiments,
models for predicting the RBE have been developed. The LEM in its original version (LEM I)
(Scholz et al 1997) and the microdosimetric kinetic model (MKM) (Hawkins 1994, 1996) are
currently the only ones used for clinical treatment planning. Within the recent years, the LEM
has been gradually improved (Elsa¨sser and Scholz 2007, Elsa¨sser et al 2008). The latest version
LEM IV (Elsa¨sser et al 2010, Friedrich et al 2012b) comprises a mechanistic interpretation on
the level of double strand break (DSB) induction. This allowed one to significantly improve
the accuracy to model the RBE for all therapy relevant ions and energies with one unique
set of necessary parameters which have been fixed once for all model calculations. As their
values, as well as other experimental parameters (e.g. those specifying the tissue considered),
are associated with uncertainties the question arises how these translate into uncertainties of
the predicted RBE. Hence, for applications in radiobiology and in the clinics it is of interest to
quantify the consequence of a change of each input parameter for the RBE. The rates of RBE
change will reflect themselves in the robustness of treatment plans for ion beam therapy.
This paper is dedicated to the sensitivity analysis of RBE, obtained by a systematic
variation of parameters used within the LEM IV. The strategy is to carry out the analysis
in a very systematic way, where at first all parameters are inspected and classified, then
their relevance is quantitatively investigated for monoenergetic beams as well as for extended
irradiated volumes6. This strategy finally allows one to understand the parameter sensitivity
based on the physical or biological meaning of the parameter under consideration and to
compare the expectations for RBE uncertainty for the different ways of beam delivery. Our
approach is complementary to a recent publication (Bo¨hlen et al 2012), where the authors
investigated the parameter influence on RBE for extended targets and in detail discuss possible
implications for ion beam therapy.
The parameters needed for calculating RBE values with LEM may be subdivided
according to the model parts they are used in:
• specification of the physical aspects of track structure
• specification of the initial DNA damage distribution
• characterization of the cell and DNA conformation geometry
• characterization of the photon dose response curve.
In section 2 the basic principles of the LEM are revisited and the parameters needed for
RBE calculations are introduced. The relevant parameters for LEM calculations are classified
and discussed in section 3. The parameter sensitivity of the RBE values for monoenergetic
beams is presented in section 4. Section 5 is dedicated to the same analysis for a clinical
situation, where a SOBP is optimized in such a way that a homogenous distribution of the
RBE-weighted dose covers the target volume. Finally, the results are discussed and conclusions
are drawn in section 6.
6 Throughout the paper with monoenergetic beams we understand that the samples are irradiated under track segment
conditions, i.e. that energy and LET do not change along an ion track through a cell nucleus.
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2. Conceptual basis of the LEM
The LEM bases on the assumptions that the nuclear DNA is the unique sensitive part of the
cell to radiation, that DSB are the most relevant lesions, and that the radiation damage on a
molecular level is predominantly mediated by secondary electrons and hence only depends on
the local distribution of these secondaries. This includes the implicit assumption that for all
radiation qualities the spectra of the slowing down secondary electrons are similar. The main
idea is then to trace back the effect of ions to the effect of photons inducing locally a similar
pattern of initial damage.
In a first step, ions are assumed to pass through the cell nucleus, in which the DNA is
assumed to be distributed homogenously. Practically, for most applications we restrict here to
one single ion passing right through the centre of the cell nucleus. This allows one to assess
the effect of exactly one ion, from which the effect of a distribution of ions can be derived as
outlined in (Scholz et al 1997). A Monte Carlo simulation of the full spatial dose distribution
of a distribution of ions has also been implemented in LEM (Friedrich et al 2012b), but is not
used for this study for the sake of computation time. We checked that this so called single
particle approximation is valid up to several Gy and hence can be used for normal fractionated
radiotherapy. Furthermore track segment conditions are required, i.e. the particles show no
significant change of kinetic energy or LET along their way through the nucleus. According
to their track structure a local dose deposition is converted into a damage pattern of DSB
distributed within the nucleus. The local rate for the induction of initial DSB is proportional to
the local dose in each location within the track. The proportionality factor is the DSB yield as
measured in experiments with low LET radiation. In addition to these DSB, further DSB arise
due to neighbouring single strand breaks (SSB) on opposite DNA strands combining to a full
break of the DNA double strand (Elsa¨sser and Scholz 2007), resulting in an overall RBE for
DSB induction greater than one. In the implementation the simulation of the damage patterns
is performed by means of a Monte Carlo routine simulating many cells, each being affected
by one spatial DSB distribution. The procedure is stopped when the number of Monte Carlo
runs is sufficient to finally determine the effect of ions within a requested accuracy.
In a second step the initial damage distribution is converted into a distribution of isolated
or clustered DSBs, where the classification is defined based on the picture of a hierarchical
compartmented organization of chromatin into DNA giant loops (Yokota et al 1995) of some
Mbp size, corresponding to the micrometer length scale. The relevance of such a length scale is
known since a long time in radiobiology (Neary et al 1959, Rossi and Zaider 1996, Goodhead
2006) and thus supportive for this conception, though its interpretation in terms of DNA
conformation is under continuous debate. It is suggestive to assume that lesions can interact
if they were induced in the same DNA loop, while lesions in different chromatin domains are
processed independently. Consequently, the model distinguishes between domains without
any DSB, with exactly one DSB (called isolated DSB), or with more than one DSB (called
clustered DSB). Note that this term is not uniquely defined and used for different constellations
of lesions by different authors. All definitions, however, have in common that the term means
an accumulation of lesions (at least one of which is a DSB) in close neighbourhood. Indeed
it is known that isolated DSB can be repaired quite efficiently by the repair mechanism of a
cell, while complex damage is believed to have a higher impact on cell killing, supporting the
assumption used in LEM, that the fraction of complex damage is a determining factor for the
RBE.
In the third step a photon dose causing the same proportion of isolated to clustered DSBs is
evaluated. The effect corresponding to that photon equivalent dose is obtained from the photon
dose response curve. As for this case the local damage pattern of ion and photon irradiation
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Table 1. Overview over the parameters of the LEM, classified in groups corresponding to different
stages of a LEM model calculation. One can distinguish specific parameters which specify the
situation to be modelled, and general parameters which have been obtained by measurements,
fitted to reference data or estimated by theoretic considerations. For general parameters, the values
used are given, and their origin is indicated.
Parameter class Parameter Type Value Origin
Track structure γ General 0.062 Measureda
δ General 1.7 Measureda
rc General 6.5 nm Fit + theoretic argumentsb
σ General 4 nm Theoretic argumentsa
E Specific
LET Specific
Initial DNA damage αDSB General 30 Gy−1 Measureda
αSSB General 1250 Gy−1 Measureda
h General 25 bp Measureda
LGen Specific
Cell nuclear geometry Vn Specific
rn Specific
lDSB General 540 nm Fitb
Photon dose response curve α Specific
β Specific
Dt Specific
a See (Elsa¨sser and Scholz 2007) and references therein.
bSee (Elsa¨sser et al 2010) and references therein.
is comparable, the effect of ions can be calculated by a proper normalization from the photon
effect, and all related quantities such as the RBE are obtained easily. For a mathematical
precise formulation of the LEM we refer to (Friedrich et al 2012b).
Note that in this general formulation up to this point no specific endpoint is considered.
The LEM is appropriate for any endpoint as long as the effect is mediated primarily by the
induction of DSB to DNA loops or correlating strongly with it. The difference in RBE between
different endpoints originates from different associated photon dose response curves. The most
prominent endpoints to which the LEM was applied up to now are cell survival for cell culture
experiments and tumour control as well as normal tissue complication in carbon ion cancer
therapy or in vivo experiments (Elsa¨sser et al 2010, Scholz and Elsa¨sser 2007, Gru¨n et al 2012).
3. Parameters of the LEM
Calculating the effect of an ion impact from a photon equivalent situation requires knowledge
or modelling of (i) physical properties of the ions, (ii) factors determining the DNA damage
induction rates, (iii) geometric properties of the cellular nucleus and the chromatin, and
(iv) the photon dose response for the endpoint under consideration. The relevant parameters
are summarized in table 1 according to this classification, and their meaning will be discussed
below.
Some of the parameters have been fixed once, because there is no evidence for any
dependence on e.g. cell type or ion species. Their values are used for all simulations and have
been either extracted from experimental results, derived by theoretic arguments, or fixed by
fitting the LEM predictions to a reference set of experimentally obtained RBE data (Furusawa
et al 2000, Suzuki et al 2000). They are marked with general in table 1 and listed along
with their attributed values. All other parameters, marked as specific parameters, specify the
experiment or clinical situation to be modelled, i.e. they characterize the cell- or tissue type
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and their radiation response, define the particle species used and the energy. The distinction
of general and specific input parameters of the LEM is used throughout this publication.
Note that both general and specific parameters are associated with uncertainties. For some
parameters these are quite large (some ten per cents), e.g. for the radical diffusion length σ
or the yield parameters αDSB and αSSB. However, as two general parameters, the giant loop
domain size for DSB interaction lDSB and the maximum inner core radius rc, have been fixed
by a fit to RBE reference data sets, the fitted parameters calibrate the model and compensate
for uncertainties in the others, and therefore the uncertainties of the general parameters do not
propagate to the uncertainty of the RBE. This compensation is not mathematically strict, and
there might be combinations of all parameters where this procedure of calibrating the LEM
model might fail, leading to systematic errors in RBEs. However, some systematic errors in
the RBE predictions are only detected at low LET values, while mostly RBE predictions are
reasonably correct. This strongly suggests that the model set-up and the chosen parameters
are sufficiently accurate, which implies that the compensation of parameter errors works good
enough to predict RBEs correctly. Moreover this is supported by the values of the two fitted
parameters which are in agreement with theoretical expectations (nm range for rc and μm
range for lDSB). As a consequence of the compensation of parameters, for an uncertainty
analysis of RBE primarily the specific parameters characterizing an experiment or a clinical
case are of relevance.
Using the set of parameters as listed in table 1 in LEM IV allows one to simulate RBE
for a wide range of LET and for all therapy relevant ion species from protons to carbon
in reasonable agreement with experimentally or clinically evaluated RBE values (Gru¨n et al
2012). The different groups of relevant parameters needed for a LEM calculation are addressed
in the following point by point.
3.1. Physical parameters of beam and track structure
The incident particle is characterized by a kinetic energy per nucleon, E, and a corresponding
LET for a given particle species. Here energy and LET are determined within the cellular
nucleus. The LEM assumes that the LET does not change considerably along a passage of an
ion through the nucleus. If track segment conditions are violated, deviations between LEM
and experimental data may occur.
Microscopically the energy is transferred from the ion to the surrounding matter in point-
like ionization events. For many purposes it is sufficient to use the average dose distribution
pattern around the central axis of a passing ion. This parametrization of the energy loss of
particles in matter is commonly referred to as amorphous track structure (Cucinotta et al 1999).
Note that the concept of dose used here is a local dose, being proportional to a probability
density function for finding an ionization. In our implementation we follow the amorphous
track structure model according to (Elsa¨sser et al 2008), where the track structure consists of
an inner core with a constant dose up to an energy dependent radius which is parameterized by
rmin = βionrc with βion = v/c, particle velocity v and velocity of light c. Its maximum value,
rc = 6.5 nm was adequately chosen in (Elsa¨sser et al 2010) to fit experimental data and matches
the order of magnitude expected from theoretic considerations perfectly (Mozumder 2007).
Beyond rmin the local dose falls off quadratically up to a maximum radius rmax = γ Eδ ,
where rmax is given in microns and E in MeV per nucleon. The parameters γ and δ have
been derived by a fit to experimental data obtained in experiments using tissue equivalent
proportional counters (Kiefer and Straaten 1986). In this work there is no analysis of involved
uncertainties given, but it is evident that the uncertainties of γ and δ are smaller than their
values, but larger than on the per cent level. Below an energy of 2 MeV u−1 this parametrization
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does not resemble the measured doses with sufficient accuracy. Here, values different from
those in table 1 are used (γ = 0.124 and δ = 0.7). As the remaining range of particles of such
small energy is very limited and track segment conditions might be violated, the accuracy of
RBE predictions might be questionable, but for the same reason their importance within a
SOBP is low.
It is known that an essential fraction of lesions is induced by an indirect effect, i.e. by free
radicals which have been produced by secondary electrons. To account for this, the initial dose
distribution according to the parametrization discussed previously is convoluted with a radial
Gaussian of width σ = 4 nm, modelling an effective diffusion of free radicals. The value of
σ was fixed in (Elsa¨sser et al 2008) and is in agreement with diffusion lengths calculated by
Monte Carlo codes (Nikjoo et al 1997, Moiseenko et al 2001). Here it is important to note that
LEM follows an effective approach: as different radical species have different mean free path
lengths, its uncertainty on the nm scale is given by the corresponding wide spread of different
radical diffusion lengths.
3.2. Parameters for damage induction to the DNA
The crucial initial lesions of interest in the LEM are DSBs. Several experiments show that for
photons the initial DSB yield is αDSB ≈ 30 Gy−1 per cell for a DNA content LGen = 5.4×109 bp
as typical for rodents (Prise et al 2001, Stenerlo¨w et al 2003). This DSB yield refers to the
initial induction of DSB and is observed experimentally with low LET radiation. Likewise,
experiments showed that the yield SSB is αSSB ≈ 1250 Gy−1.
It is well accepted that SSB can be repaired effectively. However, for high LET radiation
two SSB in close vicinity on opposite strands may combine and form an additional DSB. Hence
the number of initial DSB calculated from αDSB is enhanced. This amplification is explicitly
modelled within the LEM. A fixed threshold of h = 25 bp for the maximum interaction length
of SSB is used in our implementation, in agreement with experimental results using plasmids
(Shao et al 1999), see (Elsa¨sser and Scholz 2007) for a more detailed discussion. While it is
negligible for photon irradiation, for high LET radiation qualities this effect can enhance the
DSB yield up to one order of magnitude, depending on particle species, LET and genomic
length (Elsa¨sser and Scholz 2007). Concerning the uncertainties of the parameters for damage
induction, in the literature typically values of 20–40 DSB and 1000–1500 SSB per cell and Gy
are discussed in the literature. For the distance threshold h a huge span of 3–60 bp is reported
in the literature. This motivates a reasonable fixation to 25 bp.
3.3. Parameters of the cell nucleus geometry
We assume that the DNA content of the cell is uniformly distributed in a cylindrical cell
nucleus, specified by parameters for the volume of the nucleus, Vn and its radius, rn. The
impinging particles are assumed to hit the nucleus in direction of the symmetry axis of the
nucleus. Note that the height of the nucleus is uniquely fixed by the two geometry parameters.
Distributions of nuclear sizes are discarded up to now.
To model chromatin loop domains a three-dimensional rectangular grid is superimposed
on the cell nucleus. The boxes of the grid resemble the domains in which DSBs are counted.
They have equal side lengths of lDSB = 540 nm. This length was determined by a fit to survival
data of Furusawa and coworkers (Furusawa et al 2000), and is in agreement with the typical
interaction length scale derived from microdosimetric considerations (Goodhead 2006). The
parameter lDSB thus determines the interaction lengths of distant DSB and fixes the proportion
of isolated and clustered DSB for a given dose and radiation quality.
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3.4. Photon dose response parameters
Within the LEM usually the linear-quadratic (LQ) model is used, in which the effect is given
by αD + βD2 with photon dose D and linear and quadratic coefficient parameters α and β.
The choice of the LQ model is somewhat arbitrary but convenient, as for almost all in vitro
and in vivo data as well as for most clinical reports on radiation effects are characterized in
terms of this model (Friedrich et al 2013, Ando and Kase 2009, Steel and Peacock 1989, Fertil
and Malaise 1985).
At high doses, however, it becomes more and more evident that the LQ model loses
validity, as the dose response tends towards a pure linear component. This is suggested by
theoretic considerations of the repair dynamics of the cell (Curtis 1986, Tobias 1985) as well
as by experimental findings from both in vitro (Astrahan 2008, Garcia et al 2007, Fertil et al
1994) and in vivo experiments (Guerrero and Li 2004, Carlone et al 2005). In the LEM
we model the different properties of the dose response curves at low and high doses by a
instantaneous transition from an LQ to a linear dose response at the transition dose Dt . Then
the main principle of the LEM is the mapping of the damage pattern caused by ions to a
damage pattern as induced by photons. For regions of high local doses, photon irradiation will
induce comparable damage patterns at doses above Dt , and hence Dt is an important parameter
for RBE calculations. There are three distinct ways of asserting a numerical value to it: One
can extract it from measurements, if the photon dose response curve is available to sufficient
high doses. Alternatively an empirical linear relationship between Dt and α/β exists, which
can serve to estimate Dt (Friedrich et al 2013). If one proceeds (and only if) along these
ways, the LEM is free of any specific fit parameters. However, if both of these procedures are
not applicable or affected with unacceptable accuracy (e.g. when the photon dose response
parameters are only known within a limited low dose range), the parameter must be fitted
individually to experimental high LET data from the cells or tissues under investigation.
4. Sensitivity analysis for irradiation with monoenergetic ion beams under track
segment conditions
In this section the change of RBE-LET relationships for cells or tissues irradiated with a
monoenergetic ion beam due to parameter variation is investigated. The results can be used to
estimate the influence of parameter uncertainties on the RBE for radiobiological experiments
mimicking aspects of carbon radiotherapy in the different situations with monoenergetic beams
in track segment conditions. They might also be useful to understand differences in RBE values
if calculated for or measured with different cell lines under comparable conditions.
Both the RBE at full survival (RBEα) and at 10% survival level (RBE10) are considered
as a function of the LET. The simulations have been performed for carbon ions and two
hypothetic cell- or tissue types, characterized by α/β = 2 Gy and α/β = 10 Gy. The general
strategy of the sensitivity analysis is to calculate for each parameter listed in table 1 (except
energy and LET) three RBE-LET relationships, one for a designed value of that parameter and
the other two obtained by increasing or decreasing this parameter by 25% of its initial value7.
In particular we chose α = 0.1 Gy−1, β = 0.05 Gy−2 and Dt = 8 Gy as design parameters
for α/β = 2 Gy and α = 0.5 Gy−1, β = 0.05 Gy−2 and Dt = 14 Gy for α/β = 10 Gy.
7 We chose here the reference change of 25% for all parameters to allow for an inter-comparison of the sensitivity
on the RBE determining parameters. Moreover, 25% resemble the order of magnitude of the uncertainties of the
input parameters, as none of the parameters is known to per cent accuracy, but also the uncertainties typically do not
exceed some ten per cents. A mathematical, more rigorous treatment would require one to consider the differential
expressions dRBE/dx for any parameter x.
7.4 Article 4: Sensitivity analysis of high LET modelling 93
6834 T Friedrich et al
Figure 1. Relative change of RBEα (left) and RBE10 (right) over LET for carbon ions and cells or
tissues on the photon parameters for α/β = 2 Gy (blue) and α/β = 10 Gy (red). The horizontal
axis corresponds to the RBE at the design parameters (see text), and the dashed and dotted curve
emerge by decreasing or increasing the specific parameter about 25%, respectively. The vertical
lines indicate the LET values of 13 and 77 keV μm−1 used in table 2.
These parameter settings are typical for in vitro cell survival assays (Friedrich et al 2013).
The parameter Dt was adapted according to an empirical relation between α/β and Dt . This
linear relation was found when using the LEM over a huge set of experimental cell survival
data (Friedrich et al 2013), and is in agreement with experimental findings (Astrahan 2008).
The geometric specific parameters for both cases were chosen Vn = 500 μm3 and rn = 5 μm.
Again, these parameters approach typical values for mammalian cell lines.
For all combinations of effect levels for which the RBE is evaluated (RBEα or RBE10)
and for both α/β ratios (2 Gy or 10 Gy), we obtained for each parameter a band in the RBE-
LET characteristics which describes the variability of RBE under variation of ±25 % of this
parameter8. In all cases but one, sensitivity was investigated by varying one single parameter.
As an exception, for a change of the parameter Vn we also changed lDSB as a second parameter
in order to keep the number of chromatin loops within the cell nuclei constant. Figure 1 shows
the dependence of the RBE variation on the photon LQ parameters α, β and Dt . In figure 2 the
influence of the nuclear volume Vn, nuclear radius rn, the DNA loop domain size lDSB and the
DSB yield αDSB on RBE is presented.
8 Note that a change of one of the LQ parameters α or β immediately implies a modification of their ratio α/β. Here
the assumed α/β ratios of 2 and 10 Gy refer to the designed (unchanged) parameter values.
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Figure 2. Relative change of RBE as presented in figure 1 for the nuclear volume, the nuclear
radius, the DNA loop domain size and the DSB yield.
Generally from the figures it can be seen that in most cases there is less or at most equal
sensitivity on parameter variations for α/β = 10 Gy compared to α/β = 2 Gy. Similarly, the
RBE at 10% survival is typically less sensitive to parameter variations compared to RBEα .
Moreover it becomes evident that the increase of some parameters leads to either a decrease or
an increase of RBE. Based on some simple mechanistic interpretations within the framework
of the LEM the different sensitivity patterns can be interpreted, as shall be demonstrated at
some examples in the following.
To β, Dt , and αDSB the RBE is primarily sensitive for intermediate LET values. These
parameters show a bulb-like pattern in the plots. For very low LET they are of minor importance
(as all parameters), as the nature of the radiation field converges to that of photons, and hence
RBE will get close to one. At high LET the overkill effect will take place, i.e. in the limit of high
LET a cell will only survive if it is not hit, and will be inactivated as consequence of any hit. Due
to this simplistic picture these biologic parameters lack of importance in the high LET regime.
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The parameters α and rn in contrast show pronounced importance for high LET, which
can be explained by the same argument: The probability for a cell to be hit and with that the
effect increases with the nuclear radius and thus with the geometrical cross section rn. The
photon parameter α has, in contrast to β and Dt , for high LET almost no influence on the ion
dose response curve within LEM. Nevertheless there is a prominent dependence of RBE on α
because it directly affects the dose at which the reference effect level is reached on the photon
dose response curve.
The parameter lDSB shows two pronounced sensitivity regions, while there is almost no
sensitivity between 100 and 200 keV μm−1. The reason is an interference of the length scales
involved: Generally an increase of lDSB allows for more DSB clustering within the photon
radiation field, while this effect is not so prominent for ions, which results in a decrease of
RBE. But in the intermediate LET regime the track diameter is of the order of the loop domain
size. In this case an increase of the domain size will lead to an effective increase of clustering
almost as much as for photons, because for increased loop domains all DSB caused in the
whole track structure may contribute to DSB clusters. As there is not much differential effect
between photons and ions in this case, the RBE sensitivity to changes of lDSB is low. For very
high LET finally a further increase of lDSB will not lead to more clustered lesions caused by
the ion track, hence the sensitivity recovers.
In a similar way the direction of RBE change with respect to the direction of change of
the input parameter can be interpreted: An increase of the photon parameter α, e.g. implies a
steeper photon dose response curve and consequently a lower dose needed to reach a desired
effect level. A higher α will also correlate to a steeper ion dose response curve. But as the
enhanced effect of the ion dose response is primarily caused by the inhomogeneity of the local
dose deposition pattern in combination with the nonlinear response to local doses, which is
parameterized by β and Dt , the steepening due to an increase in α is less pronounced than for
photons. As a result the RBE will decrease, if α is increased. All parameters show a unique
directional RBE change except Vn for which at low LET a parameter decrease and at high LET
a parameter increase leads to RBE increase.
The analysis presented here has also been performed for other particle species (protons,
helium and neon). However, the results generally follow a similar systematics, and thus
no detailed discussion is presented here. The most relevant difference is that as the whole
RBE-LET characteristics is shifted towards higher LET for heavier ions, they provide a
lower sensitivity on the parameters for low LET, while lighter particles are more sensitive
there.
To project out the findings of this sensitivity analysis with monoenergetic beams for
particle therapy, the most important results of the sensitivity analysis for carbon ions are
summarized for therapy relevant LET values in tables 2 and 3 for α/β = 2 Gy and 10 Gy,
respectively. In a treatment like situation a good conformity to a tumour in the target region is
desirable and the therapy benefits from the high RBE of carbon ions just before stopping as it
allows one to keep the doses applied to normal tissue low. Hence in the target region typically a
high average LET and a high dose are expected, leading to low survival of tumour cells, while
in the entrance channel doses should remain low, and the LET of the high energetic carbon
ions is small. In the tables these situations are represented by results for RBE10 at a high LET
and for RBEα at a rather small LET, respectively. But also the complementary cases occur:
At the margins of the spread out Bragg peak (SOBP), depending on the field geometry and
the irradiation angles, some parts of the tissues might be covered by radiation with rather high
doses of rather low LET radiation or vice versa. These interfaces between peak and plateau
regions are of particular interest in therapy as all tumour cells must be inactivated, while in
the same way normal tissue shall be spared as much as possible. As tumour and healthy tissue
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Table 2. Parameter dependence of RBE for monoenergetic carbon ions in therapy comparable
situations for α/β = 2 Gy. The header part of the table contains the RBEα and RBE10 for LET
values typically found in the entrance channel and the Bragg peak region in carbon ion therapy,
respectively. Here the design parameter settings were used. Below the header part the relative
changes in RBE in per cent after change of one parameter about −25% or +25% (bottom or top
numbers) are given. The second column contains the correlation direction, labelled as 0, + or − if
RBE does not change, goes typically up or down with increasing parameter, respectively. Note that
this information is valid below the overkill regime—for high LET the correlation might change
(see text).
Entrance Bragg peak
(13 keV μm−1) (77 keV μm−1)
RBEα RBE10 RBEα RBE10
1.44 1.04 9.08 2.31
corr. RBEαRBEα (%)
RBE10
RBE10
(%) RBEαRBEα (%)
RBE10
RBE10
(%)
Vn −/+ −4.977.66 −0.771.06 −1.981.98 −2.161.73
rn +
+0.46
+0.64
+0.12
−0.04
+2.23
−5.44
+2.24
−5.44
lDSB − −9.44+19.41 −1.29+2.76 −9.13+7.27 −8.84+7.27
α − −6.19+10.30 +0.04−0.05 −17.56+29.25 −0.63+0.55
β + +7.68−7.68
+0.74
−0.83
+19.74
−20.41
+8.77
−10.15
Dt 0/+ ±0 +0.48−0.80 +14.47−17.05 +14.47−17.05
γ − −2.39+2.92 −0.33+0.40 −1.78+2.42 −1.78+2.43
δ − −8.79+13.79 −1.20+1.95 −10.42+12.46 −9.90+12.46
rc − −0.51+3.26 −0.07+0.45 −4.78+6.14 −4.77+6.14
σ − +1.96+0.46 +0.27+0.06 −6.16+8.39 −6.15+8.39
αDSB − −0.74+1.71 −0.10+0.23 −6.44+10.01 −6.44+10.01
αSSB +
+2.27
−0.77
+0.31
−0.11
+14.86
−12.62
+14.86
−11.69
h + +0.03−0.22
+0.00
−0.03
+6.46
−6.85
+6.46
−6.86
LGen − +0.43+1.31 +0.06+0.18 −5.59+8.53 −5.59+8.53
show often different radiosensitivities, beneath dose and LET also the α/β ratio plays a role
here, which reflects the complexity of RBE.
In the tables the design RBE values as well as the RBE values after parameter change
are given for typical situations in the entrance channel (LET = 13 keV μm−1) as well as in
the SOBP (LET = 77 keV μm−1). The representative values for the LETs have been adopted
from (Suzuki et al 2000). In the tables, also the direction of change of the RBE is given: when
a parameter is increased, the RBE may either typically go up as well (as marked with a ‘+’
sign to indicate that positive correlation) or down (as marked with a ‘−’ sign). In the case of
Dt there is for small LET no dependence for RBEα , which is labelled by ‘0’. Exceptions of
a unique correlation occur only for the parameter Vn where the direction of RBE change gets
reverted at an LET of 150 keV μm−1 (thus labelled with ‘+/−’ and for very small parameter
sensitivities where an increase and a decrease may hardly change RBE, while nevertheless
small changes are seen in the simulations in the same direction due to fluctuations in the Monte
Carlo calculation. The dependence on energy or LET is not listed in the tables, as LET is the
dependent variable in the figures presented, and for a given particle species energy is uniquely
defined for a given LET in the Bethe–Bloch regime.
Note that the RBE depends on each of the quantities typically less than proportional, i.e.
when a parameter is changed about 25% the RBE usually changes less than 25%. Up to few
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Table 3. As table 2, for α/β = 10 Gy.
Entrance Bragg peak
(13 keV μm−1) (77 keV μm−1)
RBEα RBE10 RBEα RBE10
1.09 1.04 3.27 2.44
corr. RBEαRBEα (%)
RBE10
RBE10
(%) RBEαRBEα (%)
RBE10
RBE10
(%)
Vn +/− −0.741.10 −0.480.58 −3.063.36 −3.283.28
rn +
+0.42
−0.54
+0.34
−0.55
+4.58
−9.94
+4.61
−9.96
lDSB − −2.49+5.12 −1.39+2.89 −13.52+10.49 −12.71+10.46
α − −1.80+2.90 −0.42+0.37 −14.21+23.44 −6.96+8.18
β + +2.03−2.02
+0.73
−0.81
+13.80
−14.49
+8.55
−9.71
Dt 0/+ ±0 +0.13−0.22 +6.08−9.50 +6.44−9.52
γ − −0.96+0.37 −0.53+0.21 −2.12+2.87 −2.01+2.85
δ − −2.76+3.77 −1.54+2.12 −12.96+14.30 −12.19+14.28
rc − −0.21+0.77 −0.12+0.43 −5.33+6.73 −5.04+6.70
σ − +0.27+0.33 +0.15+0.18 −6.66+8.89 −6.30+8.87
αDSB − −0.75+0.47 −0.42+0.27 −7.09+10.78 −6.70+10.75
αSSB +
+0.74
−0.61
+0.42
−0.34
+15.60
−13.85
+15.57
−13.02
h + +0.38−0.06
+0.21
−0.03
+6.92
−7.40
+6.90
−6.99
LGen − +0.10+0.64 +0.06+0.36 −6.06+9.06 −5.73+9.04
exceptions RBE does not change by more than 25%. From figures 1 and 2 it is evident that
for a 10% survival level only the nuclear radii rn exceed the 25% level for RBE changes. At
77 keV μm−1 as representative for the target region the RBE is very sensitive on the photon
dose response parameters, the track structure parameter δ and the yield of SSB.
5. Sensitivity analysis for a clinical situation
The application of carbon ions for cancer treatment in the clinics requires treatment planning
which accounts for the RBE in such a way, that the target volume is covered uniformly by
a described RBE-weighted dose, while the doses in the normal tissues and in particular in
organs at risk remain low. This strategy is followed in the particle treatment facilities in Japan
(Tsujii and Kamada 2012) as well as in Europe (Combs et al 2010, Schulz-Ertner et al 2007),
although their beam characteristics and the methods in accounting for RBE differ.
The RBE in a voxel based treatment plan corresponds to a mixed radiation field, because
several particle species, each having an individual energy distribution, may contribute to the
overall dose deposited due to fragmentation, straggling and scattering. Because of this mixing
the large sensitivities detected in the last section are balanced out, and hence the irradiation of
extended targets will show a damped sensitivity of RBE to its input parameters.
In this section the same sensitivity analysis is presented for SOBPs, as before for
monoenergetic beams and cells or tissues under track segment conditions. Thus, each of
the specific parameters of the LEM listed in table 1 was again modified by ±25% and the
induced change in RBE was monitored. To facilitate the analysis a sphere as idealized target
geometry with 60 mm depth extension placed in a depth of 150 mm (isocentre) was regarded9.
9 Note that this choice corresponds to rather large, deep seated tumours.
98 7 Reprints of selected publications
Sensitivity analysis of RBE 6839
Figure 3. Dependence of RBE over water equivalent depth for carbon ions and cells or tissues
with α/β = 2 Gy and α/β = 10 Gy on the LQ parameters. The corresponding RBE-weighted
dose distributions were all optimized to 3 Gy in the target region. The solid curve corresponds to
design parameters (see text), and the dashed and dotted curves emerge by decreasing or increasing
the specific parameters about 25%, respectively.
The treatment planning software TRiP98 (Kra¨mer et al 2000, Kra¨mer and Scholz 2000) was
used to optimize a physical dose leading to a homogeneous RBE-weighted dose throughout
the SOBP. In general the RBE varies with the depth in tissue because the LET distribution
changes. For this reason we here discuss depth distributions of the RBE, instead of its LET
dependencies.
The strategy closest to the clinical routine is an optimization of two directly opposing
fields to give a flat RBE-weighted dose of 3 Gy within the target, in line with the fraction
dose used in the GSI clinical trial (Schulz-Ertner et al 2007). Note that for each parameter
setting of the sensitivity analysis an individual optimization must be performed. As before, all
calculations were performed for tissues with α/β = 2 Gy and α/β = 10 Gy with the same
absolute values as in the previous section. The results are visualized in figures 3 and 4 where
the depth distributions of the RBE values along an axis right through the isocentre (beam’s eye
view) are presented. We chose here to present the absolute RBEs instead of relative changes
after parameter variation as in the previous figures, because for a SOBP the RBE profile is
very instructive. Note that the mixed radiation field provides a variation of the average LET
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Figure 4. As figure 3, for the nuclear radius and the size of the chromatin loops.
with depth. Hence here the depth is the appropriate quantity to replace the dependence on
LET, which was discussed in the last section.
At this point it is important to note that often for in vivo systems and clinical endpoints the
LQ parameters happen to be much smaller (Brenner 1993). In order to establish comparability
to the results in the previous section, here the absolute values were kept the same. However,
it is known that RBE values for small and large absolute values are comparable for the same
α/β ratios, with the only difference that overkill effects appear more pronounced for higher
absolute values. Hence for small absolute values less sensitivity on parameters which affect
overkill is expected, and we checked that conjecture at some examples (data not shown).
Generally, the curves in figures 3 and 4 show a low RBE in the entrance channels and
a considerably higher RBE in the target, where particles are stopping and have a higher
LET consequently. This is one of the superiorities of carbon ions compared to protons in
radiotherapy. For a single field treatment plan the RBE distribution across the SOBP shows
pronounced maxima towards the distal boundary of the target volume. There exclusively
stopping particles (except some fragments) are present, causing a high LET, while at the
proximal regions and within the SOBP broader mixtures of LETs exists. In a treatment plan
consisting of two or more fields the statement holds in general, i.e. at the whole boundary
of the target region. There the fraction of stopping particles is higher compared to within the
target. Consequently the high LET components, causing a high RBE, are most prominent at
the boundary. A relative uncertainty will therefore translate into a higher uncertainty of RBE-
weighted dose at the margins of a SOBP. In contrast, in the figures the RBE distributions appear
to be almost parallel for different parameter adjustments, leading to a reduced sensitivity at
the margins of the target volume. This is due to the usage of two opposing fields, where at the
margins high LET and comparably low LET components are mixed. Strategies for optimizing
treatment plans such that the high LET components in the radiation field are more uniform
distributed across the SOBP are currently discussed (Bassler et al 2010) and might help to
diminish uncertainties of RBE (Bo¨hlen et al 2012).
When varying one of the input parameters, the RBE values are shifted into the same
direction as was detected in the previous section. That means that the direction of the correlation
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between RBE and any specific parameter remains the same for both monoenergetic beams and
SOBPs.
Regarding the quantity of the deviations a damping is observed compared to the maximum
variations detected in the previous section. This is due to the mixture of LETs which is caused
by the spread of pristine Bragg peaks forming the SOBP and due to fragments, which have to
be taken into account properly (Lu¨hr et al 2012, Gunzert-Marx et al 2008). The mixed radiation
quality also implies a smaller overall RBE, also giving rise to smaller sensitivities. The feature
of damping is of interest for the robustness of treatment plans. Furthermore, as before, the
deviations typically do not exceed 25% and are therefore less than direct proportional to the
change of the specific parameters.
A RBE-weighted dose of 3 Gy approximately corresponds to about 50% and 15% cell
survival for the original set of specific parameters for α/β = 2 Gy and 10 Gy, respectively. But
in contrast to the last section, where the survival levels were fixed in advance by considering
RBEα or RBE10, here the dose remains fixed at 3 Gy, when parameters are varied. Thus an
optimization to 3 Gy when one of the LQ parameters is changed leads to slightly different
survival levels for each parameter adjustment.
Figure 4 presents the results of the sensitivity analysis of the geometric parameters rn and
lDSB. When changing the nuclear radius a variation in RBE is primarily visible in the target
region and suppressed in the entrance channel. This behaviour can be again understood by
looking at the case of monoenergetic ions, where there is only a marginal dependence on rn
in the low LET region. The difference in RBE after a change of the chromatin loop size lDSB
is, in particular for α/β = 2 Gy, comparably large and in contrast to all other parameters
also very prominent in the entrance channels. Again, the reason can be understood by looking
at figure 2 and tables 2 and 3: while the Bragg peak typically covers LETs between 50 and
100 keV μm−1, in the entrance channels lower LET values occur. For RBEα a quite high
sensitivity to lDSB has been found with monoenergetic beams at low LET values. Remnants of
this finding cause the sensitivity in an extended treatment plan.
6. Discussion
6.1. Justification of the approach
The sensitivity analysis presented in this work is based on an approach using single parameter
variations. The question arises if such a ‘factorized’ approach is appropriate and overall
RBE changes could be calculated by a linear superposition of the RBE changes of each
individual parameter. Instead, one also could expect that shifts in any two parameters act on
RBE dependent on each other in a correlated way. We will argue in the following that these
correlations between parameters with respect to RBE change play only a second order role.
Formally, the RBE can be regarded as a mathematical function dependent on a set of
parameters {pi}, i.e. RBE = RBE({pi}). If parameters are changed from {pi} to {pi + δpi}, the
RBE can be expanded in a Taylor series, where the first order term contains a sum of terms
dRBE
dpi δpi, and the second order term of type
d2RBE
dpidp j δpiδp j. Hence the ‘factorization’ approach is
resembled by first order terms, and correlated RBE change by second and higher order terms.
So, if the values of changes are not too large, the second order contributions will be smaller than
the first order contributions and thus can be neglected. For a proper uncertainty analysis this has
to be fulfilled anyway: only if the uncertainties associated with the parameters are smaller than
the parameter values (which is typically the case), the principles of error calculus will apply,
and under this conditions the argument given is valid. We also checked that numerically for
7.4 Article 4: Sensitivity analysis of high LET modelling 101
6842 T Friedrich et al
some examples by calculating the RBE after a coexisting parameter detuning and comparing
it with the RBE calculated with a linear superposition of RBE changes.
6.2. Importance of parameters for RBE uncertainty
The sensitivity analysis presented in the two previous sections reflects how RBE changes, when
one of the input parameters is varied. This allows one to assess the variability of RBE based
on the variability of one of the input parameters. While some of the general parameters such
as δ are obtained with a quite good accuracy from experimental results, others have relatively
large error bars. In this case we followed the strategy to use average values from the literature.
For instance, values in the typical range between 20 and 40 DSB per Gy are reported for αDSB.
Recent works also indicate that the yield could be much higher, but is underestimated due to
systematic experimental errors (Neumaier et al 2012). So, according to the state of research
these parameters may be subject to change in future. However, it is important to note that the
sensitivity on input parameters does not directly provide information about RBE uncertainty,
as shall be explained in the following.
Despite remarkable uncertainties in the input parameters, in combination all general
parameters form a consistent input parameter set, as two of them, lDSB and rc (cf table 1),
were fitted once to experimental data (Furusawa et al 2000, Suzuki et al 2000) to calibrate
the model. By this procedure they compensate for possible misadjustments of the measured
general parameters and minimize the model inherent systematic uncertainties of RBE. Indeed,
a large contribution of the general parameters to the overall uncertainty of RBE values has not
been observed, which indicates that the systematic errors of the LEM are small. For in vitro
cell survival experiments (Elsa¨sser et al 2010) and clinical cases (Gru¨n et al 2012) we showed
in several publications that the LEM predicts RBEs with reasonable accuracy for different
LET values or depths, dose levels and cell types.
The specific parameters characterize the experiment or clinical situation and have to be
evaluated in order to use the LEM. Among them, the genomic length and the geometric
parameters are usually known or can be obtained without too much effort. Thus the interesting
consequence is that the predominant source of uncertainty of RBE, which is a quantity for high
LET radiation is due to the uncertainty of the photon parameters α, β, and Dt , i.e. the response
parameters of the low LET radiation. Thus in the following we focus on these parameters only.
Moreover for RBE simulations it is usually sufficient to fix the ratio α/β, because the RBE
does only marginally depend on a common scaling factor of the absolute values of α and β, for
small and intermediate LET. A plausible reasoning for this is, that the nonlinear dose response
curve leads to a high RBE foremost by means of high local doses. A measure for the excess
effect due to the nonlinearity, normalized to the linear component is just the inverse of the α/β
ratio. Indeed, RBE seems to scale linearly with (α/β)−1 (Friedrich et al 2013). The α/β ratio
can also be used to find an estimate for Dt by means of an empirical relationship. Another
strategy could be to replace the linear quadratic linear model used within the current LEM
implementation by a different photon dose response model which provides the saturation of
effect increments without an explicit threshold parameter. Investigations towards this direction
are on the way, and one possible option is to use the GLOBLE model (Friedrich et al 2012a)
which fulfills these requirements.
6.3. RBE uncertainty for monoenergetic beams and SOBPs
In this section we want to make use of the presented sensitivity analysis and provide examples
for an uncertainty analysis. To understand the influence of the composition of a radiation field
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Table 4. Parameter dependence of RBE for monoenergetic carbon ions in therapy comparable
situations at 3 Gy and for a SOBP composed of two opposing fields and optimized to 3 Gy (RBE)
formed by carbon ions for α/β = 2 and 10 Gy. The upper part contains the LET or dose averaged
LET and the reference RBE values. In the middle section of the table the relative changes in RBE
after change of one parameter about −25% or +25% (bottom or top numbers) are given in per cent.
In the bottom line the overall uncertainty of the RBE value is given, provided the uncertainties of
α, β and Dt are 10%, 20% and 30%, respectively.
α/β = 2 Gy α/β = 10 Gy
Monoenergetic SOBP Monoenergetic SOBP
LET or LETD 77 keV μm−1 54 keV μm−1 77 keV μm−1 52 keV μm−1
RBE 3.63 1.98 2.52 1.48
RBE
RBE (%) RBERBE (%) RBERBE (%) RBERBE (%)
α −6.3+7.7
−4.5
+5.7
−10.1
+32.8
−5.9
+8.5
β +4.1−6.4
+1.9
−3.0
+7.7
−9.3
+3.4
−4.3
Dt +14.5−17.1
+7.6
−9.0
+6.4
−9.5
+2.5
−3.7
(%) 20.2 10.7 18.1 7.0
on the parameter sensitivity of RBE in more detail, the centre of a carbon SOBP composed
from two opposing beams and representing a mixed radiation field, was compared with a
monoenergetic beam of high LET, mimicking the distal end of a one-sided SOBP. While in the
former case the radiation field is composed of an overlay of low and high LET components, in
the latter only one high LET component is contributing. Table 4 contains the relative change of
the RBE after an initial change of one of the specific parameters α, β and Dt of ±25% for both
cases, where the restriction to the photon parameters is justified by arguments given in the last
subsection. The SOBP has been chosen as in section 5 with two opposing fields optimized to
a RBE-weighted dose of 3 Gy and extended to 60 mm in a depth of 150 mm in the isocentre.
There, the dose averaged LET is 54 keV μm−1 and 52 keV μm−1 for α/β = 2 Gy and α/β =
10 Gy, respectively, where there is a small difference as the dose optimization respects the
α/β ratio and hence results in different LET compositions of the fields. For the monoenergetic
beam an LET of 77 keV μm−1 was chosen as in section 4, but to allow comparison on the same
dose level the RBE was here evaluated at 3 Gy RBE-weighted dose instead of considering
RBEα or RBE10 as before.
For any varied parameter, the relative change of the RBE in the SOBP is damped compared
to the change detected for the monoenergetic beam. The damping can still be observed for a
comparison of the SOBP with a monoenergetic beam of comparable LET (about 50 keV μm−1,
data not shown). Thus it is obviously a consequence of the broader LET distribution within a
SOBP. But the damping of RBE sensitivity goes along with a smaller RBE. Hence for clinical
applications a compromise between the RBE and its uncertainties has to be found. If the RBE
is large, so will be its relative uncertainty, and vice versa.
When a photon dose response curve is known, often one of the parameters α and β can be
determined quite well, while the other has a higher uncertainty. The most crucial part, however,
is to determine an appropriate value for Dt , which is hardly accessible in experiments or clinical
data. As a good estimate one can apply an empirical relationship between Dt and the α/β
ratio, or determine Dt by a fit to high LET data, if available. Exemplarily we here assume that
α, β and Dt are known with uncertainties of 10%, 20% and 30%, respectively, which seem to
be typical estimates. We calculated the corresponding partial uncertainties of RBE by scaling
the numbers given in table 4 from a 25% variation to these uncertainty levels. By calculating
the propagation of the errors one can now evaluate an overall uncertainty in the following way:
7.4 Article 4: Sensitivity analysis of high LET modelling 103
6844 T Friedrich et al
bearing in mind that there is an anti-correlation between α and β induced by the common
LQ fit procedures we simply added their relative errors, which is a rather pessimistic way of
propagating errors, as it does not allow for mutual uncertainty compensation. From this sum
and the uncertainty of Dt then a total uncertainty was calculated by means of Gaussian error
propagation, allowing for such partial compensation of uncertainties. As a result, the overall
relative uncertainties  given in the bottom line of table 4 are obtained.
These numbers are on the one hand typical and indicate the order of magnitude of
uncertainty which is usually expected for RBE simulations with the LEM. They clearly
demonstrate the damping of RBE uncertainties within a SOBP compared to monoenergetic
irradiations. In particular the detected deviations for the irradiation within a SOBP is about
10%, which is in the order of magnitude acceptable for clinical applications. But this calculation
is an example and specific for the choice of the parameters and uncertainty levels of the specific
parameters as well as on the irradiation geometry. The numbers given should hence not be
understood as a general uncertainty analysis. They rather indicate the order of magnitude of
RBE uncertainty to be expected, while for any particular case such an analysis should be
considered individually.
6.4. Sensitivity on photon and ion dose response
As RBE is a relative quantity comparing the doses needed with photons and ions for the
same effect, the question arises if the RBE sensitivity on an input parameter is caused by
the sensitivity of either the ion or the photon dose response curve. This was approached by
monitoring the relative change of doses for ion and photon radiation at the same effect under
parameter variation.
Generally, a change of α will result in larger dose changes for photons as compared to
ions. Hence the RBE sensitivity on α is not due to the high LET dose response, but rather
reflects the uncertainty of the photon dose response itself. In contrast, a change of β term will,
for moderate effects, change the ion dose response curve more severely than the photon dose
response curve. This is because the initial slope of ion survival curves strongly depends on
the photon β parameter which quantifies the nonlinear dose response and hence scales the
enhanced effects of high local doses as delivered to the tissues by individual charged particles
along their tracks.
Thus, concerning α, there is a smaller level of uncertainty in ion therapy as compared to
conventional photon therapies, while for β it is just the opposite. Hence a good fraction (cf
table 4) of the overall uncertainty calculated in the last subsection, corresponding to α will
also be present in a treatment with photon radiation.
6.5. Sensitivity for fixed α/β ratio
From clinical studies there are several ways of obtaining information of the photon dose
response parameters. Quite often the α/β ratio can be fixed quite well (e.g. when found from
fractionation studies) while the derived absolute parameter values α and β can be challenged.
Hence it is also of interest to investigate the RBE dependence on photon parameter change
when the α/β ratio stays fixed, i.e. when α and β are changed jointly by the same factor
of 25%. This was checked, and we found for the therapeutic relevant LET range that there
is almost no dependence of RBEα on parameter change, and that there is about 10% or 5%
maximum change of RBE10 for α/β = 2 and 10 Gy, respectively. This can be interpreted by
the principles of LEM: The action of individual ions is expressed by the linear coefficient αI
of ion dose response curves, which directly determines RBEα . In LEM, it is obtained as an
104 7 Reprints of selected publications
Sensitivity analysis of RBE 6845
extrapolation from photon effects, which are linear in both α and β. If they both are scaled by a
common factor, so will αI , and hence RBEα remains constant. As for the quadratic component
βI nonlinear terms arise, describing the interaction of lesions from different ions, this argument
does not hold and thus a sensitivity of RBE10 on parameter change is detected.
In clinical practice, however, as both α and β are affected by uncertainties (e.g. due to a
limited patient number but also due to inter-individual differences), the α/β will also show an
uncertainty. Thus always a sensitivity analysis for different α/β ratios should be carried out
in prospective treatment planning.
6.6. Sensitivity on distributions of input parameters
In a population of cells the input parameters for estimating the RBE might not assume a single
value but rather be subject to a distribution. For instance the geometrical cross section of cell
nuclei shows a broad distribution for most cell lines. Then in a first approach the strategy is
to rely on the mean of the parameter values, resulting in a RBE which approximates the mean
RBE to first order. Associated uncertainties can be estimated using the sensitivity analysis
presented here.
A full consideration of distribution effects would require to determine the contribution of
each subpopulation of the distribution to the corresponding RBE distribution. However, for
a more pragmatic handling the parameter distribution is replaced by an effective parameter,
reproducing the mean RBE. For the nuclear geometrical cross sections at high LET where the
RBE is sensitive on the nuclear cross section due to overkill, for a given distribution of cross
sections an effective cross section of typically less than the mean (about 80%) will reproduce
the mean RBE (Elsa¨sser et al 2008).
Another example where uncertainties due to parameter distributions play a role is the
variability in dose response within a patient population in therapy. It is common procedure to
apply non-individualized regimens, where recommended doses are found by dose escalation
studies over sufficient large patient numbers. The distribution of radiosensitivity parameters
leads to a flattening of the dose response curve of tumour control (Dasu et al 2003). This
phenomenon can be quite crucial and eventually has to be taken into account for analysis
of clinical outcomes (Kanai et al 2006). However, as seen for the α term in this study the
population heterogeneity has higher impact on dose response to photon than to ion radiation
(Scholz et al 2006). A more personalized determination of input parameters, e.g. by means of
biomarkers, could help to further reduce uncertainties.
6.7. Strategies for sensitivity minimization
The general goal of any kind of radiation therapy modality is to deliver dose in the target region
and to avoid dose delivery as good as possible within the surrounding healthy tissue. Further
constraints as sparing out organs at risk may apply. But regarding charged particle therapy
recent work (Bassler et al 2010, Grassberger et al 2011) questions if a homogeneous dose
distribution across the target should be the only objective in treatment planning. Additionally,
LET homogeneity could be another promising objective. In addition to dose homogeneity,
LET homogeneity promises to reduce RBE uncertainties. Other studies investigated practical
applicability, e.g. by ramp fields (Kra¨mer and Ja¨kel 2005) or by modifying the LET distribution
by active scanning (Grassberger et al 2011) and quantified implications for the RBE uncertainty
(Bo¨hlen et al 2012). In a previous work (Gru¨n et al 2012) we demonstrated that the delivery
of dose in two opposing fields, both contributing equally to the overall dose, reduces the
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uncertainties very effectively. Table 4 gives evidence for the reduced RBE uncertainty
(damping), but also demonstrates the reduction of RBE going along.
Unavoidably, an uncertainty-free RBE model cannot exist, as the biological determinants
of RBE, i.e. the radiosensitivity parameters, are subject to variability. Hence a reduction of RBE
uncertainty as much as possible as a consequence of a more homogeneous LET distribution
might be desirable, and could be realized by combining different fields irradiated in different
angles in the target volume, or even inhomogeneous dose fields adding up to a homogeneous
dose across the target volume. Finally, depending on particular aspects of the treatment plans,
a compromise between a high RBE in the target (without caring about LET distribution) and
a lower, but less uncertain RBE (applying a rather homogeneous LET distribution) has to
be found.
6.8. Relation to other RBE models and to experimental RBE data
Throughout this paper, many aspects of RBE uncertainty have been discussed at hand of the
LEM. But most of the implications of this study are also revealed by other high LET models. In
the MKM, which is the only model apart from LEM used in clinical practice in recent versions
(Inaniwa et al 2010, Sato and Furusawa 2012), the prediction of the RBE is based on the dose
response to photon radiation, too, and hence their uncertainties are propagated to RBE in a
similar way. The model of Carabe and Jones (Carabe-Fernandez et al 2007, Jones et al 2012)
is a reformulation of the LQ model and thus input data of both radiation qualities are needed
for which the RBE is to be predicted. It uses only few assumptions and also demonstrates the
direct dependence of RBE on photon dose response parameters.
Finally, by investigating experimental RBE data (Friedrich et al 2013, Paganetti et al
2002), a scatter of measured RBE values of in vitro cell survival experiments reflects the
order of magnitude of RBE uncertainty corresponding to the model predictions (calculated
from typical uncertainties of the photon parameters as in table 4), except for low LET where
some remaining systematic deviations of LEM predictions in comparison to experimental
RBE values are present. To give an order of magnitude, for monoenergetic carbon ions with
an LET of 77 keV μm−1 at 3 Gy the typical RBE uncertainty is 20% and almost independent
on the α/β ratio. As outlined before, this number will be damped within an SOBP.
This agreement between RBE uncertainties observed in experiments and the uncertainties
predicted by RBE modelling is a further strong support that LEM is able to predict essential
characteristics of RBE. This also implies that the results presented in this study are not model
specific, but are rather general properties of RBE.
7. Conclusions
This work provides a detailed and systematic discussion of the sensitivity of RBE to its
determining parameters. It demonstrates that radiobiologic models such as LEM are suitable
to predict RBE along with the RBE uncertainty for applications in radiobiologic experiments
and particle therapy. In particular two findings which have been presented in the previous
sections are important for the discussion of simulated RBE values. First, the RBE values
depend typically less than proportional on the determining parameters, with few exceptions
only. Second, going over from cells or tissues irradiated with monoenergetic beams to extended
volumes irradiated with a SOBP, the influence of uncertainties on RBE values are damped
due to the mix of radiation qualities at each position in the SOBP. The results and methods
presented may thus be helpful for optimizing the precision of RBE predictions.
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Abstract The concept of the relative biological effec-
tiveness (RBE) is essential for treatment planning in carbon
ion therapy and for understanding the biological effects of
high-LET radiation. As this quantity depends on many
factors, both its experimental determination and the
assessment of its uncertainty are not trivial. For the limiting
case of zero dose, where the RBE takes its maximum value
RBEa, we present in this article a simple empirical-based
approach to estimate its uncertainty. A Gaussian error
calculus is applied to equally take into account both
uncertainties from experiments with high- and low-LET
radiation. From a theoretical point of view, we then infer,
using a simple Monte Carlo model, the distribution of
RBEa values. This illustrates why the conventional error
propagation approach is inappropriate in some cases. In
these cases, likewise also the error estimates have to be
obtained with a more sophisticated approach. Uncertainties
of RBE, visualized by error bars, are of importance for
treatment planning and also for setting up a precision goal
for predicting biophysical models such as the local effect
model.
Introduction
Cancer therapy with carbon ions benefits, apart from an
inverted depth-dose profile, from an enhanced RBE com-
pared to conventional photon radiation (Hall and Giaccia
2006). Thus, knowing the RBE is essential for successful
treatment planning (Kraft 1999). An analysis of its uncer-
tainties is hence relevant for establishing precision goals
for predictive models such as the local effect model, LEM
(Scholz et al. 1997; Elsa¨sser et al. 2008a, b) or the mi-
crodosimetric kinetic model (Hawkins 1994; Hawkins
2003).
The RBE is defined as the ratio of a photon dose Dc and
a corresponding ion dose DI yielding the same effect:
RBE ¼ Dc
DI




Isoeffect
ð1Þ
Henceforth, the experimental determination of RBE
involves both experiments with photon and ion radiation.
The RBE for a particular experimental or therapeutic set-up
depends on many parameters, such as tissue- or cell-type,
the LET spectrum of the radiation, on dose and several
more. It usually decreases with increasing dose and thus
reaches its maximum for the zero-dose limit,
RBEa ¼ aIac ð2Þ
where the a parameters are the linear coefficients of the
linear quadratic (LQ) model (Douglas and Fowler 1976),
which establishes a relationship between dose and effect
level.
The biological reason for an enhanced effectiveness are
high local doses restricted to small parts of the cell nuclei
as deposited by ions, compared to rather moderate doses as
deposited by photons over the whole cell nucleus (Kraft
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1999). Due to the emergence of more complex lesions, the
former case turns out to be more effective, therefore
exhibiting RBE values larger than one.
As measurements of RBE are always associated with an
uncertainty, RBEs are likewise affected with variability.
However, a prerequisite for the prediction and the effect of
different radiation qualities is the knowledge of their RBEs.
To assess them, also the associated variances (usually
visualized as error bars) are needed. The determination of
the latter is the subject of the presented work.
The emergence of the variability in RBE is caused
mainly by two distinguishable reasons. One is a composi-
tion of several stochastic processes as, e.g., those involved
in preparing cell culture assays, in cell counting and in cell
killing by radiation for the case of cell survival experiments.
The other reason is the variable radiosensitivity of the cells
that depends on many environmental conditions such as
nutrient supply, growth density or the stresses experienced
within culture preparation (which itself depends on several
factors and may vary between different laboratories), as
well as the individual cell type–specific sensitivity (Hall and
Giaccia 2006; Kraft 1999). Note that the latter is not fixed
but may change with time, as the properties of a cell line
may change gradually. As these aspects are extremely
complex, it is hardly feasible to monitor or to model them
from first principles. Starting from either a huge set of
experimental data or from reasonable assumptions based on
experience, we approach this goal in this paper from two
perspectives: In the next section, we focus on the problem
from an empirical point of view. Experimental experience
from ion and photon experiments allows to roughly estimate
the uncertainty of the a parameters of survival curves. By
means of Gaussian error calculus, those can be converted
into errors of the RBE. Application to a real data set shows
that the errors are a bit overestimated using this method, but
the error bars are still in the expected range of magnitude. A
more thorough look on the properties of RBE can be gained
by looking not only at its variability, but on its whole dis-
tribution. This is carried out in the section about theoretical
considerations, where the propagation of errors is moni-
tored, starting from a hypothetical set of generated a
parameters that follow Gaussian distributions. As will turn
out, for a correct inference of the RBE, a bias correction has
to be taken into account. Finally, we comment in the dis-
cussion section on the implications of these findings for
models predicting the RBE.
Empirical approach
On a purely empirical level, we evaluated the fluctua-
tions of a parameters for survival experiments. For the
case of low-LET irradiation (X-rays), we investigated
survival data of CHO cells, which have been taken over
several years. We found that the a values of all survival
curves were distributed with a peaked distribution with
a = (0.162 ± 0.083) Gy-1. The observed variability is
larger than that for a single set of experiments performed
at one time (Kraft 1999), where several of the systematic
errors listed previously do not enter in detected devia-
tions. For the case of high-LET irradiation, we investi-
gated the data sets provided in Furusawa et al. (2000).
This work reports the dependence of a on linear energy
transfer (LET) for different cell lines and ion species. An
appropriate model function (Takatsuji et al. 1999) allows
to successfully fit the RBE-LET dependence up to high
LETs, where the overkill effect becomes dominant. We
then could extract the remaining fluctuations of RBE
values around the fit line. We found that the absolute
fluctuation widths are almost independent from the cel-
l–ion combination. Similarly, there seems to be no
dependence on LET within the therapeutic relevant range
up to about 100 keV/lm. In this range, we found for a
variety of cell–ion combination as presented by Furusawa
and co-workers (Furusawa et al. 2000) a standard devi-
ation DaI = 0.140 Gy
-1, which differs from the uncer-
tainty detected in our analysis of photon experiments, but
is still in the same order of magnitude. We propose thus
Da  Dac  DaI ð3Þ
and assert a value of Da = 0.1 Gy-1 as a rough estimate
for the uncertainty in the a parameter both for high- and
low-LET radiation.
To transfer these uncertainties in an uncertainty of the
RBEa, we use the conventional Gaussian error propagation
on the definition of RBEa as given in Eq. (2), resulting in
DRBEa
RBEa
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Dac
ac
 2
þ DaI
aI
 2
s
: ð4Þ
Note that this equation assumes independent Gaussian
distributed uncertainties of both the ion and photon
parameters. While we checked the former assumption for
the experimental data used in this paper with statistical
tests, the latter one is not strictly true. The a parameters
appear to be slightly positively correlated, which may lead
to a further decrease in the corresponding error in
RBE. The application of Eq. (4) requires the knowledge
of uncertainties. To make use of the handy estimate
Da = 0.1 Gy-1, combining Eqs. (3) and (4) yields
DRBEa ¼ Daac
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 þ RBE2a
q
: ð5Þ
To apply this estimate for numerical values, ac and
RBEa have to be inferred from the experiment, and
346 Radiat Environ Biophys (2010) 49:345–349
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Da = 0.1 Gy-1 is used to estimate the uncertainty in the
measurements.
In Fig. 1, we show some of the data of Furusawa et al.,
where experimentally obtained RBEa values of V79 cells at
different LETs have been associated with error bars. They
were derived from deviations to a model fit (Takatsuji et al.
1999) that represents the measured data nicely as was
checked by hypothesis tests. Note that the error bars appear
larger in this figure than the residual deviations of the points
from the fit line. This reflects the fact that a deviation in the
photon parameters would result in a systematic shift of
RBEa of all data points in this plot. Moreover, the size of the
error bars matches what is expected from experimental
experience. Clearly, the uncertainties increase with rising
RBEa, as can be seen already by the investigation of Eq. (5).
Theoretical considerations
Apart from the condition of independent Gaussian distri-
bution, there is a further requirement for the validity of Eq.
(4): The errors of Da have to be much smaller than the a
parameters. Within the range of frequently occurring val-
ues, this condition is not always fulfilled.
To investigate this situation in more detail, we per-
formed a Monte Carlo model, in which we generated two
sets of hypothetical a values. Both sets consist of inde-
pendent Gaussian distributed random numbers. These sets
{ac} and {aI} mimic alpha values obtained after low- and
high-LET radiation, respectively. The mean value \ac[
obtained from the photon set is chosen smaller than \aI[
obtained from the ion set. By forming pairs (ac, aI) of
elements from both sets and dividing the second by the first
constituent, a set of hypothetical RBEa values {RBEa} is
finally obtained whose properties can then be considered.
Note that the distribution of RBEa can also be elaborated
analytically. The idea and the results are given in the
‘‘Appendix’’.
We choose \ac[ = 0.2 Gy
-1 and \aI[ = 1 Gy
-1 and
a universal uncertainty Da = 0.1 Gy-1. Thus, RBEa =
\aI[/\ac[ = 5 by design. In Fig. 2, we present the dis-
tribution of 50,000 Monte Carlo simulated RBEa values,
together with the analytic distribution. This distribution has
several interesting features: (i) it has a long tail and no
symmetries (ii) its mean value overestimates the RBEa (iii)
the RBEa at which the distribution reaches its maximum
underestimates the RBEa and (iv) its standard deviation
diverges while the width of the prominent peak is com-
parable with the expected error DRBEa = 2.55 by means
of Eq. (5). Moreover, the distribution has also a small
negative component (not shown).
The reason for these properties can be found in the
distribution of {ac}, which does not vanish at values close
to zero or even negative values. When the division by these
numbers is carried out, the RBEa is caused to diverge or to
become negative. To deal with this situation, one would
have to add a bias correction for the average \RBEa[ in
order to approach the design value. However, this proce-
dure is neither trivial nor illustrative.
Discussion
When comparing both approaches to obtain information
about the RBEa presented above, we may conclude that the
empirical approach serves as a reasonable tool to estimate
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Fig. 1 RBEa dependence on LET for V79 cells irradiated with
carbon ions. The solid line shows a non-linear fit that is capable to
reproduce the RBE-LET characteristics up to high LETs. The error
bars were associated according to Eq. (5) and contain both
contributions of uncertainties experiments with photons and ions
Fig. 2 Distribution of RBEa values simulated by a Monte Carlo
Model (points) with Gaussian distributed a parameters with
\ ac [ = 0.2 Gy
-1 and \ aI [ = 1 Gy
-1 for photon and ion exper-
iments, respectively. A category width of 0.1 was chosen for binning.
The solid curve emerges from an analytical treatment, see the
‘‘Appendix’’. The mean (dashed line) and the value where the
distribution takes its maximum (dotted line) of the distribution deviate
considerably from the design value (thick line). In contrast, the
median value provides the best approximation (dashed-dotted line)
Radiat Environ Biophys (2010) 49:345–349 347
123
7.5 Article 5: Mathematical aspects of RBE uncertainties 113
the uncertainty of the RBEa. This is confirmed by the
theoretical approach, where the width of the prominent
peak in the distribution of RBEa is of comparable size as its
estimated uncertainty, even though the determined mean
RBEa value is not a good predictor for the designed RBEa.
Hence, the question remains what one can do about a
possibly misleading inference of the RBEa value, which
has been demonstrated by the Monte Carlo model. We
suggest here two practical ways to overcome this difficulty:
First, one generally should avoid to average over RBE
values. A better way is to calculate averages from the linear
quadratic parameters and finally compute the RBE from
these averages. However, if these parameters are not at
hand, the alternative approach would consist in calculating
the median RBEa. The concept of the median lacks of an
easy statistical interpretation, but is by far less sensitive to
extreme values. For the example presented in the last
section, the median RBEa is 4.85 and thus only deviates
little from the design value, c.f. Fig. 2. The analysis pre-
sented here should be applicable for the whole spectrum of
particle radiation. For light ions, also the mean value
should be a good predictor, since they provide a rather
small RBE and the median and mean values lie close
together.
To summarize, we presented in this article an approach
to understand uncertainties of the RBE. We here covered
only the limiting case of RBEa and presented practicable
ways to infer its value from experimental data based on
dose–effect curves (by computing arithmetic means of ac
values) or measured RBEa values (by computing their
median). Although the RBEa has a simple definition, a
thorough development of its uncertainties is a non-trivial
task (c.f. the ‘‘Appendix’’). It turns out that reliable
experimental data for the dose response to photon radiation
imply reasonably low uncertainties in the RBEa, as
reflected yet by the empirical error model.
Generally, the dependence of RBE on the LQ parameters
a and b is more complicated than in the case considered
here. A rigorous error analysis for the dose-dependent RBE
has to our knowledge not been developed so far. We
suggest that the Monte Carlo simulations could prove as a
fruitful tool to monitor error propagation in these more
complicated situations, where an analytical approach is not
applicable for the evaluation of realistic uncertainties. To
perform tests on biophysical models such as the local
effect model, predictions must be compared to experi-
mental data. For establishing rigorous test procedures, the
errors of the latter have to be known. The model is then
requested to resemble the data within the experimental
accuracy. Consequently, the uncertainty analysis presented
in this paper will help to define precision goals for
approaches to estimate RBE values for treatment planning
in ion therapy.
Acknowledgments This work gained support from Siemens
Healthcare.
Appendix
In order to derive the distribution of RBEa, we set up a
statistical model starting from two sets {ac} and {aI} of
artificial parameters for photon and ion irradiation,
respectively. Their elements are Gaussian distributed
pqðaqÞ ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2pðDaÞ2
q exp  aq  aq
  	2
2ðDaÞ2
( )
ðA1Þ
where the index q = c or q = I for photon or ion
irradiation, respectively, and Da = Dac = DaI. Due to
their statistical independence, their joint probability
distribution is
pðac; aIÞ ¼ pcðacÞpIðaIÞ ðA2Þ
The distribution of a ratio Z = X/Y of two independent
random variables X and Y with joint probability function
p(x, y) is given by
PðzÞ ¼
Z1
1
yj jpðzy; yÞdy ðA3Þ
which is a result of the algebra of random variables
(Springer 1979).
Combining Eqs. (A1–A3) results in the distribution of
RBEa
PðRBEaÞ¼ exp 
ac
 2þ aIh i2
2 Dað Þ2
 !
1þ ﬃﬃﬃﬃﬃpyp exp yð ÞErf ﬃﬃyp 	 	
p 1þRBE2a
 	
ðA4Þ
where Erf(x) is the Gaussian error function and
y ¼ ac
 þ aIh iRBEa
 	2
2 Dað Þ2 1 þ RBE2a
 	 ðA5Þ
The mean value of Eq. (A4) can be also calculated as
RBEah i ¼
Z1
0
RBEaPðRBEaÞdRBEa
¼ aIh i
ac
 
ﬃﬃﬃ
p
p
c exp c2 	Erfi cð Þ
  ðA6Þ
where Erfi(x) denotes the inverse error function and
c ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ac
 2
2 Dað Þ2
v
u
u
t ðA7Þ
Note that the term in curly brackets in Eq. (A6) connects
the mean of the RBEa values with the design value and is
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thus a bias correction if the mean value is used as an
estimator for the RBEa. The bias correction depends only
on the uncertainty of photon parameters, c.f. Eq. (A7).
This is plausible as they appear in the denominator of
the definition of RBEa as given in Eq. (2). Hence, the
precise knowledge of photon parameters is essential for
determining appropriate RBE values (ICRP 2003).
Monte Carlo calculations or the analytic treatment of
ratio distributions as presented here are also applicable for
other radiobiological quantities such as a/b ratios or the
RBE in the zero-dose limit. However, in general, one has to
take into account that the LQ parameters a/b are negatively
correlated and not independent.
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For tumor therapy with light ions and for experimental aspects in particle radiobiology the relative biologic-
al effectiveness (RBE) is an important quantity to describe the increased effectiveness of particle radiation.
By establishing and analysing a database of ion and photon cell survival data, some remarkable properties
of RBE-related quantities were observed. The database consists of 855 in vitro cell survival experiments
after ion and photon irradiation. The experiments comprise curves obtained in different labs, using different
ion species, different irradiation modalities, the whole range of accessible energies and linear energy trans-
fers (LETs) and various cell types. Each survival curve has been parameterized using the linear-quadratic
(LQ) model. The photon parameters, α and β, appear to be slightly anti-correlated, which might point
toward an underlying biological mechanism. The RBE values derived from the survival curves support the
known dependence of RBE on LET, on particle species and dose. A positive correlation of RBE with the
ratio α/β of the photon LQ parameters is found at low doses, which unexpectedly changes to a negative cor-
relation at high doses. Furthermore, we investigated the course of the β coefficient of the LQ model with in-
creasing LET, finding typically a slight initial increase and a final falloff to zero. The observed fluctuations
in RBE values of comparable experiments resemble overall RBE uncertainties, which is of relevance for
treatment planning. The database can also be used for extensive testing of RBE models. We thus compare
simulations with the local effect model to achieve this goal.
Keywords: relative biological effectiveness; cell survival; ions; local effect model; linear quadratic model
INTRODUCTION
Radiation cancer therapy with carbon ions has been applied
successfully in Japan and Germany and will be used in
several other locations all around the world in the near
future [1–6]. In earlier trials at Berkeley, other ion beams
from He to Ar were used for cancer treatments. One major
rationale for the application of ion beams in radiotherapy is
their enhanced effectiveness compared with conventional
X-rays, in particular in the target region. This has given
rise to intensified research on the understanding and on the
predictability of the biological effect of ions compared with
respect to photons, usually parameterized by the relative
biological effectiveness (RBE) [7]. The RBE is an import-
ant factor to be considered in treatment planning for ion
beam therapy, since the prescribed doses have to be corres-
pondingly reduced as compared with the doses given in
conventional photon therapy [8, 9].
Generally, the RBE depends on many factors such as the
linear energy transfer (LET) at a given tissue depth, the par-
ticle species, the dose and the biological endpoint. Due to
these complex dependencies, full systematic characteriza-
tion typically requires meta-analyses based on a combin-
ation of different studies. The primary focus of this paper is
therefore to compile a large collection of experimental
results and to investigate it in order to exhibit further sys-
tematic analyses of the relevant quantities. For this purpose,
we established a database of cell survival experiments
with both photon and ion irradiation published in the
literature.
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Besides these systematic analyses, such a database is also
ideally suited to testing and validating biophysical models
that aim to predict the biological effects of ion beams. These
models are important tools, for example, in treatment plan-
ning, where they are used to estimate the RBE in situations
that are not directly experimentally accessible. For example,
the local effect model (LEM) has been implemented in treat-
ment planning for a pilot project performed at Gesellschaft
für Schwerionenforschung (GSI) [10, 11]; and the potential
application of the microdosimetric kinetic model [12, 13] is
discussed at the HIMAC/NIRS.
A prerequisite for clinical application of these models is
a thorough test and validation by means of in vitro experi-
mental data. Survival experiments are particularly suitable
here, as they are comparably easy to perform under
well-defined experimental conditions. In the design of our
database we have thus put particular emphasis on its applic-
ability for the purpose of model tests and validation.
Assessment of the accuracy of a model requires informa-
tion about the uncertainty of the experimental data. Most
published experiments report statistical errors, which
however represent only a lower limit concerning the uncer-
tainty of the data. Unfortunately, there is no unique estab-
lished way of reporting errors in cell survival values, and
indeed a full uncertainty analysis would be demanding as
both stochastic and systematic errors would have to be
respected. The overall uncertainty can hence be better esti-
mated based on the combination of larger sets of experimen-
tal data, for example, from different laboratories, obtained
under otherwise identical conditions. For such a dataset, a
measure of uncertainty can be derived empirically from the
scatter of the data, which have been obtained from compar-
able situations. The large database presented in this paper
thus is also ideally suited to analyze fluctuations from
which the overall uncertainty of RBE can be assessed directly
on purely experimental grounds. In previous attempts the
use of a data collection to analyze systematic variations of
RBE specifically for protons has been proven to be very
fruitful [14].
In this publication, we report on the set up of a database
containing results of more than 800 cell survival experiments
from different laboratories all over the world, using different
cell types and different ions at various energies. Throughout
this paper, we call this collection ‘Particle Irradiation Data
Ensemble,’ in short, PIDE. We used the database to reveal
known and new systematics of the RBE and its related quan-
tities. We (i) evaluated statistical properties of the photon
linear-quadratic (LQ) parameters and found that they are
slightly anti-correlated; (ii) we investigated the evolution of
the quadratic coefficient β of the LQ model with LET, which
is under current discussion; and (iii) we report on a survival-
dependent systematic variation of the RBE with the photon
α/β ratio. Moreover we demonstrate the capability of the
database for RBE model validation.
MATERIALS AND METHODS
Conception of the database
The main task in the development of the database was to
combine a variety of experimental results of ion irradiation
experiments with in vitro cell lines including the early
experiments from Berkeley, the huge datasets of studies
from Japan and the experiments carried out in Europe.
After a thorough literature survey, we introduced some re-
striction for the selection of the publications that we
included in the data ensemble. One of these restrictions
was that we only included publications for which the LQ
parameters of the response to photons as reference radiation
were available or derivable. This allows the determination
of the RBE values to any survival level from the LQ para-
meters (provided the LQ model holds, which is still under
debate for high doses [15–17]). We believe that we have
covered in the database a good fraction of all published sur-
vival experiments in peer-reviewed journals under these
restrictions.
Currently the PIDE contains 855 measured ion cell sur-
vival curves, taken from 77 publications (see Table 1). The
cell lines under investigation range from radio-resistant
cells with a shoulder, to radio-sensitive cells without a
visible shoulder in the photon dose–response curve. Within
all experiments, 182 different photon dose–response curves
were used as a reference to calculate RBE values. In the
experiments about 80 different cell lines were investigated.
When investigating their properties, it becomes evident that
cells of the same cell line may behave differently depending
on experimental factors or age of the cell line. In fact, cell
lines that are equal by origin and name, but maintained for
years at different institutions might not show identical
responses to radiation and thus have to be better distin-
guished by author/institution rather than pooled in the
database.
Normal cells were used for 673 curves and tumour cell
lines were used for 182 curves. In some cases mutated or
specially treated cells with repair deficiencies were investi-
gated. In 52 experiments, the cells were irradiated predom-
inantly in a specified cell cycle phase, in the other 803
experiments the cells were irradiated in an asynchronous
population. In 372 experiments human cell lines were used,
in 483 experiments rodent cell lines were used. Among the
latter, V79 cells have been studied most often and results
were reported in 29 of the 77 publications included in the
PIDE. Among all the experiments, 352 were carried out
with carbon ions, 186 with lighter (p-B) and 317 with
heavier ions (N to U). A total of 103 experiments were
carried out with a shaped beam in a spread-out Bragg peak
or the entrance channel, but the majority (752 experiments)
were carried out under track segment conditions with
monoenergetic ion beams. Throughout the text we use the
term ‘monoenergetic’ whenever a beam is not a shaped
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beam to provide an extended peak. One should keep in
mind that such a monoenergetic beam nevertheless may
show an energy distribution and may be subject to frag-
mentation. This is in particular the case when a primary
beam is decelerated by passive elements after exiting the
accelerator. As can be seen from Table 1, the publications
typically focus on one special aspect within all possible
combinations of the factors listed above.
Technically, for each of the 855 experiments, there is
one entry in the PIDE, in which the LQ parameters of the
ion response curve are listed along with other information
such as LQ parameters of photon response, cell type, LET,
energy, etc. The entries are stored separately for each publi-
cation in two text files, one of which contains information
given in the publication and the other contains information
taken from related publications or quantities that have been
derived (such as calculated RBE values or LET values for
a given particle energy). In this way, information contained
in new publications can be easily added into the PIDE.
Within an entry the information is stored in variables,
which are given a name and a value (such as LET and 120
keV/µm, for example). Table 2 gives an overview of all
quantities required for each entry. Additional variables may
be defined at any time in any entry, for example, for calcu-
lated RBE values or, for later use, oxygenation status.
The PIDE contains data obtained for a broad variety of
experimental factors, both biological and physical in nature.
However, the intention is not to pool all experiments.
Rather the database allows one to easily extract a subset of
experiments fulfilling certain requirements (such as all cells
with a small α/β ratio irradiated with monoenergetic carbon
ions) for which, for example, RBE dependence on further
parameters (such as LET) can be investigated.
Sources of the data
Our requirements for the selection of the publications for
the data ensemble were as follows. (i) We required the data
included in the PIDE to be published in peer-reviewed jour-
nals or PhD theses. Both types of publications seem to be
sufficiently reviewed, and in general accessible via libraries
from anywhere. (ii) We only took publications into account
in which data on ion radiation and photon radiation re-
sponse were provided or where the latter were found in
references or could be derived. For photon experiments
generally only hard X-rays or 60Co or 137Cs γ-rays have
been required as reference radiation. For RBE evaluations,
the slightly differing effectiveness between different photon
radiation qualities of these groups has been neglected. If
X-rays with energies below 200 kVp were used, effective-
ness could be enhanced. The corresponding publications
have been indicated in Table 1. (iii) The radiation quality
had to be described in the publication in sufficient detail, i.
e. either LET (or track or dose-averaged LET for irradiation
in a spread out Bragg peak), the specific energy on the
target or the remaining range of primary particles was
required to be reported in all publications included in the
PIDE. The quantities not given explicitly in the publica-
tions appear in italics in Table 1. (iv) LQ parameters or
related quantities (from which LQ parameters could be
derived) had to be given either numerically or as figures
(typically the survival curves) in the publications. If quan-
tities other than LQ parameters or survival levels were pre-
sented in the publications, it is mentioned in Table 1. (v)
Experiments with monoenergetic ions were excluded if
track segment conditions were not fulfilled. (vi) Some add-
itional information is requested. A list of all information for
the required variables is given in Table 2.
Extraction of relevant parameters
Once the publications forming the basis of the PIDE were
selected, the relevant information was extracted. Here the
following procedures were applied:
LET and energy
If both LET and energy for a given ion species were given
in a publication, both values were taken into the PIDE. If
only LET or energy was given in a publication, its counter-
part was determined from precalculated energy loss tables
used within the treatment planning system TRiP98 [11, 99].
These encompass ions from protons to neon within the
energy range of 0.1–1000 MeV/u. For ion species where no
such tables are available, i.e. in particular for heavier ions
that are not relevant in treatment planning, it was calculated
using the computer code ATIMA developed at GSI, which
performs energy loss calculations for charged particles in
matter based on tabled cross sections [100]. Note that for a
given energy value, slightly differing LET values may
occur depending how the LET was obtained.
For irradiations in spread out bragg peak (SOBP) the
dose-averaged LET was used as a representative quantity, if
given in the publications. However, it should be noted that
the dose-averaged LET is not always a good quantity to de-
scribe the radiation field and might be a misleading
concept. This is in particular the case for SOBP with large
depths and/or extensions, where the radiation field is a
complex mix of LET components and hence the corre-
sponding LET spectrum should be respected. Nevertheless,
since these details cannot be represented in the database,
we take (dose) average LET values as surrogates to reflect
the complex radiation field.
LQ parameters of photon and ion dose–response
curves
In about a third of all publications, numerical values for the
LQ coefficients were presented, while in the majority the
measured survival curves were shown in figures. These two
cases will be discussed in more detail now. Note that in
T. Friedrich et al.496
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Table 1. Content of the PIDE, sorted by publications
No.
Author/year/
ref.
No.
s.c.a
Cell lines
Cell
typeb
Cell
cyclec
Cell
origind
α/β
(Gy)
Ion species
Irr.
cond.e
LET
(keV/µm)f
E
(MeV/u) f
Phot. g Remarksh
1 Chapman et al.,
1977 [18]
13 V79 n s r 2.22 4He, 12C, 20Ne,
40Ar
s 2.34–402.7 26.1–
319.0
220 LET given
2 Chapman et al.,
1978 [19]
9 V79, T1 n a, s h, r 2.17–
3.80
12C s 12.16–74.99 26.1–
319.0
220 LET given
3 Blakely et al.,
1979 [20]
24 T1 n a r 2.13 12C, 20Ne, 40Ar m 11–419 10.7–
389.0
220
4 Raju et al.,
1991 [21]
5 CHO-10B, HS-23, C3H_10T1/2,
V79, AG1522
n a r 4.33–
20.0
4He m 121–136 0.65–0.8 Co
5 Goodhead et al.,
1992 [22]
10 HeLa, HeLa S3, C3H 10 T1/2 n a h, r 5.39–
30.0
1H, 4He m 20.27–23.915 1.16–8.8 250
6 Folkard et al.,
1996 [23]
10 V79 n a r 2.71 1H, 2H, 3He,
4He, 12C, 16O
m 10.1–105.8 0.465–
3.66
240
7 Eguchi-Kasai
et al., 1996
[24]
22 irs1, irs2, L5178Y, M10, LTA,
SL3-147
n a r 0.06–
31.1
4He, 12C, 20Ne m 18–327 3.1–123.2 200
8 Suzuki et al.,
1997 [25]
7 HE20 n s h 0.67 20Ne m 63–335 14.3–
120.3
Cs
9 Bettega et al.,
1998 [26]
8 C3H 10T1/2 n a r 15.0 1H, 2H m 6.65–33.2 0.72–4.89 Co
10 Tsuboi et al.,
1998 [27]
20 NB1RGB, ONS-76, A-172,
U251MG, TK-1
n, t a h 0.13–
6.89
12C m 20–105 17.4–
144.0
Cs
11 Tsuchida et al.,
1998 [28]
6 A172, TK1 t a h 2.23–
2.98
12C m 20–80 24.1–
144.0
Cs
12 Weyrather et al.,
1999 [29]
21 V79, CHO-K1, xrs5 n a r 3.57–∞ 12C m 13.7–482.7 2.4–266.4 250 Corrected
13 Furusawa et al.,
2000 [30]
138 V59, HSG, T1 n a h, r 0.52–
9.2
3He, 12C, 20Ne m 18.5–654 1.27–131 200 Values for α
and D10
given;
Corrected
14 Suzuki et al.,
2000 [31]
30 NB1RGB, HFL-III, LC-1sq, A-549,
C32TG, Marcus, U-251MGKO,
SK-MG-1, KNS-89, KS-1, A-172,
ONS-76, KNS-60, Becker, T98G,
SF126
n, t a h 0.59–
21.3
12C m 13.3–77.1 25.1–
271.2
200 Corrected
15 Belli et al.,
2000 [32]
12 HF19, M10, SCC25, SQ20B n, t a h 7.65–∞ 1H m 7.7–33 0.69–5.24 Cs + Co
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Table 1. Continued
No.
Author/year/
ref.
No.
s.c.a
Cell lines
Cell
typeb
Cell
cyclec
Cell
origind
α/β
(Gy)
Ion species
Irr.
cond.e
LET
(keV/µm)f
E
(MeV/u) f
Phot.g Remarksh
16 Tsuruoka et al.,
2005 [33]
41 NB1RGB n a h 17.47 12C, 20Ne, 28Si,
56Fe
m 13–400 19.5–500 200 Values for
RBE10
given
17 Belli et al.,
2008 [34]
37 HF19, M10, SCC25, SQ20B, V79 n, t a h, r 4.41–∞ 12C m, s 13–303 4.5–290 Cs + Co <LETD>
given
18 Belli et al.,
1998 [35]
6 V79 n a r 2.80 1H m 7.7–34.6 0.57–5.01 No X-ray
energy
given;
Data in
parts taken
from Belli
et al., 1993
[36]
19 Hall et al., 1977
[37]
3 V79 n a r 3.24 40Ar s 110.9–409.2 48–330 250 <LETD>
given
20 Bird and Burki,
1975 [38]
6 V79 n a r 18.6 4He, 7Li, 11B,
12C, 20Ne,
40Ar
m 19.1–2000 5.09–9.93 145 Low X-ray
energy;
X-ray
curve
taken from
Sinclair
and
Morton,
1966 [39]
21 v. Neubeck,
2009 [40]
6 RAT-1, IEC-6 n, t a r 6.69–
15.9
12C m 13.3–163 9.9–270 250
22 Perris et al.,
1986 [41]
2 V79 n a r 25.5 1H m 6–12 3–7.4 Co
23 Bettega et al.,
1983 [42]
3 EUE n a h 211 1H m 1.83–5.8 8–31 Co Photon data
taken from
Bettega
et al., 1979
[43]
24 Cox et al., 1977
[44]
4 V79, HF19 n a h, r 5.52–∞ 4He m 20–68 1.9–8.8 250
25 Wouters et al.,
1996 [45]
11 V79 n a r 2.73 1H s 2.33–6.23 6.8–22.8 250 <LETD>
given
26 Combs et al.,
2009 [46]
4 U87-MG, LN229 t a h 4.53–
6.52
12C m, s 103–170 9.8–18 250 <LETD>
given
T
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27 Kitajima et al.,
2010 [47]
10 SuSa, AT1OS n s h ∞ 12C m 24–200 35–450 150 Low X-ray
energy;
values for
RBEα
given
28 Blomquist et al.,
1993 [48]
2 LS-147T, V79 n, t a h, r 3.65–∞ 1H s 4 11.6 Co <LETD>
given
29 Yang et al.,
1985 [49]
9 C3H 10T1/2 n a r 0.36–
13.4
12C, 20Ne, 28Si,
56Fe, 238U
m 10.5–2080 103–990 225 E and LET
from
remaining
range
30 Miller et al.,
1995 [50]
10 C3H 10T1/2 n a r 2.80 1H, 2H, 3He,
4He, 12C, 16O
m 3.8–418 0.275–
12.9
250
31 Czub et al.,
2008 [51]
4 CHO n a r 8.5 12C, 20Ne m 438–1245 1.69-2.78 Co
32 Kamlah et al.,
2011 [52]
1 A594 t a h 11.6 12C m 168 9.9 6 MV
33 Aoki et al.,
2000 [53]
6 V79 n a r 7.95 12C m 13–237 6.4–283 200
34 Han et al., 1998
[54]
6 SHE n a r 13.7 12C, 26Si m 13–400 18.5–283 250
35 Hamada et al.,
2010 [55]
8 H1299 t a h 0.95 12C, 20Ne, 26Si,
40Ar, 56Fe
m 13–200 20–600 200
36 Claesson et al.,
2011 [56]
6 V79 n a, s r 4.33–∞ 4He m 110 1.625 100 Low X-ray
energy
37 Wedenberg
et al., 2010
[57]
5 T1 n a h 9.00 4He m 25–165 0.46–6.8 250
38 Miller et al.,
1990 [58]
1 C3H 10T1/2 n a h 2.80 2H m 40 0.55 Photon data
taken from
Miller,
1995 [50]
39 Tobias et al.,
1980 [59]
2 V79 n s r 11.5–
21.3
40Ar m 370 55 220 E and LET
from
remaining
range
40 Cox and
Masson, 1979
[60]
7 HF19 n a h ∞ 4He, 11B, 14N m 20–470 1.24–10.3 250
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Table 1. Continued
No.
Author/year/
ref.
No.
s.c.a
Cell lines
Cell
typeb
Cell
cyclec
Cell
origind
α/β
(Gy)
Ion species
Irr.
cond.e
LET
(keV/µm)f
E
(MeV/u) f
Phot.g Remarksh
41 Ito et al., 2006
[61]
7 HL-60 t a h 4.78 12C, 26Si, 56Fe m 20–440 26–126 4 MV
42 Tilly et al.,
1999 [62]
3 V79 n a r 3.73 4He, 14N m 6–165 14.4–39 Co
43 Thacker et al.,
1979 [63]
6 V79 n a r 3.90 4He, 11B, 14N m 28–470 1.24–10.3 Co
44 Hirayama et al.,
2009 [64]
5 V79 n a r 3.57 12C, 56Fe m 20–2106 16–416 200
45 Hirayama et al.,
2005 [65]
1 CHO n a r 3.23 12C m 79.6 24 200
46 Curtis et al.,
1982 [66]
28 R-1 t a r 2.26 12C, 20Ne, 40Ar s 11–750 19.5–428 225 <LETD>
given
47 Boehrnsen
et al., 2002
[67]
2 V79 n a r 2.50 12C m 27.5–153 10.2–92.5 6 MV
48 Fournier et al.,
2001 [68]
4 AG1522B, PS1 n a h 13.5–
25.6
12C, 48Ni m 16.6–2455 9.9–195 250
49 Wulf et al.,
1985 [69]
106 B14FAF28, V79 n a r 11.7–
14.3
12C, 16O, 40Ca,
40Ar, 48Ti,
56Fe, 58Ni,
84Kr, 132Xe,
142Nd, 208Pb,
238U
m 150–15 800 0.1–400 Values for
cross-
sections
given;
photon
parameters
taken from
Wulf, 1983
[70] and
Kraft,
1987 [71]
50 Scholz, 2003
[72]
8 CHO, V79 n a r 3.58–
11.4
12C, 16O, 20Ne,
238U
m 13.3–16 500 5–396 Photon
parameters
adapted
from
Weyrather
et al., 1999
[29]
51 Persson et al.,
2002 [73]
3 AA t a h 0.98 10B m 40-160 6.6–36.6 Co
T
.F
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52 Yang and
Tobias, 1984
[74]
2 C3H 10 T1/2 n a r 1.07–
2.07
56Fe, 238U m 500–1900 300–960 225
53 Scholz et al.,
1997 [10]
8 CHO n a r 6.43 12C, 16O m 13.5–265 11–395 250
54 Prise et al.,
1990 [75]
4 V79 n a r 4.07 1H, 4He m 16.9–108 0.76–1.9 250
55 Terato et al.,
2008 [76]
4 AA8 n a r 30.0 12C m 13–200 43–290 Co
56 Suzuki et al.,
1996 [77]
8 HE n s h 0.66 12C m 22–230 6.6–126 Cs
57 Matsumoto
et al., 2008
[78]
6 C32TG, Colo679, HMV-I, HMV-II,
92-1, MeWo
t a h 3.29–
68
12C s 50 43.4 200 <LETD>
given
58 Mehnati et al.,
2005 [79]
13 CHO n a r 11.65 12C, 20Ne, 40Ar,
56Fe
m 20–2000 13–144 200
59 Stenerloew
et al., 1995
[80]
10 HTh7, B16, IGR, V79, LS-174T,
U-343MG, DU-145
n, t a h, r 0.91–∞ 4He, 14N s,m 40–125 3.82–20.3 Co Unclear if
LET or
<LETD>
given
60 Okayasu et al.,
2006 [81]
10 CHO, xrs6, xrs6-hamKu80, HFLIII,
180BR
n a h, r 2.70–∞ 12C, 56Fe m 70–200 28.5–430 No X-ray
energy
given
61 Tsuboi et al.,
2007 [82]
9 U87MG, TK1 n, t a h 2.31–
6.25
12C m 20–80 24–144 Cs
62 Todd, 1975 [83] 10 ChangHL, M3-1 n a h, r 0.64–
10.42
7Li, 11B, 12C,
14N, 16O,
20Ne, 40Ar
m 55–1940 5.3–7 50 Low X-ray
energy
63 Hall et al., 1972
[84]
1 V79 n a r 41.1 4He m 106 1.3 210
64 Takahashi et al.,
2000 [85]
8 A172, A172neo, A172mp53,
TG98G
t a h 0.14–
0.92
4He, 12C s 70–156 0.51–28.5 150 Low X-ray
energy;
<LETD>
given
65 Takahashi et al.,
2004 [86]
12 H1299wtp53, H1299tp53,
H1299tp53-null
t a h 0.00–
2.56
12C m 30–100 18.5–83 200
66 Matsuzaki et al.,
1998 [87]
3 OCUB-M, CRL-1500, YMB-1 t a h 4.45–
21.3
12C s 80 24 200 <LETD>
given;
corrected
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Table 1. Continued
No.
Author/year/
ref.
No.
s.c.a
Cell lines
Cell
typeb
Cell
cyclec
Cell
origind
α/β
(Gy)
Ion species
Irr.
cond.e
LET
(keV/µm)f
E
(MeV/u) f
Phot.g Remarksh
67 Kronenberg
et al., 2009
[88]
1 Aprt n a r ∞ 56Fe m 151.4 1000 150 Values for D0
given; low
X-ray
energy
68 Hamada et al.,
2006 [89]
6 AG01522 n a h ∞ 4He, 12C, 20Ne,
40Ar
m 16.2–1610 7–25.5 Co Values for D0
given
69 Zhou et al.,
2006 [90]
1 V79 n a r 3.63 12C m 100 18.5 200
70 Jenner et al.,
1993 [91]
1 V79 n a r 2.2 4He m 120 0.81 Co
71 Furusawa et al.,
2002 [92]
2 V79 n a r 7.15–
11.4
40Ar, 58Fe m 86–442 115–575 150 Low X-ray
energy
72 Takahashi et al.,
2001 [93]
8 SASmp53, SASneo t a h 3.77–
10.0
12C m 30–150 11–83 150 Low X-ray
energy
73 Bettega et al.,
2005 [94]
5 AG1522 n a h ∞ 26Si, 48Ti, 56Fe m 56–442 200–1000 Co
74 Ibañez et al.,
2009 [95]
3 B16-F0 t a r 2.17 1H, 6Li m 3.4–135 2.9–14.4 Cs
75 Hellweg et al.,
2011 [96]
2 HEK n a h 2.55 13C m 33–73 28–72 150 Low X-ray
energy
76 Napolitano
et al., 1992
[97]
1 C3H 10T1/2 n s r 9.0 4He m 177 0.45 80 Low X-ray
energy
77 Hill et al., 2004
[98]
7 V79-4, irs1, irs2, irs3, CHO-K1,
xrs5
n a r 3.7–∞ 4He m 121 3.26 250
Notes: For each publication, the first author, along with the year of publication, as well as the number of survival curves taken into the PIDE are given. Furthermore, summarizing
properties of the used cells and radiation qualities are provided.
a No. s.c. = number of survival curves described in the publication.
b cell type: n = normal, t = tumor.
c cell cycle: a = asynchronous, s = synchronized in a particular phase of cell cycle.
d cell origin: h = human, r = rodent.
e irradiation conditions: m =monoenergetic, s = within a spread out Bragg peak.
f values given in italics if not given in the publications.
g X-ray energy in kVp or photon energy in MV for clinical accelerators if this unit is given, or Co = 60Co and Cs = 137Cs source.
h If linear quadratic parameters are not directly taken from figures or tables or from accessible survival values, the procedure is outlined here. Correction: shifting of one determined LQ
parameters if the other is smaller than 0. Also other comments are given in this column. For spread out Bragg peaks, the quantities LET and kLETDl refer to track and dose averaged
LET values, respectively.
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some rare cases different quantities such as RBE values or
cross sections were given either numerically or in figures.
If LQ parameters were published as numbers they were
simply copied into the PIDE. If other quantities were given
as numbers, the corresponding LQ parameters were calcu-
lated. In some cases, one of the LQ parameters was
reported or obtained with a negative value, which may
occur due to either statistical fluctuations or systematic
deviations from LQ behaviour. Then a purely linear or
purely quadratic dose response (i.e. shifted β or α to zero)
was assumed and the remaining LQ parameter was corres-
pondingly shifted according to the formalism presented in
the next section on the fit-induced anti-correlation between
α and β. This formalism quantifies how a shift in one par-
ameter approximately compensates for setting the other arti-
ficially to zero.
If no numerical values for the LQ parameters were pre-
sented but instead only the survival curves figures, the LQ
parameters were derived from the graphs. For that purpose
a computer program was developed and used to digitize the
data points in the figures. Then the LQ parameters were
been determined by fitting a second order polynomial with
an ordinary χ2 fit to the effect, i.e. the negative logarithm
of the survival. We are aware that there are more sophisti-
cated methods to derive LQ parameters from a measured
survival curve, which take into account the correlation of
the fit parameters by means of their covariance. However,
as these methods are rarely used and the resulting fit para-
meters do not differ too much, we applied the conventional
fit procedure, in line with most of the publications that
provide numerical values for LQ parameters. If by visual
inspection the quadratic coefficient β could not be reliably
determined by curve fitting (e.g. when there were only a
few data points and the errors of the fit parameters were
large) only a straight line fit was performed and β was set
to zero. Similarly, if an LQ fit yielded one negative fit par-
ameter, a purely linear or purely quadratic fit was used,
which is analogous to the shifting of parameters as
described above, when numerical values are given in the
publications.
Cell cycle
If no statements were made it was assumed that the cells
were irradiated as an asynchronous population.
Fit induced anti-correlation of LQ parameters
In the following section the anti-correlation of LQ para-
meters due to the fit procedure shall be investigated.
Consider an LQ dose–response curve with non-vanishing
coefficients α and β. If α is set artificially to zero one can
ask how β must be changed to get an appropriate quadratic
fit. Likewise, if β is set artificially to zero one can ask how
α must be changed to get an appropriate linear fit.
Mathematically, this question can be answered to a good
approximation analytically. We assume that all dose points
are continuously distributed and introduce a generalized χ2
value on continuous functions. Let f1 and f2 be two func-
tions, so the well known sum of least squares converts into
Table 2. Required information for each experiment in the PIDE
Quality Content
ID Running number labeling the publication
Paper Short name of the publication, containing first author and year of publication
No Running number labeling the entry within a publication
Ion Ion species
Charge Charge of ions
Irrmods Irradiation modalities (monoenergetic or spread out Bragg peak)
LET Linear energy transfer in water (in keV/µm, for irradiation in spread out Bragg peak dose mean or track averaged LET)
E Specific energy of ions (in MeV/u, evaluated at the target)
Cell Name of cell line
Phase Information on cell cycle phase
Type Tumor or normal cells
Genl Genomic length of diploid cells (in 109 bp, 5.6 for rodent and 6 for human cells)
αX Linear coefficient of LQ model (in Gy
−1 for response to photon reference radiation)
βX Quadratic coefficient of LQ model (in Gy
−2 for response to photon reference radiation)
αI Linear coefficient of LQ model (in Gy
−1 for response to ion radiation)
βI Quadratic coefficient of LQ model (in Gy
−2 for response to ion radiation)
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an integral over least squares in the continuous formulation:
x2 ¼
ð
f1ðxÞ  f2ðxÞ½ 2dx ð1Þ
The integral has to be evaluated over some interval, and the
χ2 value is then a distance measure for two functions on
that interval.
For approximating an LQ curve with a purely quadratic
one we have to evaluate:
x2 ¼ 1
Dmax
ðDmax
0
aDþ bD2  b0D2  2dD ð2Þ
where β′ is the shifted β parameter used to replace the ori-
ginal LQ parameters α and β. In Eq. (2) Dmax is the dose
up to which the survival curve was recorded and is typical-
ly in the order of 5–10 Gy for experiments with photons
and 3–7 Gy for ions.
Setting the derivative of χ2 with respect to β’ to zero and
solving for β′ results in:
Db ¼ b0  b ¼ 5
4
a
Dmax
ð3Þ
Consequently, if α <0 we may lower the β term by means
of that expression to compensate for α and thus get an esti-
mator for the best purely quadratic fit.
In the opposite case where a purely linear fit is requested
the corresponding equation reads:
Da ¼ a0  a ¼ 3
4
bDmax ð4Þ
Again, if β <0, which may happen ‘by accident’ when, for
example, only a small number of dose points are available
in an experiment, we may lower α by means of that expres-
sion to compensate for β and thus get an estimator for the
best purely linear fit. Equations (3) and (4) were used to
correct the LQ parameters in the PIDE if one of the para-
meters was given numerically as a negative value in the
publications. The publications for which this procedure was
applied were marked with ‘corrected’ in Table 1.
RESULTS
Photon dose response
To obtain an overview about the variety of cell lines
forming the basis of the PIDE, we first looked at their
photon response. Note that here with the term ‘cell line’,
we understand not only the classification by name (such as
V79) but also their sensitivity to radiation, as cell lines
with the same name might show a different behaviour de-
pendent on their history. Figure 1 shows frequency histo-
grams of α and β among all cell lines included in the
PIDE. While α shows a peak at relatively small values with
a wide falloff beyond, the distribution of β is not so skewed
and peaked at intermediate values. In addition the histo-
gram of β shows a pronounced first bin, which reflects the
fact that several cell lines show a purely linear response to
photon radiation. Typically, α is found in the range 0.05–
0.5 Gy−1 and β in the range 0.01–0.07 Gy−2. The mean
values are < α > = 0.32 Gy−1 and < β > = 0.039 Gy−2, while
the medians are αm = 0.20 Gy
−1 and βm = 0.033 Gy
−2.
Here, the brackets < . > denote averaged quantities. However,
these quantities have to be taken with care, as the underlying
distributions are non-symmetric and therefore the means and
medians do not reflect the most likely values of the LQ para-
meters, i.e. the maxima of the presented histograms.
For clinical applications, often the ratio α/β of the photon
LQ parameters is of interest and is used to classify the
tissue type. In Fig. 2 the histogram of this quantity is
shown. Clearly, the typical spectrum of α/β up to 10 Gy is
covered quite uniformly in the PIDE. Values beyond occur
less often. However, there are also 18 cases where β is zero
and hence the α/β ratio diverges.
Fig. 1. Histograms of the linear-quadratic parameters α (left) and β (right) for photon dose response curves of the cell lines of the
experiments included in the PIDE.
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In order to investigate the interdependence of the LQ
parameters, Fig. 3 displays the quadratic LQ parameter β
plotted against the linear parameter α. As a trend, survival
curves with a very prominent β term typically are found for
small α values. Likewise, very large values of α occur
mostly at rather small values of β. In particular the cell
lines without a β component have a steep exponential sur-
vival curve, i.e. show a large α. This trend suggests the ex-
istence of a small anti-correlation between the LQ
parameters. Indeed, a linear regression reveals a negative
slope of (–0.0204 ± 0.0056) Gy−1, where the uncertainty is
given by the standard error of the fit parameters. Figure 3
contains the corresponding linear regression line. The fit
parameter errors make up a 68% confidence interval, but
even the corresponding 95% confidence interval only
covers negative slopes (from –0.0314 to –0.0093), thus in-
dicating significance to that confidence level. As a further
check, we performed a hypothesis test on the correlation
coefficient between α and β. The coefficient is r = –0.262
and the P-value is P = 0.0002, which shows that it signifi-
cantly differs from zero on a 95% confidence level.
Dose response to ion irradiation
In addition to the quantities that play a role for photon ir-
radiation, the LET is another factor to take into account for
particle irradiation. All the following analysis has been per-
formed using information from experiments with monoe-
nergetic beams only, to avoid peculiarities due to broad
LET distributions as present in extended Bragg peaks.
Cell type specificity of RBE
For the investigation of ion dose responses in the PIDE, we
calculated RBE values from the LQ parameters. Note that
these may deviate from directly measured RBE values (i.e.
the ratio of doses needed for a fixed effect), in particular
for higher doses where it is under discussion as to whether
the LQ model is valid any more [15, 16]. To investigate the
impact of LET on radio-sensitivity we show the RBE
plotted against LET for different particle species in Fig. 4.
We restricted the analysis to the RBEα and RBE10 corre-
sponding to the initial slope (upper row) and 10% survival
level (lower row), respectively. All cells were classified into
two classes of low and high photon α/β ratios with values
below or above 4 Gy, respectively (left and right columns,
respectively). The latter distinction is somewhat arbitrary,
and pooling the data in classes of intervals of α/β is a ques-
tionable procedure, as RBE generally depends on this quan-
tity. However, as the scatter of the RBE values even for
small intervals of α/β is quite large, categorizing into two
classes is appropriate at least for demonstrating the depend-
ence on α/β in a plot. Below, this dependence is investi-
gated in more detail. For individual cell lines, systematics
of this kind have been frequently evaluated [29, 30]. It was
found that (i) the characteristics provide a maximum in
RBE dependent on the particle species, where heavier parti-
cles have the maximum at higher LET values; (ii) that
lighter particles provide higher RBEs for a fixed LET; and
(iii) that the RBE decreases with increasing dose, i.e. with
decreasing survival level. All findings are confirmed with
the PIDE. While these trends might not be detectable due
to fluctuations when only a few survival curves are consid-
ered, they are clearly observed in the present data
ensemble.
LET dependence of β
There is an on-going discussion about the evolution of the
β-term with increasing LET [101], debating whether β
increases or decreases with rising LET. The ratio β/βγ,
where βγ denotes the value of β for photon radiation, is an
interesting quantity to look at because, at low LET where
the radiation becomes photon like, this ratio converts to
one. In Fig. 5 this ratio is plotted against LET for
Fig. 2. Histogram of the ratio α/β for photon dose–response
curves of the cell lines used in experiments included in the PIDE.
Fig. 3. Photon linear-quadratic parameters of the cell lines of the
experiments included in the PIDE plotted against each other.
Higher values of β occur for small values of α only. The straight
line emerges from a linear fit to the data points.
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monoenergetic ions. The figure includes different ion
species with the same colour coding as in Fig. 4.
The data shown are pooled for all photon α/β ratios, and
it was checked that in contrast to the α term β depends
only slightly on α/β. For intermediate and high LET values
many data show a vanishing β term. For all ions a running
average curve is also provided in the plot. It was calculated
by summing contributions from all data points with a
Gaussian weighting, i.e. for a given LET the running
average is mostly determined by data points close to that
LET (on the logarithmic scale), while data points further
away have a smaller impact on the running average. The
general trend, an increase at low LETs followed by a de-
crease at higher LETs, is obvious and is seen for all ion
species except for protons, where the initial increase is
not that obvious. Similar to the RBE maximum, the
falloff for β is shifted to higher LET values for heavier
ions. However, it should be noted that the fluctuations
of the data points around these average curves are huge,
as usually β is much harder to fix in a fit procedure
than α.
Relevance of dose level and α/β ratio for RBE
In Fig. 6 we show RBE values for monoenergetic carbon
ions within an LET window of 70–130 keV/µm. This range
of LETs is typically found in a spread out Bragg peak, and
the results may be henceforth regarded to be representative.
The RBE for the initial slope (often referred to as RBEα)
and 10% survival level (RBE10) are plotted vs. the inverse
α/β ratio, i.e. β/α. This way of plotting [102] is motivated,
Fig. 4. RBE for monoenergetic ion beams in the limit of full survival level (upper row) and 10% survival level (lower
row) vs. LET for experiments with shouldered (left column, α/β = 1–4 Gy) and less shouldered (right column, α/β = 4–30
Gy) photon dose–response curves. The colors refer to different ion species (p: red; He: blue; C: gray; Ne: orange; heavier
ions than Ne: green). Note the different scales of RBE in the upper and lower row. Clearly, lighter particles show a
maximum at lower LETs and have higher RBE values for a given LET.
Fig. 5. Ratio of the linear-quadratic parameter β of ions to that
of photons vs. LET for monoenergetic ions for different ion
species with color coding as in Fig. 4. The solid lines are running
averages generated by a convolution of the data points with a
Gaussian function of width of 0.1 in the decadic logarithmic scale
of LET values in keV/µm (i.e. a tenth of the interval between 10
and 100 keV/µm, see the black horizontal bar for an indication of
that width). Lighter particles show a vanishing β at lower LET.
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as the dependence of RBE on that quantity is consistent
with a linear relationship, as can be shown by a signifi-
cance analysis. Note that for large values of β/α the corre-
sponding α/β ratio as used in Fig. 4 will be small. Again,
in order to keep errors reasonably small, α/β values from
1–30 Gy have been taken into account for analysis. Data
outside this interval have been excluded because the asso-
ciated errors for α and/or β are enormous and the RBE
values might not be sufficiently reliable. Interestingly,
while for small doses the RBE increases with β/α, we find
a slight decrease for doses corresponding to 10% survival.
The slope for the fit to RBEα is (5.1 ± 1.6) Gy and for
RBE10 (–0.96 ± 0.52) Gy, where the errors are the standard
error of the fit parameter.
Model validation
One goal of the set up of the database was to establish sys-
tematic comparisons of biophysical models for the RBE
with experimental data. As a start we present here a first
comparison of the RBE dependence on tissue type as seen
in experiments and as predicted by the LEM. The simula-
tions have been carried out with the most recent version of
the LEM [103, 104], in which the calculation of the effect
is based on the spatial distribution of double strand breaks
of the DNA. All relevant parameters describing the
amorphous track structure of the ions and the size of the
damage sites have been chosen as in Friedrich et al. [104].
For all cells, an average nuclear radius of 5 µm has been
assumed, which is a reasonable first order estimate. In Fig.
7 the same data points as in Fig. 6 are shown, along with
LEM simulations for three different LETs where the photon
parameter β = 0.03 Gy−2 has been fixed while α varies. The
restriction of β is an important issue: it is artificial and, and
β has been chosen as close to the median value (0.033
Gy−2) of all cell lines in the PIDE. We must state here that
fixing β is an approach only for revealing trends of the
RBE from simulations with the LEM. A more thorough ap-
proach for the calculation of individual RBEs should take
into account the LET and the photon parameters separately
for each experiment, i.e. individual simulations would be
performed with the specific LQ parameters α and β. Here,
however, we can not expect the simulation to reflect the
RBE of each individual cell line with high exactitude, but
rather we have obtained an estimate for the behaviour of
the ensemble of cell lines. The threshold dose Dt above
which the LQ model was assumed to enter into a linear
dose response [10] was chosen as Dt = 4 Gy + 1.1 α/β. The
latter relationship has been found empirically to match
survival data with LEM simulations. An increase in Dt with
α/β has also been suggested in a study by Astrahan [105]
based on experimental motivation. The LEM clearly
reveals the general systematics, i.e. the increase (decrease)
of the RBE with β/α for high (low) survival levels.
Moreover, for 10% survival LEM predicts a small
maximum at β/α = 0.1 Gy−1, which, however, is neither in
contrast with nor reflected significantly by the data.
Regarding the evolution of the β term presented above,
we compared the prediction of several RBE models with an
individual data set, where no cell line-dependent fluctua-
tions of β are expected. Figure 8 shows the ratio β/βγ for
HSG and V79 cells irradiated with carbon ions as measured
by Furusawa et al. [30]. Again it becomes evident that for
lower LET values the ratio exceeds one, while it finally
decreases to zero. We indicated in the figure model predic-
tions of the LEM, the repair–misrepair–fixation (RMF)
model [106] as published recently by Frese et al. [107], and
the microdosimetric kinetic model (MKM). Interestingly,
none of the models is able to correctly reproduce the
experimental findings. The LEM reveals a monotonically
Fig. 6. RBEα derived from the initial slope of survival curves
(blue) and RBE10 for 10% survival (red) for experiments with
monoenergetic carbon ions in the LET range 70–130 keV/µm vs
the inverse of the photon LQ parameter ratio α/β. While for low
doses the RBE increases with β/α, a decrease is observed for high
doses. The data shown are restricted to α/β = 1–30 Gy. The solid
lines are linear fits to the data points.
Fig. 7. Data as in Fig. 6 along with simulations of the LEM for
LETs of 70, 100 and 130 keV/µm (dashed, solid and dotted lines,
respectively, see text for details.
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decreasing characteristic with increasing LET, while the
RMF predicts a continuously increasing β term. The MKM
predicts no changes in β/βγ. Consequently for lower LET
the LEM underestimates β, and for high LET the RMF fails
to reproduce the transition to a vanishing β. The MKM
suffers from both shortcomings but reveals good predictions
in the intermediate LET regime. Using the PIDE model,
comparisons with larger sets of data can be carried out
easily and it is a useful tool to exploit the limits of RBE
models.
DISCUSSION
As the PIDE comprises a large set of experiments, one may
suspect that the variety of α and β values for photon dose
responses is representative for all mammalian cell lines.
Before discussing the properties of the particle dose–re-
sponse curves, we first concentrate here on the photon
properties.
Photon dose response
From Fig. 1 it is evident that both LQ parameters have a
peaked distribution. However, despite the peak for very
small or vanishing β, the distribution of β values is less
skewed and more peaked at intermediate values, compared
with the distribution of α. Consequently, the variation in
the radio-sensitivity observed in cell lines is most likely
due to the variability of α. Taking the average <β> as a rep-
resentative quadratic parameter may be misleading, as can
be seen by regarding the α/β ratio: as here β occurs in the
denominator, small β values lead to large ratios as can be
seen in Fig. 2. Applying <β> instead will result in artificially
smaller α/β ratios, see Friedrich et al. [108] for details.
The large first bin of the distribution of β values is
mainly reflecting the fact that many publications are con-
cerned with repair-deficient cell lines. These cells lack the
capability for repair of DNA lesions and show a linear or
an almost linear dose response to low LET radiation. While
this peak in the distribution seems to be non-generic
because of the specific selection of cell lines, we believe
the gross part of the distribution to be representative for
cultured mammalian cells in general. This statement is a
conjecture. However, if it holds, then the distributions
shown in Fig. 1 can be used to define typical LQ parameter
values for cultured cells as well as the corresponding
typical intervals LQ parameters cover.
Fig. 3 suggests an anti-correlation between the LQ para-
meters α and β. Besides a simple expansion in powers of
the dose there are several mechanistic interpretations of the
LQ model in the literature [109], which give meaning to
these parameters. Similarly, the LQ model emerges as a
low dose approximation of many other survival models
[110]. From this point of view it is interesting to note that a
negative correlation observed in Fig. 3 would imply that
the linear and quadratic components of the LQ model
do not refer to totally independent processes. The
anti-correlation is significant as judged by the standard
error of the fit function. It is also observed in other data
sets of survival curves after photon irradiation [111, 112].
The reason for this anti-correlation is still unclear.
However, it can be excluded that the dependence between
α and β is because of the inherent anti-correlation induced
by the LQ least square fit procedure, where one parameter
accounts for the other, as this only applies to multiple sur-
vival curves taken from one and the same assay. For inde-
pendent survival curves no correlation is expected at all by
the fit procedure. We hence believe that this observation is
either because of the particular selection of cell lines
studied in the literature or because there is a biological
reason for the observed anti-correlation. If the latter was
true the question arises as to whether this finding will influ-
ence the mechanistic interpretation of survival models. One
possible explanation is a saturation of damage in organiza-
tional substructures of mega base pair size of the chroma-
tin. We discuss the considerations about such a mechanism
in a separate publication [113].
Dose response to ion irradiation
For the ion dose–response curves, the characteristics of
RBE vs. LET in Fig. 4 summarizes the findings from cell
survival studies during the last 50 years. Note that though
fluctuations in RBE are huge, a dependence of RBE on
particle species and α/β is clearly present. Having this in
Fig. 8. Ratio of the LQ parameter β of carbon ions to that of
photons vs. LET for two individual cell lines, V79 cells (red) and
HSG cells (green), as measured by Furusawa et al. [30]. As in
Fig. 5 the thick lines are obtained as a running average of the data
points. The dashed, dotted and dashed–dotted lines show model
predictions of the RMF (reproduced from [107] model, the LEM
and the MKM, respectively. The photon parameters used for the
LEM calculations are α = 0.184 Gy−1, β = 0.02 Gy−2 and the
threshold dose [10, 105] Dt = 17 Gy for V79 cells and α = 0.313
Gy−1, β = 0.0615 Gy−2 and Dt = 7.5 Gy for HSG cells.
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mind we regard our work as an extension to the plots pre-
sented in Ando and Kase [114] where the RBE was pre-
sented as a function of LET only.
As a consequence, when modeling the RBE for therapy,
its dependence on particle species and the α/β ratio has to
be respected. These findings do not support the conclusions
drawn in Sørensen et al. [115], where a collection of sur-
vival data is also considered and the authors conclude that
the dependence of RBE on the particle species and the cell
type is small and might be neglected for a 10% survival
level. However, although a considerable scatter of the indi-
vidual data points around a hypothetic ‘best fit’ curve is
observed, the average RBE10 of helium ions (blue data
points) turns out to exceed the one for neon ions (orange
data points) for a given LET by a factor of almost two, and
the maxima of RBE–LET relationships are shifted to higher
LETs for heavier particles. This clearly proves that a reduc-
tion to taking the LET as the only predictor for RBE is an
oversimplification of the picture. Even if one respects that
the scatter of data points is large, the necessity to discrimin-
ate not only by LET but also by particle species and α/β
ratios holds for therapy applications, where the RBE is
desired to be known to an accuracy level of about 10% to
keep the variations in tumor control reasonably low.
Nevertheless the observed scatter of the data for the same
particles and comparable α/β ratio corresponds to an uncer-
tainty in RBE. This is also an important issue for the as-
sessment of treatment plans, where the data ensemble
might help to estimate the uncertainty of RBE values.
In the literature, the behavior of the LQ parameter β with
varying LET is still unclear. For neutron radiation, whose
radiation response is believed to be mediated by protons as
secondary particles, there are indications for an increase of
β with LET [116]. Other authors do not find such obvious
systematics [30]. Using the data from PIDE presented in
Fig. 5 an initial increase of β for low LET is suggested
(except for protons), followed by a clear rapid falloff at
higher LETs. Facing these partially contradictory statements
one has to keep in mind that the extracted values for β are
the result of a fit and therefore subject to fit errors. For in-
stance, if a survival curve consists of a small number of
dose points or an inappropriate fit interval is used, it is
hardly feasible to obtain a β term with good accuracy.
Currently no error analysis has been carried out with the
PIDE. It is on our agenda, and maybe the question of how
β varies with LET can be answered more clearly then. A
clarification on this point would again be of great interest
with respect to RBE models.
The trend curves in Fig. 5 show an increase in β with
LET followed by a rapid falloff down to zero. These fea-
tures might be understood qualitatively in a microscopic
picture: The enhanced radiation response with dose is due
to the track-to-track interaction (‘intertrack effect’) of differ-
ent ions passing through a cell nucleus. This means that the
β term for particle radiation emerges as a consequence of
overlapping particle tracks. For high energy particles the
track diameter is largest, while the local doses are rather
low. When lowering the energy and thereby raising the
LET, two competing processes occur: first, the inhomogen-
eity of the microscopic dose distribution increases, as the
track radii get smaller and the energy lost by the passing
particle is distributed within a smaller volume, and more-
over this amount of lost energy is larger due to the
increased LET. Hence the number of induced lesions
within a particle track is enhanced, and thereby potentially
also the rates of lesions emerging from track to track inter-
action are enhanced. However, on the other hand there is a
second, competing process, as due to the smaller track radii
the geometrical probability for tracks to overlap gets
smaller. Moreover, due to the higher LET, for a given dose
the overall fluence is smaller, again leading to a mitigation
of overlapping of different ion tracks. For light particles
and not-too-high LET the first process is more important,
while for heavier particles and/or higher LETs the second
one dominates the picture. Consequently, β rises first and
then decreases with rising LET. At even larger LET values
where one ion passing through a cell nucleus is sufficient
to ‘overkill’ the cell, i.e. more energy than needed for cell
death is deposited, there is a further argument that no β
term occurs: even if tracks overlap, the consequence in
terms of cell death will be just the same and no additional
effect is expected, because any hit causes cell death. The
same characteristics are also seen in individual cell lines, as
demonstrated in Fig. 8, which is supportive of the interpret-
ation given above.
An interesting feature in the ion dose–response curves is
the increasing or decreasing course of RBE with β/α, de-
pending on the survival level. This behavior is significant.
In Fig. 6 it can be seen that for high doses (at 10% sur-
vival) where a negative slope is observed in the fit line, ion
irradiation to cells with a high α/β ratio, often labeled as
radio-sensitive (with respect to photon irradiation), is more
effective than to cells with a small α/β ratio, which are
usually labeled as radio-resistant. This is counterintuitive
and we do not have an explanation for this finding yet.
For clinical applications this observation suggests two
implications, provided these findings are still valid for
tissues just as for cell survival assays: first, tissues with a
high α/β ratio provide larger RBEs for sufficient high doses
compared with tissues with smaller α/β ratios. Due to that,
patients with tumors with high α/β ratios surrounded by
normal tissues with smaller α/β ratios will benefit more
from hypofractionated regimens than from normal fraction-
ation schemes. This feature would constitute an additional
rationale for carbon ion therapy for these tumor entities. A
potential biological benefit of a small fraction number was
also demonstrated with in vivo experiments [116]. On the
other hand, if tumors with a low α/β ratio are embedded in
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normal tissues with high α/β ratios, hypofractionation
would be less advantageous. Second, at intermediate doses
there is a survival range (~0.5–0.8) where RBE values are
rather insensitive to the tissue type, i.e. to the α/β ratio.
One may question the impact of these findings for biologic-
al treatment planning, but obviously in the entrance, where
low doses are desired, RBE has to be taken into account as
a tissue-dependent quantity.
In Fig. 7 we also present the first steps of the comparison
of the experimental data in the PIDE with the LEM. Note
that this comparison is carried out on a very basic level
here, as the simulations have been carried out for a unique
β term, while the exact properties of the individual experi-
ments have been neglected. A ‘point by point’ simulation
is an additional open task, where we hope to further eluci-
date the potential and limits of the LEM. Besides that, it is
impressive to see that a less detailed simulation is capable
of reproducing the increase and decrease in RBE with β/α
for high and low survival levels, respectively, with reason-
able accuracy. Moreover, if the peak predicted by the LEM
simulations for the 10% survival level reflects reality
(which cannot be assessed based on the available data),
there will be a maximum RBE corresponding to α/β ≈ 10
Gy. Again questioning the meaning for clinical application
the existence of such a peak would suggest that carbon ion
therapy for tumors with that α/β ratio is particularly useful
when applied as a hypofractionated regimen.
While the LEM is based on the considerations within the
formalism of amorphous track structure and predicts a vari-
ation of β with LET [10], the MKM [12, 13] assumes a
fixed β value for all LET. A ‘saturation correction’ at very
high LET in the ‘overkill effect’ is taken into account in
both models, but acts only on the α term in the MKM,
leaving β constant even at high LET values. As can be seen
in Fig. 8 the LEM does reveal a sudden decrease of the β
term and even predicts the correct ordering, i.e. for HSG
cells the falloff takes place at lower LET compared with
V79 cells. While the ordering is correct, the absolute LET
values for the decrease in β are not predicted correctly.
Furthermore, the β term is underestimated for the lower to
intermediate LET range. For obtaining the simulation
results shown, we used an economic LEM algorithm, deriv-
ing the properties of the cell line after ion irradiation from
the action of single hits [10]. A full Monte Carlo simulation
of the damage induction processes involved in the LEM
helps to partially overcome these shortcomings, allowing
also a small initial increase of β/βγ [104]. We plan to
discuss this improvement in more detail in a separate publi-
cation. The RMF model (in combination with a Monte
Carlo model for simulating aspects of track structure) pre-
dicts continuously increasing characteristics, which does
not seem to be dependent on the cell line. In particular for
the high LET regime this leads to a large overestimate of
the β values. Possible reasons are discussed by the founders
of the model [106]. To summarize, none of the models is
able to predict the characteristics of the β term in full cor-
respondence with the data, justifying the ongoing concen-
trated development in RBE models. However, in the
context of the focus of this paper it becomes clear that data-
bases generally are a powerful tool for model testing. As
has been shown here the PIDE can be used conveniently to
exploit the limits of RBE-predicting models. Likewise, the
fluctuations in RBE observed in the database give insight
into the accuracy level one can expect when applying RBE
models to individual survival experiments [104].
Finally, from the discussed examples it becomes clear
that the database is a powerful tool for revealing systematic
properties of quantities relevant in radiobiology and therapy
that may be hard to detect when reviewing a limited
number of experiments only. We propose the PIDE as a
standard data collection to benchmark RBE models and
suggest that it is also suitable for comparing different
models. From the PIDE one also can identify biological
and/or physical parameters for which not so much experi-
mental information has been available up to now and con-
sequently further experimental work would be desirable,
such as for Li, Be and B ions or for higher α/β values. We
plan to share the content of the PIDE with the community
and put the data on the research section (modelling group)
of the website of the GSI biophysics department, where
they can be downloaded after contacting the authors to
obtain access. In the future we plan to maintain the PIDE
continuously by inputting more data. For that reason, we
invite the researchers in the field to make us aware of any
suitable dataset that is missing in the PIDE.
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